Abstract is: The World Journal of Urology is a peer-reviewed scientific journal of urology published by Springer in collaboration with the (SIU). It is the official journal of both the Société Internationale d'Urologie and of the . The journal was established in April 1983 and is published on an monthly basis. Martin Burchardt is the editor-in-chief since January 2008. The second editor-in-chief is Alexandre de la Taille.
scientific journal | Q5633421 |
hybrid open access journal | Q5953270 |
medical journal | Q16024164 |
P6981 | ACNP journal ID | 15242 |
2342872 | ||
P1159 | CODEN | WJURDJ |
P8375 | Crossref journal ID | 998 |
P1250 | Danish Bibliometric Research Indicator (BFI) SNO/CNO | 10621 |
P1058 | ERA Journal ID | 16952 |
P2671 | Google Knowledge Graph ID | /g/11bbqp8p36 |
P236 | ISSN | 0724-4983 |
1433-8726 | ||
P7363 | ISSN-L | 0724-4983 |
P1277 | JUFO ID | 69229 |
P1055 | NLM Unique ID | 8307716 |
P856 | official website | http://link.springer-ny.com/link/service/journals/00345/index.htm |
http://link.springer.com/journal/345 | ||
http://link.springer.de/link/service/journals/00345/index.htm | ||
P10283 | OpenAlex ID | S49004918 |
P3181 | OpenCitations bibliographic resource ID | 946 |
P8104 | Paperity journal ID | 26433 |
P7461 | Publons journals/conferences ID | 3156 |
P7662 | Scilit journal ID | 484524 |
P1156 | Scopus source ID | 20577 |
P5983 | Springer journal ID | 345 |
P4616 | UniProt journal ID | 4343 |
P495 | country of origin | United States of America | Q30 |
Germany | Q183 | ||
P1240 | Danish Bibliometric Research Indicator level | 1 | |
P571 | inception | 1983-01-01 | |
P8875 | indexed in bibliographic review | Science Citation Index Expanded | Q104047209 |
Scopus | Q371467 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | urology | Q105650 |
P123 | publisher | Springer Science+Business Media | Q176916 |
P1476 | title | World Journal of Urology |
Q36374556 | "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP). |
Q57175114 | "Three horse shoe-like incision" holmium laser enucleation of the prostate: first experience with a novel en bloc technique for anatomic transurethral prostatectomy |
Q91413039 | 'En Bloc' HoLEP with early apical release in men with benign prostatic hyperplasia |
Q46568884 | 'Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS). |
Q38627292 | 'Real-life experience': recurrence rate at 3 years with Hexvix(®) photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC-a prospective controlled study |
Q100468910 | 'Seven-step two-lobe' HoLEP: a modification to gain efficiency of the enucleation applying relatively low-power holmium laser devices |
Q53018341 | (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy. |
Q46780712 | (99m)Tc-HDP bone scintigraphy and (18)F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer. |
Q46322291 | 17Beta-estradiol affects the proliferation and apoptosis of rat bladder neck smooth muscle cells by modulating cell cycle transition and related proteins |
Q39421983 | 1999 rerun of the 1996 German Urinary Incontinence Survey: will doctors ever ask? |
Q91264177 | 3-dimensional ultrasound-guided percutaneous nephrolithotomy: total free versus partial fluoroscopy |
Q53161715 | 33% radius evaluation to assess bone mineral density in prostate cancer patients. |
Q40022276 | 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection |
Q92915498 | 3D imaging applications for robotic urologic surgery: an ESUT YAUWP review |
Q91063199 | 3D printing technology and its role in urological training |
Q92408285 | 3D printing technology in percutaneous nephrolithotomy: babyhood but will be promising |
Q89901859 | 68Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy |
Q92692222 | 68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study |
Q92063968 | 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy |
Q91170757 | 68Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer |
Q48222301 | 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review. |
Q40508734 | 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study |
Q48351157 | A 12-year follow-up of ANNA/C-TRUS image-targeted biopsies in patients suspicious for prostate cancer. |
Q46106785 | A 16-year clinical experience with intermittent androgen deprivation for prostate cancer: oncological results |
Q48031584 | A 2-year follow-up of quality of life, pain, and psychosocial factors in patients with chronic prostatitis/chronic pelvic pain syndrome and their spouses |
Q39387342 | A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancer. |
Q40386540 | A brief review of ultrasensitive prostate-specific antigen assays for the evaluation of patients after radical prostatectomy |
Q84382500 | A call to action: the compelling need to advance the role of urgency |
Q99602897 | A clinical experience of thulium fibre laser in miniperc to dust with suction: a new horizon |
Q45250754 | A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients |
Q40540620 | A clinical view of pressure-flow studies |
Q47599400 | A collagen matrix derived from bladder can be used to engineer smooth muscle tissue |
Q87858711 | A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center |
Q85524477 | A comparative study of the use of a transverse preputial island flap (the Duckett technique) to treat primary and secondary hypospadias in older Chinese patients with severe chordee |
Q47327743 | A comparison between an in vitro ureteroscopic stone size estimation and the stone size measurement with the help of a scale on stone baskets. |
Q40311748 | A comparison between laparoscopic and retroperitoneoscopic approach for partial nephrectomy in children with duplex kidney: a multicentric survey |
Q97555085 | A comparison of flow rate curve shape and video-urodynamic findings in women with lower urinary tract symptoms: can flow rate curve shape predict female bladder outflow obstruction or detrusor underactivity? |
Q45928075 | A comparison of prostate cancer detection rates by 12 or 6 core biopsy at different prostate-specific antigen densities in Korean men. |
Q36679092 | A comparison of transurethral prostatectomy with visual laser ablation of the prostate using the Urolase right-angle fiber for the treatment of BPH. |
Q35043202 | A complementary approach to urolithiasis prevention |
Q57063458 | A comprehensive analysis of cost of an active surveillance cohort compared to radical prostatectomy as primary treatment for prostate cancer |
Q52332628 | A contemporary lower pole approach for complete staghorn calculi: outcomes and efficacy. |
Q101240134 | A cover flap reduces the rate of fistula after urethroplasty whatever the severity of hypospadias |
Q93143783 | A critical appraisal of biomarkers in prostate cancer |
Q48044115 | A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial |
Q92009658 | A critical outcome analysis of Asopa single-stage dorsal inlay substitution urethroplasty for penile urethral stricture |
Q39085013 | A double-blind, placebo-controlled randomized clinical trial to evaluate the efficacy of tranexamic acid in irrigant solution on blood loss during percutaneous nephrolithotomy: a pilot study from tertiary care center of North India |
Q42688885 | A finite element model validates an external mechanism for opening the urethral tube prior to micturition in the female |
Q78033755 | A historian is a prophet in reverse |
Q50793884 | A learning curve assessment of real-time sonoelastography of the prostate. |
Q50712396 | A model for assuring clamping success during laparoscopic partial nephrectomy with segmental renal artery clamping. |
Q72017500 | A model for the function of glycosaminoglycans in the urinary tract |
Q47599391 | A modified approach for feminizing genitoplasty. |
Q92452124 | A modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease results in reduced procedural morbidity using a standardized hematoma classification rubric |
Q83188926 | A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging |
Q99566437 | A multi-institutional critical assessment of dorsal onlay urethroplasty for post-radiation urethral stenosis |
Q91083761 | A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy |
Q31004954 | A national benchmark for the initial assessment of men with LUTS: data from the 2010 Royal College of Physicians National Audit of Continence Care |
Q91172254 | A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer |
Q44615912 | A new and automated method for objective analysis of detrusor rhythm during the filling phase |
Q51023679 | A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder. |
Q74782516 | A new approach in hypospadias repair |
Q71951434 | A new approach to the closure of cloacal exstrophy |
Q91324979 | A new checklist method enhances treatment compliance and response of behavioural therapy for primary monosymptomatic nocturnal enuresis: a prospective randomised controlled trial |
Q33973411 | A new oral testosterone undecanoate formulation |
Q128506763 | A new perspective on the treatment of upper ureteric stones |
Q88766163 | A new prognostic model for localized renal cell carcinoma |
Q51412251 | A new technique combining both polypropylene and vaginal wall sling procedures: can it minimize the risk of urethral and vaginal erosion occurring with synthetic materials? |
Q52686554 | A new treatment of female stress urinary incontinence with vaginal antetheca-retropubic space mesh repair surgery: a clinical trial. |
Q91711967 | A new urethral catheterisation device (UCD) to manage difficult urethral catheterisation |
Q90601339 | A newly developed porcine training model for transurethral piecemeal and en bloc resection of bladder tumour |
Q30981992 | A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy |
Q94497401 | A non-diploid DNA status is linked to poor prognosis in renal cell cancer |
Q44929065 | A novel "intuitive" surgical technique for right robot-assisted retroperitoneal lymph node dissection for stage I testicular NSGCT. |
Q53166537 | A novel approach for the surgical management of Peyronie's disease using an acellular, human dermis tissue graft: preliminary results. |
Q71675390 | A novel canine model of partial outlet obstruction secondary to prostatic hypertrophy |
Q77740454 | A novel method of surgical instruction: international telementoring |
Q47261920 | A novel vaporization-enucleation technique for benign prostate hyperplasia using 120-W HPS GreenLight™ laser: Seoul technique II in comparison with vaporization and previously reported modified vaporization-resection technique. |
Q82669515 | A novel videomicroscopic technique for studying rat ureteral peristalsis in vivo |
Q92807346 | A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients |
Q64959299 | A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model. |
Q44015387 | A population-based survey of lower urinary tract symptoms (LUTS) and symptom-specific bother: results from the Brazilian LUTS epidemiology study (BLUES). |
Q92053262 | A preliminary study on the role of Bacteroides fragilis in stent encrustation |
Q40706344 | A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients |
Q86622902 | A prospective comparative study of haemodynamic, electrolyte, and metabolic changes during percutaneous nephrolithotomy and minimally invasive percutaneous nephrolithotomy |
Q99419895 | A prospective comparative study of routine versus deferred pelvic drain placement after radical prostatectomy: impact on complications and opioid use |
Q42594642 | A prospective comparison of laparoscopic and robotic radical nephrectomy for T1-2N0M0 renal cell carcinoma |
Q91933318 | A prospective double-blind, randomized, placebo-controlled study to evaluate the efficacy of silodosin 8 mg as an on-demand, reversible, nonhormonal oral contraceptive for males: a pilot study |
Q100390849 | A prospective multicenter randomized comparison between Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP) |
Q50898144 | A prospective randomized comparative study on the use of ventral subcutaneous flap to prevent fistulas in the Snodgrass repair for distal hypospadias. |
Q48030297 | A prospective randomized comparison among SWL, PCNL and RIRS for lower calyceal stones less than 2 cm: a multicenter experience : A better understanding on the treatment options for lower pole stones |
Q50597378 | A prospective randomized comparison of micropercutaneous nephrolithotomy (Microperc) and retrograde intrarenal surgery (RIRS) for the management of lower pole kidney stones. |
Q48342930 | A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer. |
Q51521845 | A prospective randomized study comparing the four tract dilation methods of percutaneous nephrolithotomy. |
Q40883396 | A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. |
Q49937026 | A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient |
Q99419891 | A prospective, multi-center, open-label, single-arm phase 2b study of autologous adult live cultured buccal epithelial cells (AALBEC) in the treatment of bulbar urethral stricture |
Q38683123 | A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy |
Q95655525 | A quick stone component analysis matters in postoperative fever: a propensity score matching study of 1493 retrograde intrarenal surgery |
Q92318191 | A randomized controlled comparison between periprostatic nerve block and pelvic plexus block at the base and apex of 14-core prostate biopsies |
Q38402225 | A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms |
Q53681445 | A randomized controlled trial evaluating sildenafil citrate in relieving ureteral stent-related symptoms. |
Q40579713 | A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life |
Q34891734 | A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results |
Q48111725 | A randomized, prospective study of laparoendoscopic single-site plus one-port versus mini laparoscopic technique for live donor nephrectomy. |
Q39717326 | A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma |
Q38252737 | A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience |
Q37258361 | A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies |
Q92692233 | A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie's disease |
Q34364422 | A review of urologic cancer patients with multiple primary malignancies |
Q99210560 | A right colon pouch with a novel efferent channel concept: long-term results of the Turin pouch |
Q58614974 | A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease |
Q51840639 | A simple and reliable continent bladder stoma constructed from bladder wall. |
Q53994277 | A simplified technique for ureteroneocystostomy in renal transplantation. |
Q111896965 | A single center study that evaluates the preclinical use of a newly developed software and moving bed system to facilitate the spontaneous excretion of residual fragments after primary stone treatment (RIRS or PCNL) |
Q40115001 | A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance |
Q49719286 | A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA 'grey zone'. |
Q57800281 | A specific scoring system able to predict the efficacy of the therapy for bladder cancer: why not? |
Q84364571 | A study on comparative outcomes of percutaneous nephrolithotomy in prone, supine, and flank positions |
Q83971937 | A switch from GnRH agonist to GnRH antagonist in castration-resistant prostate cancer patients leads to a low response rate on PSA |
Q90600172 | A systematic review and meta-analysis of the safety and efficacy of endoscopic enucleation and non-enucleation procedures for benign prostatic enlargement |
Q91299502 | A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills? |
Q91413025 | A systematic review of the clinical significance of nephrostomy urine cultures |
Q33439263 | A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting |
Q38115706 | A systematic review of the treatment for female stress urinary incontinence by ACT® balloon placement (Uromedica, Irvine, CA, USA). |
Q95936741 | A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions |
Q96157370 | A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer |
Q97867830 | A temperature model for laser lithotripsy |
Q92785788 | A treatment strategy to help select patients who may not need secondary intervention to remove symptomatic ureteral stones after previous stenting |
Q100737617 | A uro-protective agent with restorative actions on urethral and striated muscle morphology |
Q98293983 | A-blockers for the management of lower urinary tract symptoms in patients with prostate cancer treated with external beam radiotherapy: a randomized controlled study |
Q39390992 | AR-Q640X, a model to study the effects of constitutively active C-terminally truncated AR variants in prostate cancer cells |
Q48099257 | AR-V7 predicting treatment response in metastasized prostate cancer: has it peaked? |
Q89251156 | Ablation energies for focal treatment of prostate cancer |
Q35029219 | Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study. |
Q71341511 | Abnormal ultrasonic pattern in contralateral testes in patients with unilateral testicular cancer |
Q93143796 | Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor |
Q71324657 | Absorbable stapling techniques in continent urinary diversion |
Q35896926 | Absorption of irrigation fluid during XPS™ GreenLight laser vaporization of the prostate: results from a prospective breath ethanol monitoring study. |
Q88361046 | Abstract SIU 2016 Buenos Aires, Argentina book |
Q57063451 | Abstracts from 38th Congress of the Société Internationale d'Urologie Seoul Dragon City, October 4-7, 2018 |
Q89690050 | Abstracts from the 37th Congress of the Société Internationale d'Urologie, Centro de Congressos de Lisboa, October 19-22, 2017 |
Q90761808 | Abstracts from the 39th Congress of the Société Internationale d'Urologie, Athens, Greece, October 17-20, 2019 |
Q93132923 | Accelerated Skills Acquisition Protocol (ASAP) in optimizing robotic surgical simulation training: a prospective randomized study |
Q50062164 | Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder |
Q40218177 | Accuracy in detecting and measuring residual fragments with the Uro Dyna-CT. |
Q53504232 | Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest. |
Q37946312 | Accuracy of concepts in female pelvic floor anatomy: facts and myths! |
Q91531901 | Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors |
Q53183600 | Accuracy of multi-detector computed tomography (MDCT) in staging of renal cell carcinoma (RCC): analysis of risk factors for mis-staging and its impact on surgical intervention. |
Q39590006 | Accuracy of preoperative endo-rectal coil magnetic resonance imaging in detecting clinical under-staging of localized prostate cancer |
Q83254417 | Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy |
Q88548776 | Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy |
Q92363318 | Accuracy of the preoperative PSA level for predicting clinically significant incidental transitional zone-prostate cancer before endoscopic enucleation of very large adenoma |
Q37731119 | Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer |
Q86644002 | Achievement of trifecta in minimally invasive partial nephrectomy correlates with functional preservation of operated kidney: a multi-institutional assessment using MAG3 renal scan |
Q97533625 | Achieving the "trifecta" with open versus minimally invasive partial nephrectomy |
Q35854186 | Acid-base and electrolyte disorders after urinary diversion |
Q40958221 | Activation of the androgen receptor by polypeptide growth factors and cellular regulators |
Q37243866 | Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way? |
Q90707295 | Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study |
Q48946859 | Active surveillance for incidental renal mass in the octogenarian |
Q37278137 | Active surveillance for prostate cancer: trials and tribulations |
Q90291482 | Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection |
Q46345992 | Acupuncture for overactive bladder in female adult: a randomized controlled trial |
Q48252506 | Acute and chronic interstitial cryotherapy of the adrenal as a treatment modality |
Q82375910 | Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract |
Q38225379 | Acute management of stones: when to treat or not to treat? |
Q33943092 | Ad5CMVp53 gene therapy for locally advanced prostate cancer--where do we stand? |
Q48080772 | AdVance and AdVance XP slings for the treatment of post-prostatectomy incontinence |
Q48915641 | AdVanceXP male sling: 2-year results of a multicentre study |
Q36012645 | Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study |
Q98303832 | Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study |
Q90246718 | Additional assessment of Acute Cystitis Symptom Score questionnaire for patient-reported outcome measure in female patients with acute uncomplicated cystitis: part II |
Q40415928 | Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomy |
Q94555923 | Additional surgical procedures and perioperative morbidity in post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer in two intermediate volume hospitals |
Q87239892 | Additional value of PCA3 density to predict initial prostate biopsy outcome |
Q71951436 | Adenocarcinoma of the rete testis |
Q43577616 | Adenovirus p16 gene therapy for prostate cancer |
Q58099607 | Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study |
Q37119880 | Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study |
Q91955854 | Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey |
Q46188383 | Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunction |
Q38923252 | Adipose-derived stem cells seeded on polyglycolic acid for the treatment of stress urinary incontinence |
Q41652764 | Adjustable continence therapy (ProACT™) after male sling failure for patients with post-radical prostatectomy urinary incontinence: a prospective study with one-year follow-up. |
Q40860545 | Adjuvant chemotherapy following radical cystectomy |
Q45975592 | Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience. |
Q89741695 | Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort |
Q34262367 | Adjuvant chemotherapy in stage I and stage II testicular cancer |
Q87091388 | Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer |
Q97877838 | Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent |
Q45788946 | Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccines |
Q35178078 | Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible? |
Q38072557 | Adrenal tumours are more predominant in females regardless of their histological subtype: a review |
Q33545990 | Adrenocortical carcinoma |
Q38120184 | Adult inguinoscrotal sarcomas: outcome analysis of 21 cases, systematic review of the literature and meta-analysis |
Q90736860 | Advanced Reconstruction of Vesicourethral Support (ARVUS) during robot-assisted radical prostatectomy: first independent evaluation and review of other factors influencing 1 year continence outcomes |
Q74662688 | Advanced bladder cancer...where are we now and where are we going? |
Q88912827 | Advanced non-contrasted computed tomography post-processing by CT-Calculometry (CT-CM) outperforms established predictors for the outcome of shock wave lithotripsy |
Q92041623 | Advanced ultrasound in the diagnosis of prostate cancer |
Q37879963 | Advances in non-surgical treatments for urinary tract infections in children |
Q79853340 | Advances in our understanding of the biology, new diagnostic approaches and recent treatment strategies for testicular germ cell cancer |
Q92887554 | Advances in robotic surgery for pediatric ureteropelvic junction obstruction and vesicoureteral reflux: history, present, and future |
Q33990433 | Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer. |
Q41685662 | Advances in the evaluation and treatment of the infertile man. |
Q34041739 | Advances in ureteral stent technology |
Q100478637 | Adverse effects of chronic nitrofurantoin therapy in women with recurrent urinary tract infections in an outpatient setting |
Q36647829 | Adverse effects of drug therapies on male and female sexual function |
Q40219984 | Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy |
Q86425425 | Age--an independent prognostic factor of clinical outcome in renal malignancies: results of a large study over two decades |
Q52355157 | Age-related increase in an advanced glycation end product in penile tissue. |
Q44039508 | Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study |
Q89732005 | Age-related urologic problems in the complex urologic patient |
Q39996595 | Age-specific PCA3 score reference values for diagnosis of prostate cancer |
Q48711505 | Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older |
Q112277251 | Age-stratified outcomes after radical prostatectomy in a randomized setting (LAP-01): do younger patients have more to lose? |
Q34712038 | Ageing, hormones, body composition, metabolic effects |
Q44404683 | Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma. |
Q33868975 | Albert Adamkiewicz (1850-1921)--his artery and its significance for the retroperitoneal surgeon |
Q87913520 | Ales Vidlar, Vladimir Student Jr., Jitka Vostalova, Emilie Fromentin, Marc Roller, Vilím Simanek, Vladimir Student: Cranberry fruit powder (Flowens™) improves lower urinary tract symptoms in men: a double-blind, randomized, placebo-controlled study. |
Q34648312 | Alfuzosin: a clinically uroselective alpha1-blocker |
Q95789999 | Alfuzosin: a clinically uroselective α1-blocker |
Q37184507 | Algorithms, nomograms and the detection of indolent prostate cancer |
Q34648289 | Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists |
Q93361409 | Alpha-blockers are widely used in medical expulsion therapy for ureteral stones besides management of lower urinary tract symptoms |
Q89282306 | Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis |
Q39678597 | Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha |
Q44538922 | Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression? |
Q94957455 | Altered gut microbiome associated with overactive bladder and daily urinary urgency |
Q34348938 | Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome |
Q91342763 | Alvimopan usage increasing following radical cystectomy |
Q39801447 | American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy |
Q98179247 | An adaptive randomized clinical trial in interstitial cystitis/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner's lesions |
Q39370004 | An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density |
Q47588561 | An alternative continence tube for continent urinary reservoirs: evaluation of surgical technique, pressure and continence study in an ex-vivo model |
Q77740482 | An alternative procedure for the creation of an ileal conduit in patients undergoing pelvic exenteration: dextrotransmesenteric location |
Q108925127 | An analysis of misleading YouTube videos on urological conditions: what to do about the danger of spreading misinformation of the YouTube videos? |
Q40984656 | An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy |
Q91531914 | An evaluation of multidrug-resistant (MDR) bacteria in patients with urinary stone disease: data from a high-volume stone management center |
Q96766602 | An evaluation of the federal adverse events reporting system data on adverse effects of 5-alpha reductase inhibitors |
Q30939263 | An evaluation of the timing of surgical complications following nephrectomy: data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). |
Q36199134 | An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? |
Q44539406 | An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity |
Q89542896 | An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer |
Q35043197 | An overview of holistic medicine and complementary and alternative medicine for the prevention and treatment of BPH, prostatitis, and prostate cancer |
Q58099611 | An overview of the ATOMS generations: port types, functionality and risk factors |
Q89184326 | An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer |
Q87431291 | An update on metabolic assessment in patients with urinary lithiasis |
Q91778032 | An updated meta-analysis of prostatic arterial embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia |
Q91324975 | Analysis of a practical surgical skills laboratory for nerve sparing radical prostatectomy |
Q38905626 | Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study |
Q89770690 | Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer |
Q40540612 | Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple |
Q37275581 | Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years |
Q57042572 | Analysis of factors affecting re-admission after retrograde intrarenal surgery for renal stone |
Q84907003 | Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy |
Q34028672 | Analysis of lymph node dissection in patients with ≥7-cm renal tumors |
Q36706706 | Analysis of pressure-flow data in terms of computer-derived urethral resistance parameters |
Q92970906 | Analysis of quality of life and late biochemical predictors for localized cancer recurrence following radical prostatectomy |
Q41452772 | Analysis of the impact of adherent perirenal fat on peri-operative outcomes of robotic partial nephrectomy |
Q38170269 | Analysis of the pentafecta learning curve for laparoscopic radical prostatectomy. |
Q44216015 | Analysis of three different vesicourethral anastomotic techniques in laparoscopic radical prostatectomy |
Q73330271 | Anatomic and functional studies of the male and female urethral sphincter |
Q82679077 | Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer |
Q39946584 | Anatomical description of the periprostatic nerves in the male rhesus monkey (Macaca mulatta). |
Q36499035 | Anatomy of autonomic nerve component in the male pelvis: the new concept from a perspective for robotic nerve sparing radical prostatectomy |
Q44637416 | Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results |
Q50890383 | Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer. |
Q86342949 | Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system? |
Q35881896 | Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy? |
Q38998300 | Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells |
Q38534949 | Androgen receptor aberrations in the era of abiraterone and enzalutamide |
Q97532523 | Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival |
Q37959244 | Androgen receptor co-activators in the regulation of cellular events in prostate cancer. |
Q38812564 | Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract |
Q26825402 | Androgen receptor footprint on the way to prostate cancer progression |
Q40703740 | Androgen signal transduction and prostatic carcinoma |
Q35567346 | Androgen therapy in the aging male |
Q35556843 | Androgen therapy with dehydroepiandrosterone |
Q41205966 | Androgen-receptor gene structure and function in prostate cancer |
Q96128912 | Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data |
Q34270904 | Androgens and male fertility |
Q35571886 | Androgens and prostate cancer |
Q77877198 | Angiomyolipoma of the kidney and lymph nodes |
Q41583046 | Animal models of kidney stone formation: an analysis |
Q46531946 | Animal models of premature and retarded ejaculation |
Q90324660 | Answer to comment on manuscript "Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients" |
Q35571067 | Antegrade pressure measurement as a diagnostic tool in modern pediatric urology. |
Q73885704 | Antegrade techniques of collagen injection for post-prostatectomy stress urinary incontinence: the Washington University experience |
Q91977196 | Anterior or posterior SWL in proximal ureteral stones opposite to 4th and 5th lumbar vertebrae? |
Q33657218 | Anterior urethral injury |
Q51705882 | Anterior urethral reconstruction using the circular fasciocutaneous flap technique: long-term follow-up. |
Q51825683 | Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis. |
Q39755154 | Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer |
Q92095397 | Antibiotic prophylaxis after urethroplasty may offer no benefit |
Q88318517 | Antibiotic prophylaxis for prevention of febrile urinary tract infections in children with vesicoureteral reflux: a meta-analysis of randomized, controlled trials comparing dilated to nondilated vesicoureteral reflux |
Q91437806 | Antibiotic prophylaxis in TURP: a prospective analysis concerning antibiotic stewardship and a potential reduction of antibiotic use in TURP |
Q92528914 | Antibiotic prophylaxis in TURP: a prospective analysis concerning antibiotic stewardship and a potential reduction of antibiotic use in TURP |
Q90340990 | Antibiotic prophylaxis in perioperative period of percutaneous nephrolithotomy: a systematic review and meta-analysis of comparative studies |
Q95331985 | Antibiotic prophylaxis in ureteroscopy-time for a good quality randomised controlled trial? |
Q92648047 | Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry |
Q38979767 | Antibiotic use and the prevention and management of infectious complications in stone disease |
Q37073600 | Antibody therapy in renal cell carcinoma |
Q35131296 | Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk |
Q50126301 | Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy: results from a prospective randomized trial |
Q39720552 | Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. |
Q37119884 | Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013. |
Q36093425 | Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development |
Q73748606 | Apical dissection during radical retropubic prostatectomy without ligature |
Q45047435 | Apoptosis of corpus cavernosum in patients with organic erectile dysfunction |
Q40607319 | Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer |
Q57565054 | Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy |
Q71324646 | Appendiceal continence mechanisms in continent urinary diversion |
Q83943751 | Application of a temporary ureter clamp for retroperitoneal laparoscopic ureterolithotomy |
Q92565921 | Application of artificial neural networks for automated analysis of cystoscopic images: a review of the current status and future prospects |
Q46113490 | Application of new technology in bladder cancer diagnosis and treatment |
Q54773918 | Application of real-time polymerase chain reaction technology to detect prostatic bacteria in patients with chronic prostatitis/chronic pelvic pain syndrome |
Q88113636 | Application of the 2013 American Urological Association early detection of prostate cancer guideline: who will we miss? |
Q34114702 | Application of the T-mechanism to an orthotopic (T-pouch) neobladder: a new era of urinary diversion |
Q41465662 | Applications of telomerase in urologic oncology |
Q100431971 | Appropriate pre-operative preparation and strict compliance with surgical principles should be the main mechanism to prevent infectious complications in endoscopic stone surgery |
Q37419099 | Aptness and complications of labial mucosa grafts for the repair of anterior urethral defects in children and adults: single centre experience with 115 cases |
Q57032531 | Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort |
Q52677843 | Are 10-, 10-12-, or > 12-mm prostate biopsy core quality control cutoffs reasonable? |
Q93169236 | Are 200 units of onabotulinumtoxin A sufficient for the suppression of neurogenic detrusor overactivity in individuals with established 300-unit botulinum toxin treatment? A retrospective cohort study |
Q38094612 | Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases? |
Q53699103 | Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology. |
Q94597431 | Are decision aids for all? Time to take care of the millions of low literate |
Q39123658 | Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study. |
Q44295893 | Are warm ischemia and ischemia time still predictive factors of poor renal function after partial nephrectomy in the setting of elective indication? |
Q48899485 | Are we ready for day-case partial nephrectomy? |
Q39823876 | Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy |
Q28397390 | Arsenic exposure predicts bladder cancer survival in a US population |
Q91498233 | Artificial intelligence and robotics: a combination that is changing the operating room |
Q40831086 | Artificial intelligence in medicine and male infertility |
Q92078035 | Artificial urinary sphincter longevity following transurethral resection of the prostate in the setting of prostate cancer |
Q51921250 | Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men. |
Q47298449 | Assessing the effects of modality of surgery on postoperative weight loss in patients undergoing partial nephrectomy |
Q35805463 | Assessment and management of newborn hydronephrosis |
Q50051543 | Assessment of readability, quality and popularity of online information on ureteral stents. |
Q92649029 | Assessment of the effects of autologous muscle-derived cell injections on urethral sphincter morphometry using 3D/4D ultrasound |
Q35000445 | Assessment of the learning curves for photoselective vaporization of the prostate using GreenLight™ 180-Watt-XPS laser therapy: defining the intra-operative parameters within a prospective cohort. |
Q93118137 | Associated measures to antibiotic prophylaxis in urology |
Q115201923 | Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis |
Q81287857 | Association between atherosclerosis and urothelial tumors of the renal pelvis |
Q50070001 | Association between coronary artery disease severity and overactive bladder in geriatric patients |
Q40050608 | Association between family history of prostate cancer and positive biopsies in a Brazilian screening program |
Q91613785 | Association between hypertension and 24-h urine composition in adults without urolithiasis in China |
Q38454578 | Association between percent-free prostate-specific antigen and glomerular filtration rate in transrectal ultrasound-guided biopsy-proven patients with prostate-specific antigen levels ranging from 4 to 10 ng/ml |
Q57109100 | Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study |
Q96173056 | Association between sex hormones and kidney stones: analysis of the National Health and Nutrition Examination Survey |
Q87367066 | Association between the bladder wall thickness and urodynamic findings in patients with spinal cord injury |
Q86433018 | Association of DAZ1/DAZ2 deletion with spermatogenic impairment and male infertility in the South Chinese population |
Q98514041 | Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC) |
Q79190490 | Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters |
Q92717399 | Association of TRPV5 gene polymorphism with calcium urolithiasis: a case-control study from West Bengal, India |
Q53658289 | Association of benign prostatic hyperplasia (BPH) volume and prostate cancer: consecutive data from an academic institution in respect to the current scientific view. |
Q50090660 | Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study. |
Q91925900 | Association of body mass index with bladder cancer risk in men depends on abdominal obesity |
Q62774656 | Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer |
Q39249689 | Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness |
Q39928318 | Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample. |
Q90043400 | Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization |
Q90601357 | Association of training level and outcome of software-based image fusion-guided targeted prostate biopsies |
Q84522692 | Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder |
Q54646132 | Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer. |
Q45191971 | Athermal nerve sparing robot-assisted radical prostatectomy: initial experience with microporous polysaccharide hemospheres as a topical hemostatic agent |
Q98188209 | Athermal versus ultrasonic nerve-sparing laparoscopic radical prostatectomy: a comparison of functional and oncological outcomes |
Q38399398 | Atherosclerosis within the non-neoplastic margin of partial nephrectomy specimens: implications for medical management |
Q90070434 | Augmentation cystoplasty in the patient with neurogenic bladder |
Q39097143 | Augmented perineal urethrostomy using a dorsal buccal mucosal graft, bi-institutional study. |
Q54375562 | Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer. |
Q88336370 | Author Correction to: The transgluteal approach to shockwave lithotripsy to treat distal ureter stones: a prospective, randomized, and multicenter study |
Q88956017 | Author reply: Letter to editor on the effect of corticosteroid on postoperative early pain, renal colic and total analgesic consumption after uncomplicated and unstented ureteroscopy: a matched-pair analysis by Mark C. Kendall |
Q47609833 | Autoaugmentation demucosalized enterocystoplasty |
Q50243169 | Autologous fibroblast transplantation at the vesico-ureteral junction as potential reconstructive cell replacement in an animal model |
Q41685422 | Autonomic dysreflexia and repeatability of cardiovascular changes during same session repeat urodynamic investigation in women with spinal cord injury |
Q93196121 | Available ablation energies to treat cT1 renal cell cancer: emerging technologies |
Q41758679 | Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programs. |
Q90185198 | Awareness of European practitioners toward uncommon tropical diseases: are we prepared to deal with mass migration? Results of an international survey |
Q33943118 | B7-1 gene-modified autologous tumor-cell vaccines for renal-cell carcinoma |
Q94954909 | BCG versus COVID-19: impact on urology |
Q50942062 | BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS). |
Q34334684 | Bacterial prostatitis |
Q41085821 | Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy |
Q30980857 | Balanitis xerotica obliterans--a review |
Q127027466 | Basal metabolic rate and the risk of urolithiasis: a two-sample Mendelian randomization study |
Q40599242 | Basic experimental studies on corpus cavernosum electromyography and smooth-muscle electromyography of the urinary bladder |
Q37428717 | Basic mechanisms of urgency: roles and benefits of pharmacotherapy |
Q36749359 | Basic principles of anatomy for optimal surgical treatment of prostate cancer |
Q40540604 | Basics of pressure-flow studies |
Q84533916 | Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia |
Q37787087 | Benchmarks for success in focal therapy of prostate cancer: cure or control? |
Q87269010 | Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample |
Q71696031 | Benign prostatic hyperplasia, a common disease of the ageing male |
Q91728303 | Best practices in near-infrared fluorescence imaging with indocyanine green (NIRF/ICG)-guided robotic urologic surgery: a systematic review-based expert consensus |
Q39897388 | Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia |
Q82488458 | Beyond ESWL: new concepts for definitive stone removal |
Q91627712 | Beyond medications: office-based procedures for benign prostatic obstruction |
Q60685252 | Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches |
Q48658427 | Bicentric prospective evaluation of corporoplasty with porcine small intestinal submucosa (SIS) in patients with severe Peyronie's disease |
Q51185700 | Bilateral ureterocutaneostomy with modified stoma: long-term follow-up. |
Q45911408 | Bilateral urinary calculi with discordant stone composition. |
Q71721275 | Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid |
Q41465632 | Biologic response modifiers in the management of superficial bladder cancer |
Q41111930 | Biology of metastases and its clinical implications: testicular germ-cell tumors |
Q40958442 | Biology of metastasis and its clinical implications: renal-cell cancer |
Q36906722 | Biomarkers for prostate cancer |
Q40769785 | Biomaterials for tissue engineering. |
Q41503570 | Biometric assessment of prostate cancer's metastatic potential |
Q93111655 | Biopsy Grade Group as a reliable prognostic factor for BCR in Afro-Caribbean men with intermediate- and high-risk prostate cancer |
Q84484256 | Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion |
Q36753424 | Biopsy standards for detection of prostate cancer |
Q92190349 | Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis |
Q38243606 | Bipolar plasma vaporization of the prostate: ready to replace GreenLight? A systematic review of randomized control trials |
Q95936735 | Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials |
Q58603538 | Bladder and ureteral injuries during benign hysterectomy: an observational cohort analysis in New York State |
Q97427677 | Bladder cancer in patients with spina bifida: a serious risk |
Q98184563 | Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database |
Q80149234 | Bladder cancer markers in patient management: the current perspective |
Q33414689 | Bladder cancer: new TUR techniques |
Q40625796 | Bladder cancer: the molecular progression to invasive disease |
Q98471834 | Bladder infusion versus standard catheter removal for trial of void: a systematic review and meta-analysis |
Q50060300 | Bladder injuries after external trauma: 20 years experience report in a population-based cross-sectional view |
Q98179245 | Bladder lesions as incidental findings during transurethral resection of the prostate: prevalence, diagnosis, and pathological findings |
Q33283412 | Bladder neck incision using a 70 W 2 micron continuous wave laser (RevoLix). |
Q46166955 | Bladder outlet obstruction in men with acute urinary retention: an urodynamic study |
Q37529480 | Bladder pain syndrome/interstitial cystitis: a sense of urgency. |
Q44510360 | Bladder reconstruction with adipose-derived stem cell-seeded bladder acellular matrix grafts improve morphology composition |
Q77877177 | Bladder rupture from external trauma: diagnosis and management |
Q37184512 | Bladder tissue engineering through nanotechnology. |
Q35865814 | Bladder, bowel and bones--skeletal changes after intestinal urinary diversion |
Q35862198 | Bladder, bowel and bugs--bacteriuria in patients with intestinal urinary diversion |
Q71696035 | Bladder-outlet obstruction--assessment of symptoms |
Q36643625 | Bladder-sparing approaches to invasive disease |
Q92721057 | Blunt trauma pelvic fracture-associated genitourinary and concomitant lower gastrointestinal injury: incidence, morbidity, and mortality |
Q72608621 | Body mass index and adult female urinary incontinence |
Q35292828 | Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer. |
Q46154664 | Bone marrow stem cells for urologic tissue engineering |
Q28235960 | Bone morphogenetic protein-6 expression in normal and malignant prostate |
Q96128904 | Boosting bladder cancer treatment by intravesical nitazoxanide and bacillus calmette-guérin association |
Q35043200 | Botanical medicines for the urinary tract |
Q34538480 | Both the middle and distal sections of the urethra may be regarded as optimal targets for 'outside-in' transobturator tape placement |
Q37946313 | Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults |
Q35876105 | Bowel function after urinary diversion |
Q53808535 | Bowel function in patients with urinary diversion: a gender-matched comparison of continent urinary diversion with the ileocecal pouch and ileal conduit. |
Q77422143 | Bowel-flap tubes for continent cutaneous urinary diversion |
Q34209726 | Brain control of penile erection |
Q36568768 | Brain penetration of the OAB drug trospium chloride is not increased in aged mice |
Q57286809 | Buccal mucosa graft for simultaneous correction of severe chordee and urethroplasty as a one-stage repair of scrotal hypospadias (watch technique) |
Q89749180 | Buccal mucosal graft urethroplasty for radiation-induced urethral strictures: an evaluation using the extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM) |
Q88886426 | CATCH-22: a manual bladder washout protocol to improve care for clot retention |
Q38960744 | CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro |
Q85037239 | CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma |
Q92345408 | CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder |
Q40401363 | CHESS classification of bladder-outflow obstruction. A consequence in the discussion of current concepts |
Q100937771 | COVID-19 and financial toxicity in patients with renal cell carcinoma |
Q93217835 | COVID-19 outbreak situation and its psychological impact among surgeon in training in France |
Q47673346 | CT-calculometry (CT-CM): advanced NCCT post-processing to investigate urinary calculi. |
Q50943950 | CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression. |
Q45122565 | CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers |
Q90857740 | Cabazitaxel inhibits prostate cancer cell growth by inhibition of androgen receptor and heat shock protein expression |
Q71691021 | Cadaver kidney transplantation in patients more than 65 years old |
Q41895002 | Calcium oxalate nephrolithiasis and expression of matrix GLA protein in the kidneys |
Q94497393 | Can "strictures" following hypospadias repair be called true strictures?: the need for redefining terminology |
Q53233702 | Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance? |
Q96772069 | Can anterior approach be used for all patients with upper ureteric stones for shock wave lithotripsy? |
Q57466518 | Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation |
Q43428500 | Can high-spatial resolution T2-weighted endorectal MRI rule out clinically significant prostate cancer? |
Q51792066 | Can intraperitoneal bupivacaine decreases pain in patients undergoing laparoscopic live donor nephrectomy? A randomized control trial. |
Q92738538 | Can men with lower urinary tract symptoms (LUTs) predict voided volumes? |
Q98160254 | Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy? |
Q41251318 | Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer? |
Q39452085 | Can prostate-specific antigen reverse transcriptase-polymerase chain reaction be used as a prospective test to diagnose prostate cancer? |
Q91308799 | Can readmissions be reduced after retrograde intrarenal surgery for renal stone? |
Q51601615 | Can robot-assisted laparoscopic radical prostatectomy (RALP) be performed very soon after biopsy? |
Q70949779 | Can semen analysis predict the presence of antisperm antibodies in patients with primary infertility? |
Q80786569 | Can the ice-water test predict the outcome of intradetrusor injections of botulinum toxin in patients with neurogenic bladder dysfunction? |
Q96580909 | Can the robotic approach replace open surgery in kidney transplantation? |
Q40338893 | Can ureteral stones cause pain without causing hydronephrosis? |
Q57042577 | Can urinary biomarkers replace cystoscopy? |
Q91833822 | Can we count on popcorn technique in lithotripsy: based on recent in vitro studies? |
Q43914387 | Can we predict the clinical outcome of patients with bladder trauma? |
Q54745123 | Can we predict the clinical outcomes of genitourinary trauma patients and offer them an evidence-based support? The case for telemedicine network. |
Q31110115 | Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study |
Q43703904 | Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis |
Q60622169 | Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy |
Q90951895 | Candida urinary tract infections in adults |
Q43699999 | Capsular incision in normal prostatic tissue during robot-assisted radical prostatectomy: a new concept or a waste of time? |
Q43129844 | Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer |
Q73157925 | Carcinosarcoma of the prostate |
Q38267215 | Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis |
Q99729863 | Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice |
Q74321116 | Case selection for high-energy transurethral microwave thermotherapy |
Q36362473 | Categorisation of complications of endoscopic extraperitoneal and laparoscopic transperitoneal radical prostatectomy |
Q38090498 | Categorization of intraoperative ureteroscopy complications using modified Satava classification system |
Q85939753 | Causal effect of vitamin D on prostate cancer using Mendelian randomization approach |
Q50999369 | Causes of long-term graft failure in renal transplantation. |
Q28375977 | Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review |
Q53468715 | Cavernous nerve regeneration using acellular nerve grafts. |
Q41583037 | Cell cultures and nephrolithiasis |
Q34559012 | Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells. |
Q48319800 | Central autonomic innervation of the lower urinary tract--a neuroanatomy study |
Q43566599 | Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials |
Q34557382 | Central nervous system control of ejaculation |
Q84847992 | Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases |
Q90664560 | Centralization tendencies of retroperitoneal lymph node dissection for testicular cancer in Germany? A total population-based analysis from 2006 to 2015 |
Q89604067 | Challenges facing the urologist in low- and middle-income countries |
Q93201641 | Challenges in pediatric urologic practice: a lifelong view |
Q84243467 | Challenges in testicular cancer management |
Q93170951 | Challenges in urogenital tuberculosis |
Q37050438 | Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform |
Q39502643 | Challenging the wisdom of puncture at the calyceal fornix in percutaneous nephrolithotripsy: feasibility and safety study with 137 patients operated via a non-calyceal percutaneous track. |
Q38132679 | Challenging treatment decision-making in older urologic cancer patients. |
Q46108593 | Change in renal function following laparoscopic donor nephrectomy using 99 mTc-diethylenetriaminepentaacetic acid scan |
Q35401704 | Change in storage symptoms following laser prostatectomy: comparison between photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP). |
Q43566594 | Changes in ED therapy in the Viagra era. |
Q51478549 | Changes in aquaporin (AQP)2 and AQP3 expression in ovariectomized rat urinary bladder: potential implication of water permeability in urinary bladder. |
Q100390848 | Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer |
Q57109092 | Changes in the levels of testosterone profile over time in relation to clinical parameters in a cohort of patients with prostate cancer managed by active surveillance |
Q41486507 | Changes of muscarinic receptors and connexin-43 expression as a mechanism of overactive bladder in ovariectomized rats |
Q51964525 | Changing concepts in the surgery of renal cell carcinoma. |
Q35881943 | Changing the double-pigtail stent by a new suture stent to improve patient's quality of life: a prospective study. |
Q38892092 | Characteristics and outcomes of ureteroscopic treatment in 2650 patients with impacted ureteral stones |
Q38152998 | Characteristics of modern Gleason 9/10 prostate adenocarcinoma: a single tertiary centre experience within the Republic of Ireland |
Q93092901 | Characteristics predictive of response to collagenase clostridium histolyticum for Peyronie's disease: a review of the literature |
Q54037398 | Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. |
Q95936732 | Characterization of intracalyceal pressure during ureteroscopy |
Q89282318 | Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era |
Q57565097 | Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses |
Q79263915 | Chemoprevention of bladder cancer |
Q37975188 | Chemoprevention of prostate cancer: an updated view |
Q42502335 | Chemopreventive property of dietary ginger in rat urinary bladder chemical carcinogenesis |
Q53684997 | Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial. |
Q40568436 | Chemoresistance of renal cell carcinoma: 1986-1994. |
Q81348915 | Chemotherapy for androgen-independent prostate cancer |
Q37426349 | Chemotherapy for patients with poor prognosis germ cell tumors |
Q73930278 | Chemotherapy for urogenital malignancies |
Q36052220 | Chemotherapy in metastatic renal cell cancer |
Q34798495 | Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy |
Q34262371 | Chemotherapy of disseminated germ cell tumors |
Q43730561 | Chest X-ray in the follow-up of renal cell carcinoma |
Q83567885 | Childhood dysfunctional voiding is differentially associated with urinary incontinence subtypes in women |
Q44321327 | Children and adolescents with ureteropelvic junction obstruction: is an additional voiding cystourethrogram necessary? Results of a multicenter study |
Q36372008 | Chlamydial infections in urology |
Q58564396 | Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study |
Q47417416 | Choosing the nephrostomy size after percutaneous nephrolithotomy |
Q51235838 | Chronic bacterial prostatitis in men with spinal cord injury. |
Q83500523 | Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat model |
Q96232407 | Chronic kidney disease and upper tract concerns after congenital and acquired urinary tract abnormalities: considerations for transition of care in teens and young adults |
Q74255056 | Chronic pelvic pain |
Q82227644 | Chronic pelvic pain syndrome/chronic prostatitis affect the acrosome reaction in human spermatozoa |
Q35159825 | Chronic pelvic pain syndrome: a non-prostatocentric perspective |
Q74255078 | Chronic perineal pain and lower urinary tract dysfunction--a clinical feature of the "Gulf War syndrome"? |
Q73257493 | Chronic prostatitis/chronic pelvic pain pyndrome): seminal markers of inflammation |
Q35139890 | Chronic prostatitis: what we know, what we do not know, and what we should do! |
Q83341466 | Chronic pulmonary disease negatively influences the prognosis of patients with advanced prostate cancer |
Q48101725 | Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies. |
Q44505483 | Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy |
Q36754208 | Circulating biomarkers for prostate cancer |
Q47417933 | Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer |
Q85784261 | Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? |
Q97590636 | Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies |
Q85830212 | Circulating sex steroids and prostate cancer: introducing the time-dependency theory |
Q48071912 | Circumcision plus antibiotic, anti-inflammatory, and α-blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial |
Q38099240 | Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system |
Q38537234 | Classification of stress urinary incontinence |
Q90472955 | Classification of the renal papillary abnormalities by flexible ureteroscopy: evaluation of the 2016 version and update |
Q95833446 | Classification systems for anterior urethral stricture disease in men: a systematic review |
Q91347123 | Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer |
Q89533216 | Clear pooled results but unclear pooled bias: commentary for a recent meta-analysis |
Q35965284 | Clearance rates of residual stone fragments and dusts after endoscopic lithotripsy procedures using a holmium laser: 2-year follow-up results |
Q86897782 | Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation |
Q43744999 | Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population |
Q41471527 | Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy |
Q73502983 | Clinical application of NMP22 and urinary cytology in patients with hematuria or a history of urothelial carcinoma |
Q91243689 | Clinical application of super-mini PCNL (SMP) in the treatment of upper urinary tract stones under ultrasound guidance |
Q96610769 | Clinical characteristics and prognostic factors of male yolk sac tumor: a Surveillance, Epidemiology, and End Results program study |
Q91952752 | Clinical characteristics and surgical outcomes in men undergoing tunica albuginea plication for congenital penile curvature who present with worsening penile deformity |
Q43333441 | Clinical characteristics, nocturnal antidiuretic hormone levels, and responsiveness to DDAVP of school children with primary nocturnal enuresis. |
Q81528476 | Clinical characterization of the prostatitis patient in Italy: a prospective urology outpatient study |
Q83318588 | Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays? |
Q91571252 | Clinical efficacy and safety of flexible ureteroscopic lithotripsy using 365 μm holmium laser for nephrolithiasis: a prospective, randomized, controlled trial |
Q45781552 | Clinical efficacy of a loading dose of naftopidil for patients with benign prostate hyperplasia |
Q42690619 | Clinical efficacy of bipolar radiofrequency ablation of small renal masses |
Q48868453 | Clinical efficacy of combination therapy with an alpha blocker and low-dose sildenafil on post-therapy lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer |
Q35701235 | Clinical epidemiology of testicular germ cell tumors |
Q86029398 | Clinical evaluation and technical features of three-dimensional laparoscopic partial nephrectomy with selective segmental artery clamping |
Q99637610 | Clinical evaluation of COVID-19/SARS-CoV-2 diagnostic testing in asymptomatic urology patients: implications for resumption of elective surgical care |
Q39496827 | Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy |
Q45800588 | Clinical experience with survivin as a biomarker for urothelial bladder cancer |
Q43644314 | Clinical features of supervoiders who suffer from lower urinary tract symptoms: a propensity score-matching study |
Q57466515 | Clinical grading and color Doppler ultrasonography-based grading of varicocele: how compatible are the two grading systems? |
Q51380035 | Clinical impact of body mass index on the outcome of the SPARC-sling system for the treatment of female stress urinary incontinence. |
Q83969442 | Clinical impact of intraoperative frozen sections during nerve-sparing radical prostatectomy |
Q35941781 | Clinical impact of prostate biopsy undergrading in an academic and community setting |
Q93119450 | Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC) |
Q38206128 | Clinical management of renal cell carcinoma with venous tumor thrombus |
Q33543811 | Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience |
Q99588398 | Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor |
Q46689552 | Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study |
Q40821665 | Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer |
Q38109510 | Clinical outcomes and patient satisfaction rates among elderly male aged ≥75 years with inflatable penile prosthesis implant for medically refractory erectile dysfunction |
Q37940895 | Clinical outcomes of laparo-endoscopic single-site surgery radical nephrectomy |
Q91131484 | Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) pr |
Q92751006 | Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries |
Q37844481 | Clinical practice guidelines to inform evidence-based clinical practice |
Q46829994 | Clinical predictors and risk factors for vaginal mesh extrusion. |
Q91916718 | Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience |
Q61901631 | Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent |
Q97546600 | Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts |
Q91285071 | Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5 |
Q40256817 | Clinical relevance of maspin expression in bladder cancer |
Q89424908 | Clinical results of a dorsally positioned hydraulic ID-sling in male patients with post-prostatectomy-incontinence |
Q50855366 | Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. |
Q39855461 | Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. |
Q91319032 | Clinical significance of cystoscopic urethral stricture recurrence after anterior urethroplasty: a multi-institution analysis from Trauma and Urologic Reconstructive Network of Surgeons (TURNS) |
Q45774263 | Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC). |
Q46045392 | Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma |
Q35819954 | Clinical significance of residual fragments in 2015: impact, detection, and how to avoid them |
Q91571261 | Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor |
Q37514958 | Clinical stage I seminoma: the case for surveillance. |
Q38709399 | Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment |
Q79858901 | Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis |
Q98949426 | Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective |
Q36307484 | Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction |
Q85206835 | Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: urodynamics made easy? |
Q88037180 | Clinical values of selective-clamp technique in robotic partial nephrectomy |
Q104798793 | Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium |
Q87517848 | Clinically high-risk prostate cancer patients comprise a relevant number of cancers with overall favorable tumor characteristics |
Q41313563 | Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. |
Q91118047 | Clinically occult prostate cancer cases may distort the effect of testosterone replacement therapy on risk of PCa |
Q74744431 | Cloning of COX4 cDNA from the NZ white rabbit and expression of this gene in bladder smooth muscle following partial outlet obstruction |
Q81833851 | Cognitive and partner-related factors in rapid ejaculation: differences between dysfunctional and functional men |
Q45986446 | Collagen I:III ratio in canine heterologous bladder acellular matrix grafts. |
Q51122686 | Collagen cell carriers seeded with human urothelial cells for urethral reconstructive surgery: first results in a xenograft minipig model. |
Q85118706 | Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer |
Q42599853 | Collecting system involvement by renal tumor: are CT measurements reliable enough? |
Q51106919 | Colonization of internal ureteral stent and bacteriuria. |
Q84183172 | Color Doppler ultrasound imaging in varicoceles: is the venous diameter sufficient for predicting clinical and subclinical varicocele? |
Q35868147 | Color Doppler ultrasound investigation of varicocele |
Q41738391 | Color and power Doppler imaging of the kidneys |
Q41738384 | Color-flow and power Doppler imaging of the testes |
Q37500031 | Combination of BCG and interferon intravesical immunotherapy: an update. |
Q84778123 | Combination of C-TRUS with multiparametric MRI: potential for improving detection of prostate cancer |
Q89741704 | Combination of holmium and thulium laser ablation in upper tract urothelial carcinoma |
Q90857746 | Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer |
Q90377422 | Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis |
Q36080492 | Combination of surgery and immunotherapy in metastatic renal cell carcinoma |
Q47677924 | Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II stud |
Q37610819 | Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies. |
Q92672799 | Combined androgen blockade (CAB) versus luteinizing hormone-releasing hormone (LHRH) agonist monotherapy for androgen deprivation therapy |
Q49948754 | Combined prostatic urethral lift and remodeling of the prostate and bladder neck: a modified transurethral approach in the treatment of symptomatic lower urinary tract obstruction. |
Q99354331 | Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response |
Q34791176 | Combined semirigid and flexible ureterorenoscopy via a large ureteral access sheath for kidney stones >2 cm: a bicentric prospective assessment. |
Q91572535 | Combined systematic versus stand-alone multiparametric MRI-guided targeted fusion biopsy: nomogram prediction of non-organ-confined prostate cancer |
Q91303654 | Combined-modality 125J-seed-brachytherapy, external beam radiation and androgen deprivation therapy of unfavorable-risk prostate cancer: report of outcomes and side-effects |
Q92804284 | Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population |
Q91715907 | Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up |
Q96307271 | Comment on "Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials" |
Q98879232 | Comment on "Bladder infusion versus standard catheter removal for trial of void: a systematic review and meta-analysis" |
Q90838359 | Comment on "Deep learning computer vision algorithm for detecting kidney stone composition" |
Q96033884 | Comment on "Efficacy and safety of oral phosphodiesterase 5 inhibitor for erectile dysfunction: a network meta-analysis and multicriteria decision" |
Q44017236 | Comment on "Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study". |
Q96173043 | Comment on "Safety and efficacy of bipolar versus monopolar transurethral resection of bladder tumor: a systematic review and meta-analysis" |
Q51317249 | Comment on "efficacy and safety of skeletonized mesh implants for advanced pelvic organ prolapse: 12 month follow up". |
Q87077739 | Comment on "secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot study" |
Q129178093 | Comment on ‘A new position utilizing the effect of gravity in proximal ureteral stones, ureteroscopic lithotripsy in the reverse Trendelenburg position: a prospective, randomized, comparative study’ |
Q86253869 | Comment on: "Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years" |
Q88687650 | Comment on: "The effect of corticosteroid on postoperative early pain, renal colic and total analgesic consumption after uncomplicated and unstented ureteroscopy: a matched-pair analysis" |
Q96340802 | Comment on: Shatagopam K, Bahler CD, Sundaram CP. Renorrhaphy techniques and effect on renal function with robotic partial nephrectomy. World J Urol. 2020;38: 1109-12 |
Q43079252 | Comments on the article "Biomarkers for prostate cancer" by Eric Schiffer |
Q81441785 | Comments on the article "Targeted therapy in renal cell carcinoma" by J.-J. Patard et al |
Q90951887 | Comments to "Systematic review and cumulative analysis of the managements for proximal impacted ureteral stones" |
Q38918805 | Common medications and prostate cancer mortality: a review |
Q35188315 | Common trend: move to enucleation-Is there a case for GreenLight enucleation? Development and description of the technique |
Q40504173 | Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer |
Q37824275 | Comparative effectiveness research in urology |
Q90318488 | Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials |
Q92389186 | Comparative evaluation of tissue damage induced by ultrasound and impact dual-mode endoscopic lithotripsy versus conventional single-mode ultrasound lithotripsy |
Q53563999 | Comparative pilot study of implantation techniques for pudendal neuromodulation: technical and clinical outcome in first 20 patients with chronic pelvic pain. |
Q34605829 | Comparative proteomic study between human normal motility sperm and idiopathic asthenozoospermia |
Q91014519 | Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis |
Q46371104 | Comparative studies on urethral function |
Q50747322 | Comparative study of one-stitch versus Lich-Gregoir ureterovesical implantation for kidney transplants. |
Q52656906 | Comparative study of the treatment of 20-30 mm renal stones with miniaturized percutaneous nephrolithotomy and flexible ureterorenoscopy in obese patients. |
Q44384166 | Comparative survival following different treatment modalities for stage T2 bladder cancer in octogenarians |
Q95274205 | Comparing a new risk prediction model with prostate cancer risk calculator apps in a Taiwanese population |
Q84774138 | Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones |
Q37959798 | Comparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response |
Q38371337 | Comparing the efficacy and safety between robotic-assisted versus open pyeloplasty in children: a systemic review and meta-analysis |
Q91831190 | Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and |
Q90325857 | Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomy |
Q92516007 | Comparison between cold knife and laser urethrotomy for urethral stricture: a systematic review and meta-analysis of comparative trials |
Q64938850 | Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. |
Q49720922 | Comparison between open simple prostatectomy and green laser enucleation of the prostate for treating large benign prostatic hyperplasia: a single-centre experience |
Q95655538 | Comparison between shockpulse and pneumatic lithotripsy in percutaneous nephrolithotomy |
Q89396679 | Comparison between the effects of deep and moderate neuromuscular blockade during transurethral resection of bladder tumor on endoscopic surgical condition and recovery profile: a prospective, randomized, and controlled trial |
Q35628339 | Comparison of 30-day perioperative outcomes in adults undergoing open versus minimally invasive pyeloplasty for ureteropelvic junction obstruction: analysis of 593 patients in a prospective national database. |
Q57811833 | Comparison of adjustable male slings and artificial urinary sphincter in the treatment of male urinary incontinence: a retrospective analysis of patient selection and postoperative continence status |
Q90601347 | Comparison of biopsy devices in upper tract urothelial carcinoma |
Q52717818 | Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy. |
Q91289266 | Comparison of clinical outcomes and automated performance metrics in robot-assisted radical prostatectomy with and without trainee involvement |
Q53569770 | Comparison of clinical outcomes between upgraded pathologic Gleason score 3 + 4 and non-upgraded 3 + 4 prostate cancer among patients who are candidates for active surveillance. |
Q91308922 | Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients |
Q82866600 | Comparison of efficacy and safety of shockwave lithotripsy for upper urinary tract stones of different locations in children: a study of 311 cases |
Q91192542 | Comparison of electrohydraulic and electromagnetic extracorporeal shock wave lithotriptors for upper urinary tract stones in a single center |
Q43977768 | Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients |
Q41355781 | Comparison of flexible ureterorenoscopy and micropercutaneous nephrolithotomy in the treatment for moderately size lower-pole stones |
Q87903990 | Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis |
Q47232199 | Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. |
Q52357988 | Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study. |
Q38219598 | Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies |
Q93163807 | Comparison of intra- and postoperative analgesia and pain perception in robot-assisted vs. open radical prostatectomy |
Q99588395 | Comparison of intrapelvic pressures during flexible ureteroscopy, mini-percutaneous nephrolithotomy, standard percutaneous nephrolithotomy, and endoscopic combined intrarenal surgery in a kidney model |
Q36051809 | Comparison of laser fiber passage in ureteroscopic maximum deflection and their influence on deflection and irrigation: Do we really need the ball tip concept? |
Q42620093 | Comparison of mid-term carcinologic control obtained after open, laparoscopic, and robot-assisted radical prostatectomy for localized prostate cancer |
Q51602483 | Comparison of miniaturized percutaneous nephrolithotomy and flexible ureterorenoscopy for the management of 10-20 mm renal stones in obese patients. |
Q90758239 | Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations? |
Q43735798 | Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL. |
Q40894890 | Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma |
Q42619673 | Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. |
Q39458834 | Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer |
Q53473927 | Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsies within a prospective randomized trial. |
Q85717544 | Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma |
Q47898943 | Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy |
Q46979065 | Comparison of prolonged warm and cold ischemia on the solitary kidney during partial nephrectomy in a rabbit model |
Q86835572 | Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results |
Q53311851 | Comparison of radiographic and pathologic sizes of renal tumors. |
Q47326201 | Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy |
Q43488685 | Comparison of renal function and metabolic abnormalities of cystine stone patients and calcium oxalate stone patients in China |
Q41690774 | Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma |
Q96580906 | Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma |
Q44488659 | Comparison of retrograde intrarenal surgery, shockwave lithotripsy, and percutaneous nephrolithotomy for treatment of medium-sized radiolucent renal stones |
Q50557693 | Comparison of retroperitoneal and transperitoneal robotic partial nephrectomy for Pentafecta perioperative and renal functional outcomes. |
Q48179639 | Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner? |
Q100937772 | Comparison of risk-calculator and MRI and consecutive pathways as upfront stratification for prostate biopsy |
Q100563512 | Comparison of scoring systems for predicting stone-free status and complications after retrograde ıntrarenal surgery |
Q91818105 | Comparison of stone elimination capacity and drilling speed of endoscopic clearance lithotripsy devices |
Q91014512 | Comparison of suctioning and traditional ureteral access sheath during flexible ureteroscopy in the treatment of renal stones |
Q48128182 | Comparison of super-mini PCNL (SMP) versus Miniperc for stones larger than 2 cm: a propensity score-matching study. |
Q90416153 | Comparison of super-mini-PCNL and flexible ureteroscopy for the management of upper urinary tract calculus (1-2 cm) in children |
Q84372934 | Comparison of surgical stress response to laparoscopic and open radical cystectomy |
Q91613802 | Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis |
Q30752503 | Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer |
Q91613830 | Comparison of the ablation rates, fissures and fragments produced with 150 µm and 272 µm laser fibers with superpulsed thulium fiber laser: an in vitro study |
Q101477061 | Comparison of the efficacy and safety of microscopic and laparoscopic surgery for varicocele |
Q100440526 | Comparison of the iliac, vaginal and umbilical graft extraction in robot-assisted laparoscopic living donor nephrectomy |
Q87153709 | Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma |
Q43539389 | Comparison of the roll-plate and sonication techniques in the diagnosis of microbial ureteral stent colonisation: results of the first prospective randomised study |
Q53251362 | Comparison of treatment outcomes according to output voltage during shockwave lithotripsy for ureteral calculi: a prospective randomized multicenter study. |
Q114213399 | Comparison of two techniques for the management of 2–3 cm lower pole renal calculi in obese patients |
Q46120045 | Comparison of unilateral renal artery embolization versus bilateral for treatment of severe refractory hypertension in hemodialysis patients |
Q58109692 | Comparison of 100 cc prostates undergoing aquablation for benign prostatic hyperplasia |
Q78775369 | Complementary medicine in urology - a different approach |
Q47353899 | Complete bladder neck preservation promotes long-term post-prostatectomy continence without compromising midterm oncological outcome: analysis of a randomised controlled cohort |
Q91131487 | Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases |
Q124829028 | Complication rate after pediatric shock wave lithotripsy according to Clavien–Dindo grading system: results from a systematic review and meta-analysis of the existing literature |
Q93382407 | Complications and functional outcomes of high-risk patient with cardiovascular disease on antithrombotic medication treated with the 532-nm-laser photo-vaporization Greenlight XPS-180 W for benign prostate hyperplasia |
Q37719150 | Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study. |
Q96306208 | Complications in adulthood for patients with paediatric genitourinary reconstruction |
Q79804587 | Complications in laparoscopic urology |
Q41740346 | Complications in percutaneous nephrolithotomy |
Q36645754 | Complications of endoscopic extraperitoneal radical prostatectomy (EERPE): prevention and management |
Q43663713 | Complications of kidney transplantation with grafts from expanded criteria donors |
Q37291036 | Complications of laparoscopic partial nephrectomy |
Q37159311 | Complications of laparoscopic pyeloplasty |
Q37205032 | Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer |
Q33522265 | Complications of laser prostatectomy: a review of recent data |
Q47696353 | Complications of penile self-injections: investigation of 680 patients with complications following penile self-injections with mineral oil. |
Q72781952 | Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancer |
Q37201451 | Complications of retroperitoneoscopic living donor nephrectomy: single center experience after 164 cases |
Q40076901 | Complications of robotic assisted radical prostatectomy |
Q90203141 | Complications of the urinary incontinence system ATOMS: description of risk factors and how to prevent these pitfalls |
Q91363603 | Complications of ureteroscopy: a complete overview |
Q91547350 | Complications related to use of mesh implants in surgical treatment of stress urinary incontinence and pelvic organ prolapse: infection or inflammation? |
Q91312674 | Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review |
Q39441626 | Computer-assisted interpretation of electromyograms of corpora cavernosa using fuzzy logic |
Q39638224 | Computerized tomography attenuation values can be used to differentiate hydronephrosis from pyonephrosis |
Q39808468 | Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies |
Q39987974 | Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies |
Q89036843 | Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy |
Q46929643 | Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients |
Q92663523 | Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis |
Q50215107 | Concordance of Gleason grading with three-dimensional ultrasound systematic biopsy and biopsy core pre-embedding |
Q90295113 | Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study |
Q91815660 | Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality |
Q91229860 | Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading |
Q40831102 | Congenital bilateral absence of the vas deferens and cystic fibrosis. A genetic commonality. |
Q33399990 | Connexin45 expression in the human obstructed detrusor muscle |
Q40905636 | Consensus of lithotriptor terminology |
Q102329826 | Consensus of multiple national guidelines: agreed strategies for initial stone management during COVID-19 |
Q77422118 | Consensus report on pelvic floor weakness of the elderly female |
Q37582301 | Considerations for the management of urgency symptoms in patients with overactive bladder syndrome |
Q38523169 | Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency |
Q84564182 | Considerations on prostate cancer: diagnosis and treatment decisions |
Q37037452 | Considerations on the use of diagnostic markers in management of patients with bladder cancer. |
Q87127584 | Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies |
Q51820246 | Construct, content and face validity of the camera handling trainer (CHT): a new E-BLUS training task for 30° laparoscope navigation skills. |
Q85638919 | Construction of a three-dimensional model of renal stones: comprehensive planning for percutaneous nephrolithotomy and assistance in surgery |
Q93173106 | Consultation on UTUC Stockholm 2018 |
Q92641651 | Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma |
Q92835136 | Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up |
Q92259183 | Consultation on UTUC, Stockholm 2018: aspects of treatment |
Q100694852 | Consultation on kidney stones, Copenhagen 2019: aspects of intracorporeal lithotripsy in flexible ureterorenoscopy |
Q98165509 | Consultation on kidney stones, Copenhagen 2019: lithotripsy in percutaneous nephrolithotomy |
Q36679078 | Contact laser prostatectomy |
Q92970939 | Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis |
Q92063961 | Contemporary analysis of management of isolated pendulous urethral strictures using pedicled skin flap urethroplasty repair |
Q91955847 | Contemporary application of autologous muscle-derived cells for urinary sphincter regeneration |
Q63966772 | Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study) |
Q33990920 | Contemporary chemotherapeutic approaches for the treatment of hormone-refractory prostate carcinoma |
Q40957140 | Contemporary criteria for cadaveric organ donation in renal transplantation: the need for better selection parameters |
Q34798501 | Contemporary cystectomy and urinary diversion |
Q37730560 | Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention |
Q33545988 | Contemporary evaluation and management of Cushing's syndrome |
Q37258351 | Contemporary inguinal lymph node dissection: minimizing complications |
Q37872240 | Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy |
Q79347844 | Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan |
Q37684845 | Contemporary open partial nephrectomy is associated with diminished procedure-specific morbidity despite increasing technical challenges: a single institutional experience |
Q37777340 | Contemporary outcomes of focal therapy in prostate cancer: what do we know so far… |
Q41901097 | Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol |
Q88498839 | Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study |
Q38711264 | Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma |
Q101147250 | Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer |
Q38800577 | Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer. |
Q114213400 | Contemporary treatment trends for upper urinary tract stones in a total population analysis in Germany from 2006 to 2019: will shock wave lithotripsy become extinct? |
Q100694849 | Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia: results from the EVOLUTION European registry |
Q46634661 | Continence mechanism of the ileal neobladder in women: a urodynamics study |
Q35207151 | Continent bladder stoma |
Q51210575 | Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs. |
Q71324636 | Continent diversion with the Mainz pouch |
Q71324652 | Continent gastric pouch |
Q71951424 | Continent small-intestine reservoir construction: a tapered intussusceptum promotes sustained continence |
Q93061664 | Continuation rates of alpha-blockers mono-therapy in adult men, prescribed by urologists or general practitioners: a pharmacy-based study |
Q97546583 | Continuous intrapelvic pressure monitoring in flexible ureteroscopy: a bright prospect and some other concerns |
Q94555895 | Continuous monitoring of intrapelvic pressure during flexible ureteroscopy using a sensor wire: a pilot study |
Q38979986 | Contralateral biopsies in patients with testicular germ cell tumours: What is the rationale? |
Q90185191 | Contrast media kinetics in multiparametric magnetic resonance imaging before radical prostatectomy predicts the probability of postoperative incontinence |
Q35916397 | Contrast specific imaging in the detection and localization of prostate cancer |
Q89802589 | Contrast-enhanced ultrasound with dispersion analysis for the localization of prostate cancer: correlation with radical prostatectomy specimens |
Q73678774 | Controlled release of therapeutic agents: slow delivery and cell encapsulation |
Q44481198 | Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability |
Q38414402 | Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer. |
Q90895228 | Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach? |
Q33827795 | Controversies in childhood urinary tract infections |
Q95648701 | Correction to: COVID-19 outbreak situation and its psychological impact among surgeons in training in France |
Q104618197 | Correction to: Consultation on kidney stones, Copenhagen 2019: lithotripsy in percutaneous nephrolithotomy |
Q91902639 | Correction to: Evidence-based approach to active surveillance of prostate cancer |
Q96307269 | Correction to: Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia |
Q92785773 | Correction to: Mechanical and functional validation of a perfused, robot-assisted partial nephrectomy simulation platform using a combination of 3D printing and hydrogel casting |
Q90716015 | Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancer |
Q100960080 | Correction to: National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men |
Q99545554 | Correction to: Preoperative urine nitrite versus urine culture for predicting postoperative fever following flexible ureteroscopic lithotripsy: a propensity score matching analysis |
Q89794815 | Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence |
Q93024860 | Correction to: Tissue engineering of the urethra: where are we in 2019? |
Q92095387 | Correction to: Unintended consequences of decreased PSA-based prostate cancer screening |
Q113905239 | Correction: Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study |
Q90703099 | Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia |
Q39699530 | Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway |
Q90915178 | Correlation between prostatic urethral angulation and symptomatic improvement after surgery in patients with lower urinary tract symptoms according to prostate size |
Q90472935 | Correlation between translabial ultrasound parameters and outcomes in retropubic mid-urethral slings: can we predict success? |
Q80559749 | Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage |
Q33405274 | Correlation of in vivo bladder blood flow measurements with tissue hypoxia |
Q50243127 | Correlation of pretreatment clinical parameters and PSA nadir after high-intensity focused ultrasound (HIFU) for localised prostate cancer |
Q51376141 | Correlation of the RENAL nephrometry score with warm ischemia time after robotic partial nephrectomy. |
Q48339903 | Cortical evoked potentials of the vesicourethral junction--a predictor for the outcome of intravesical electrostimulation in patients with sensory and motor detrusor dysfunction |
Q89450490 | Cost analysis of prostate cancer detection including the prostate health index (phi) |
Q92828046 | Cost, training and simulation models for robotic-assisted surgery in pediatric urology |
Q48823810 | Cost-effective management of pelvic fracture urethral injuries. |
Q36008515 | Cost-effectiveness comparison of ureteral calculi treated with ureteroscopic laser lithotripsy versus shockwave lithotripsy |
Q54225407 | Cost-effectiveness of antimicrobial prophylaxis for children in the RIVUR trial. |
Q40219567 | Cost-effectiveness of robot-assisted partial nephrectomy for the prevention of perioperative complications |
Q47936438 | Costs analysis of laparoendoscopic, single-site laparoscopic and open surgery for cT1 renal masses in a European high-volume centre. |
Q49040330 | Cranberry fruit powder (Flowens™) improves lower urinary tract symptoms in men: a double-blind, randomized, placebo-controlled study |
Q97548728 | Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review |
Q91303190 | Critical analysis of urethroplasty for male anterior urethral stricture: a single-center experience |
Q38990697 | Critical appraisal of consecutive 36 cases of post renal transplant lymphocele: a proposed algorithm |
Q51750213 | Cross-cultural differences for adapting overactive bladder symptoms: results of an epidemiologic survey in Korea. |
Q46676983 | Curcumin protects against ischemia/reperfusion injury in rat kidneys |
Q91131481 | Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer |
Q52615656 | Current and future international patterns of care of neurogenic bladder after spinal cord injury. |
Q40958445 | Current and future strategies to block tumor angiogenesis, invasion, and metastasis |
Q57109403 | Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer |
Q41536004 | Current aspects of epidemiology and nutrition in urinary stone disease |
Q33990901 | Current concepts in androgen deprivation therapy--is there a "best" endocrine treatment? |
Q33545980 | Current concepts in imaging of adrenal masses |
Q41465623 | Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. The Finnbladder Research Group |
Q72781945 | Current concepts of radiation treatment of carcinoma in situ of the testis |
Q38202059 | Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies |
Q74782507 | Current controversies in anterior urethral stricture repair: free-graft versus pedicled skin-flap reconstruction |
Q40407404 | Current controversies in nephron-sparing surgery for renal-cell carcinoma |
Q37872241 | Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer |
Q35189268 | Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014. |
Q35200544 | Current evidence on lasers in laparoscopy: partial nephrectomy. |
Q53063187 | Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk. |
Q33657202 | Current methods of diagnosis and management of ureteral injuries |
Q91416816 | Current perspectives on urolithiasis management in China |
Q129178024 | Current practice and unmet training needs in robotic-assisted radical prostatectomy: investigation from the Junior ERUS/YAU working group |
Q38074845 | Current role of salvage robotic-assisted laparoscopic prostatectomy |
Q41738366 | Current roles and controversies in the imaging evaluation of acute renal infection |
Q33827762 | Current scientific understanding of urinary tract infections in women: an overview |
Q95661361 | Current state of image-guided focal therapy for prostate cancer |
Q33602452 | Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH. |
Q37569796 | Current status of laparoendoscopic single-site surgery in urology |
Q33237425 | Current status of robotics in female urology and gynecology |
Q93077435 | Current status of urology surgical training in Europe: an ESRU-ESU-ESUT collaborative study |
Q35790453 | Current status of vesicoureteral reflux diagnosis |
Q91743951 | Current treatment of lichen sclerosus and stricture |
Q83660489 | Current treatment options for clinical stage I seminoma |
Q92226926 | Current use of telehealth in urology: a review |
Q81051017 | Current usefulness of free/total PSA ratio in the diagnosis of prostate cancer at an early stage |
Q53471606 | CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed. |
Q46808305 | Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries--immunohistochemical distribution and functional significance |
Q73146055 | Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle |
Q40401344 | Cystoscopy in the evaluation of benign prostatic hyperplasia |
Q41111895 | Cytokines in tumour growth, migration and metastasis |
Q36553493 | Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis |
Q90019389 | Cytoreductive nephrectomy in metastatic renal cell carcinoma: outcome of patients treated with a multidisciplinary, algorithm-driven approach |
Q38681585 | Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review |
Q38833214 | Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense? |
Q86695688 | D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial |
Q38199640 | DNA comparison between operative and biopsy specimens to investigate stage pT0 after radical prostatectomy. |
Q52010121 | Da Vinci robot assisted Anderson-Hynes dismembered pyeloplasty: technique and 1 year follow-up. |
Q40926947 | Damage to the urinary tract secondary to irradiation |
Q96232403 | Day-case robotic-assisted partial nephrectomy: feasibility and preliminary results of a prospective evaluation (UroCCR-25 AMBU-REIN study) |
Q91237216 | Day-surgery percutaneous nephrolithotomy: a gap between inspiring results and the reality |
Q90111422 | Day-surgery percutaneous nephrolithotomy: a high-volume center retrospective experience |
Q43598363 | Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohort |
Q30808954 | Decrease in apoptosis of germ cells in the testes of infertile men with varicocele |
Q91985085 | Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery |
Q37023860 | Defining the role of NMP22 in bladder cancer surveillance |
Q130024287 | Defining the role of multiparametric MRI in predicting prostate cancer extracapsular extension |
Q77422159 | Defining the role of the bladder-neck sling in the surgical treatment of urinary incontinence in children with neurogenic incontinence |
Q89396671 | Defining the target prior to prostate fusion biopsy: the effect of MRI reporting on cancer detection |
Q102370066 | Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes |
Q88085992 | Delays in radical prostatectomy for prostate cancer and survival outcomes |
Q41709993 | Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different? |
Q53793986 | Denovo urothelial carcinoma of the upper and lower urinary tract in kidney--transplant patients with end-stage analgesic nephropathy. |
Q91389102 | Dependence of laser-induced tissue ablation on optical fiber movements for laser prostatectomy |
Q30308443 | Depression and incontinence |
Q36688941 | Depth of penetration of the neodymium: yttrium-aluminum-garnet laser in the human prostate and clinical results of high-dose laser energy in 50 patients |
Q52906278 | Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors. |
Q35290698 | Description of a modular mentorship programme for holmium laser enucleation of the prostate |
Q89630096 | Design, implementation, and evaluation of a novel curriculum to teach transurethral resection of the prostate (TURP): a 3-year experience of urology simulation bootcamp course |
Q97646940 | Detectable Prostate-specific antigen value between 0.01 and 0.1 ng/ml following robotic-assisted radical prostatectomy (RARP): does it correlate with future biochemical recurrence? |
Q72608634 | Detection of P53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications |
Q100739031 | Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial |
Q37653128 | Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma |
Q92190335 | Determinants and prognostic value of post-operative maximum urethral closure pressure after artificial urinary sphincter in men |
Q89630088 | Determinants of self-reported functional status (EPIC-26) in prostate cancer patients prior to treatment |
Q38922207 | Determining optimal prostate-specific antigen thresholds to identify an increased 4-year risk of prostate cancer development: an analysis within the Veterans Affairs Health Care System |
Q39162308 | Detrusor contraction power parameters (BCI and W max) rise with increasing bladder outlet obstruction grade in men with lower urinary tract symptoms: results from a urodynamic database analysis |
Q51583107 | Detubularized right colonic reservoir with intussuscepted ileal nipple valve or stapled ileal ("Lundiana") outlet. Clinical and urodynamic results in a prospective randomized study. |
Q90394289 | Developing a five-step training model for transperineal prostate biopsies in a naïve residents' group: a prospective observational randomised study of two different techniques |
Q58603535 | Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma |
Q41647263 | Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy |
Q91560732 | Development and internal validation of a nomogram to predict perioperative complications after flexible ureteroscopy for renal stones in overnight ureteral catheterization cases |
Q45072669 | Development and validation of 3D printed virtual models for robot-assisted radical prostatectomy and partial nephrectomy: urologists' and patients' perception |
Q129670017 | Development and validation of a novel home-made bench-top training model for retrograde intrarenal surgery |
Q89845720 | Development and validation of a prediction model for failed shockwave lithotripsy of upper urinary tract calculi using computed tomography information: the S3HoCKwave score |
Q90951897 | Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma |
Q95842680 | Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma |
Q43582044 | Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence |
Q74497067 | Development of a large bladder calculus on sutures used for pubic bone closure following extrophy repair |
Q92762656 | Development of a model to predict prostate cancer at the apex (PCAP model) in patients undergoing robot-assisted radical prostatectomy |
Q97636936 | Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients |
Q50803113 | Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis/chronic pelvic pain syndrome. |
Q89949511 | Development of bioabsorbable zinc-magnesium alloy wire and validation of its application to urinary tract surgeries |
Q56892193 | Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways |
Q31030291 | Development of kidney scars after acute uncomplicated pyelonephritis: relationship with clinical, laboratory and imaging data at diagnosis |
Q53362202 | Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism. |
Q58071276 | Development of novel prognostic models for predicting complications of urethroplasty |
Q34512659 | Development of robotic program: an Asian experience |
Q39257071 | Development of urologic laparoscopy in Germany, Austria, and Switzerland: a survey among urologists |
Q58092284 | Developments in oligometastatic hormone-sensitive prostate cancer |
Q91200096 | Developments in oligometastatic hormone-sensitive prostate cancer |
Q36741342 | Developments in the ureteroscopes, techniques and accessories associated with laser lithotripsy |
Q43347270 | Dhat syndrome, an emergent condition within urology in Spain |
Q73503008 | Diagnosis and management of incidental ureterocele during the treatment of clinically localized prostate cancer |
Q57032539 | Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them? |
Q36325704 | Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline |
Q40407399 | Diagnosis and prognosis of renal-cell tumors: a molecular approach |
Q34317268 | Diagnosis and treatment issues of chronic pelvic pain |
Q74649297 | Diagnosis and treatment of adrenal disorders |
Q33545985 | Diagnosis and treatment of primary aldosteronism |
Q87415953 | Diagnosis of renal tumors by in vivo proton magnetic resonance spectroscopy |
Q48320897 | Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. |
Q90444989 | Diagnostic accuracy of contrast-enhanced voiding urosonogram using second-generation contrast with harmonic imaging (CEVUS-HI) study for assessment of vesicoureteral reflux in children: a meta-analysis |
Q41617234 | Diagnostic accuracy of neonatal kidney ultrasound in children having antenatal hydronephrosis without ureter and bladder abnormalities |
Q90748253 | Diagnostic accuracy of third-generation dual-source dual-energy CT: a prospective trial and protocol for clinical implementation |
Q91509181 | Diagnostic accuracy of ultrasonography, computed tomography, cystoscopy and cytology to detect urinary tract malignancies in patients with asymptomatic hematuria |
Q128581771 | Diagnostic and treatment patterns in urinary and genital tract infections: insights from a referral clinic in Beirut, Lebanon |
Q34712030 | Diagnostic approach to the aging male |
Q93361498 | Diagnostic biomarkers in non-muscle invasive bladder cancer |
Q39794124 | Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy |
Q92009666 | Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis |
Q45211941 | Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range |
Q93143802 | Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage |
Q90673461 | Diagnostic utility of penile ultrasound in Peyronie's disease |
Q38542673 | Diagnostic value of serum procalcitonin for acute pyelonephritis in infants and children with urinary tract infections: an updated meta-analysis. |
Q44743836 | Diagnostic value of the pediatric lower urinary tract symptom score in children with overactive bladder. |
Q88250585 | Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies |
Q93201636 | Diagnostic accuracy of ultrasonography to detect urinary tract malignancies in patients with asymptomatic hematuria: importance of diagnostic added value to avoid misinterpretation |
Q35002417 | Diet and prostate cancer prevention |
Q38220973 | Diet: from food to stone |
Q40685549 | Differences between intrinsic and extrinsic ureteropelvic junction obstruction related to crossing vessels: histology and functional analyses |
Q101404051 | Differences between rural and urban prostate cancer patients |
Q46836320 | Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival. |
Q87019072 | Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey |
Q36304478 | Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study |
Q91363605 | Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis |
Q53142704 | Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis. |
Q38924997 | Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity |
Q71646676 | Differential expression of transforming growth factor-?1 and ?3 as well as C-FOS mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer |
Q84757529 | Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography |
Q34320021 | Diffusion of robotics into clinical practice in the United States: process, patient safety, learning curves, and the public health |
Q56114101 | Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia |
Q60061112 | Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time |
Q45843908 | Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma |
Q34278564 | Dismembered and non-dismembered retroperitoneoscopic pyeloplasty for the treatment of ureteropelvic junction obstruction in children |
Q35215383 | Disposable devices for RIRS: where do we stand in 2013? What do we need in the future? |
Q38044251 | Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours |
Q36332512 | Distribution and functional significance of phosphodiesterase isoenzymes in the human lower urinary tract |
Q47865409 | Distribution of prostate carcinoma foci within the peripheral zone: analysis of 8,062 prostate biopsy cores |
Q46113610 | Do current bladder smooth muscle cell isolation procedures result in a homogeneous cell population? Implications for bladder tissue engineering |
Q81425093 | Do early injections of bulking agents following radical prostatectomy improve early continence? |
Q88498836 | Do longer or shorter cores yield more cancer? |
Q35630890 | Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis. |
Q89396675 | Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment |
Q93169238 | Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group |
Q44617181 | Do pure squamous cell carcinomas and urothelial carcinomas have similar prognosis after radical cystectomy? |
Q38149731 | Do robotic prostatectomy positive surgical margins occur in the same location as extraprostatic extension? |
Q38084591 | Do targeted agents offer clinical benefit as presurgical therapy? |
Q38199639 | Do we know (or just believe) that partial nephrectomy leads to better survival than radical nephrectomy for renal cancer? |
Q37956117 | Do we need meshes in pelvic floor reconstruction? |
Q53777559 | Do we need new trials for the abiraterone, enzalutamide and cabazitaxel in metastatic castrate-resistant prostate cancer for confirmation of treatment indications? |
Q43539044 | Do we need the nerve sparing radical prostatectomy techniques (intrafascial vs. interfascial) in men with erectile dysfunction? Results of a single-centre study |
Q46506804 | Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation |
Q63966580 | Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort |
Q37275577 | Does 3-Dimensional (3-D) visualization improve the quality of assistance during robotic radical prostatectomy? |
Q92137463 | Does COVID-19 affect male fertility? |
Q46656192 | Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate |
Q92535848 | Does YouTube include high-quality resources for training on laparoscopic and robotic radical prostatectomy? |
Q96766458 | Does bipolar energy provide any advantage over monopolar surgery in transurethral resection of non-muscle invasive bladder tumors? A systematic review and meta-analysis |
Q97546591 | Does bipolar energy provide any advantage over monopolar surgery in transurethral resection of non-muscle invasive bladder tumors? A systematic review and meta-analysis |
Q39843486 | Does educational printed material manage to change compliance with prostate cancer screening? |
Q43582440 | Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? |
Q52855567 | Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies? |
Q57806100 | Does mechanical morcellation of large glands compromise incidental prostate cancer detection on specimen analysis? A pathological comparison with open simple prostatectomy |
Q37238892 | Does mechanical stimulation have any role in urinary bladder tissue engineering? |
Q37929644 | Does partial nephrectomy at an academic institution result in better outcomes? |
Q44216237 | Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series |
Q40607322 | Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? |
Q37262835 | Does radical treatment have a role in the management of low-risk prostate cancer? The place for brachytherapy and external beam radiotherapy |
Q44669201 | Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T-pouch ileal neobladders |
Q57063461 | Does routine repeat imaging change management in high-grade renal trauma? Results from three level 1 trauma centers |
Q50101167 | Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort |
Q83219199 | Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy? |
Q41111225 | Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival? |
Q46774640 | Does tourniquet application alter the nitrergic responses of rabbit corpus cavernosum penis? A functional study |
Q90895190 | Donate or not to donate if with visceral obesity |
Q90318495 | Donor kidney volume measured by computed tomography is a strong predictor of recipient eGFR in living donor kidney transplantation |
Q74782510 | Dorsal onlay urethroplasty for urethral stricture repair |
Q38720755 | Dose dense MVAC prior to radical cystectomy: a real-world experience |
Q39488508 | Double-blind study with dipyrone versus tramadol and butylscopolamine in acute renal colic pain |
Q96820021 | Double-face preputial island flap revisited: is it a reliable one-stage repair for severe hypospadias? |
Q120633377 | Double-sheath vacuum suction versus vacuum-assisted sheath minimally invasive percutaneous nephrolithotomy for management of large renal stones: single-center experience |
Q54692840 | Down-regulation of Ku 70 and Ku 80 mRNA expression in transitional cell carcinomas of the urinary bladder related to tumor progression. |
Q73157917 | Down-regulation of endothelin-B receptor sites in cavernosal tissue of a rabbit model of partial bladder outlet obstruction: potential clinical relevance |
Q28262766 | Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease |
Q50205625 | Dual energy can accurately differentiate uric acid-containing urinary calculi from calcium stones |
Q49827595 | Dual-centre randomized-controlled trial comparing transurethral endoscopic enucleation of the prostate using diode laser vs. bipolar plasmakinetic for the treatment of LUTS secondary of benign prostate obstruction: 1-year follow-up results. |
Q36679106 | Durability of laser fibers |
Q88361042 | Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial |
Q38378257 | Dutasteride is associated with reduced risk of transrectal prostate biopsy-associated urinary tract infection and related hospitalizations |
Q37953221 | ECIRS (Endoscopic Combined Intrarenal Surgery) in the Galdakao-modified supine Valdivia position: a new life for percutaneous surgery? |
Q92608782 | EMS Lithoclast Trilogy™: an effective single-probe dual-energy lithotripter for mini and standard PCNL |
Q36741346 | ESWL and the future of stone management |
Q36782574 | ESWL in situ or ureteroscopy for ureteric stones? |
Q102202197 | Early continence after ileal neobladder: objective data from inpatient rehabilitation |
Q93118125 | Early discharge in selected patients with low-grade renal trauma |
Q93232326 | Early experience with Watson for Oncology: a clinical decision-support system for prostate cancer treatment recommendations |
Q38014679 | Early hypospadias repair: the contributions of Harvey Cushing |
Q88886435 | Early neurological care of patients with spinal cord injury |
Q89986167 | Early recovery after surgery for radical cystectomy: comprehensive assessment and meta-analysis of existing protocols |
Q35877277 | Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings |
Q38567164 | Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia. |
Q52588920 | Early tumor shrinkage is independently associated with improved overall survival among patients with metastatic renal cell carcinoma: a validation study using the COMPARZ cohort. |
Q89282303 | Early urological care of patients with spinal cord injury |
Q38127349 | Early versus delayed hormonal treatment in locally advanced or asymptomatic metastatic prostatic cancer patient dilemma |
Q37409352 | Economic aspects of bladder cancer: what are the benefits and costs? |
Q34694701 | Economics of transurethral thermotherapy of the prostate |
Q74111379 | Ectopic refluxing ureter entering a seminal vesicle cyst associated with ipsilateral renal dysplasia |
Q86877263 | Editorial for a special issue on kidney transplant |
Q59575018 | Editorial for special issue on epidemiology and prevention of prostate cancer |
Q37835751 | Education and training in evidence-based urology |
Q91303196 | Effect of active versus passive void trials on time to patient discharge, urinary tract infection, and urinary retention: a randomized clinical trial |
Q45839479 | Effect of dorsal vascular complex size on the recovery of continence after radical prostatectomy |
Q38637432 | Effect of endoplasmic reticulum stress inhibition on hyperoxaluria-induced oxidative stress: influence on cellular ROS sources |
Q91857355 | Effect of hospital volume on 90-day mortality after radical cystectomy for bladder cancer in Spain |
Q96023586 | Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies |
Q40584336 | Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP. |
Q51302414 | Effect of minimizing tension during robotic-assisted laparoscopic radical prostatectomy on urinary function recovery. |
Q90084421 | Effect of optical fiber diameter and laser emission mode (cw vs pulse) on tissue damage profile using 1.94 µm Tm:fiber lasers in a porcine kidney model |
Q35127204 | Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat |
Q73157904 | Effect of partial outflow obstruction on the distribution of free fatty acids and phospholipids in the rabbit bladder |
Q47902492 | Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy |
Q43347576 | Effect of pelvic floor muscle contraction on vesical and rectal function with identification of puborectalis-rectovesical inhibitory reflex and levator-rectovesical excitatory reflex |
Q50074126 | Effect of post-nephrectomy acute kidney injury on renal outcome: a retrospective long-term study. |
Q97070380 | Effect of potassium sodium hydrogen citrate granules on preventing adherent stones on ureteral stent after retrograde intrarenal surgery |
Q42655948 | Effect of pre-contraction on β-adrenoceptor-mediated relaxation of rat urinary bladder |
Q46285307 | Effect of renal pelvic distension on the ureteropelvic and ureterovesical junctions and the urinary bladder: the renal pelvivesical reflex |
Q37288488 | Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats |
Q39390985 | Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells |
Q90156004 | Effect of urodynamic preoperative detrusor overactivity on the outcomes of transurethral surgery in patients with male bladder outlet obstruction: a systematic review and meta-analysis |
Q88610744 | Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma |
Q53176671 | Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial. |
Q46054345 | Effects of arginase inhibitors on the contractile and relaxant responses of isolated human penile erectile tissue |
Q96581310 | Effects of irrigation parameters and access sheath size on the intra-renal temperature during flexible ureteroscopy with a high-power laser |
Q72608625 | Effects of magnesium citrate and phytin on reducing urinary calcium excretion in rats |
Q57222130 | Effects of partial outlet obstruction on bladder-strip sensitivity to glucose deprivation: an in vitro study in the rat |
Q41733923 | Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1. |
Q30751186 | Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies |
Q41953078 | Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy |
Q51245873 | Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review. |
Q92597291 | Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer |
Q41705995 | Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study |
Q90322131 | Efficacy and safety of aquablation of the prostate for patients with symptomatic benign prostatic enlargement: a systematic review |
Q35087049 | Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis |
Q87774091 | Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis |
Q99637612 | Efficacy and safety of mirabegron versus solifenacin as additional therapy for persistent OAB symptoms after tamsulosin monotherapy in men with probable BPO |
Q90235571 | Efficacy and safety of mirabegron, a β3-adrenoceptor agonist, for treating neurogenic bladder in pediatric patients with spina bifida: a retrospective pilot study |
Q91245087 | Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists |
Q94597421 | Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis |
Q39976026 | Efficacy and safety of skeletonized mesh implants for advanced pelvic organ prolapse: 12-month follow-up |
Q40777782 | Efficacy and safety of the ZSI375 artificial urinary sphincter for male stress urinary incontinence: lessons learned. |
Q48075632 | Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity |
Q53363335 | Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group. |
Q46535726 | Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder |
Q48150004 | Efficacy and tolerability of solifenacin in men with overactive bladder: results of an observational study |
Q46778581 | Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy |
Q47981131 | Efficacy of PDE5Is and SSRIs in men with premature ejaculation: a new systematic review and five meta-analyses. |
Q43408939 | Efficacy of antibiotic prophylaxis in patients undergoing cystoscopy: a randomized clinical trial |
Q48279396 | Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysis. |
Q91324973 | Efficacy of intra-arterial chemotherapy combined with intravesical chemotherapy in T1G3 bladder cancer when compared with intravesical chemotherapy alone after bladder-sparing surgery: a retrospective study |
Q48293327 | Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study |
Q34709479 | Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study |
Q43479226 | Efficacy of routine follow-up after first-line treatment for testicular cancer |
Q48095532 | Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study |
Q34473221 | Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic). |
Q39370001 | Efficient pathway for early detection of prostate cancer concluded from a 5-year prospective study. |
Q99419893 | Ejaculation-sparing thulium laser enucleation of the prostate (ES-ThuLEP): outcomes on a large cohort |
Q44263180 | Ejaculatory disorders |
Q91778035 | Ejaculatory disorders after prostatic artery embolization: a reassessment of two prospective clinical trials |
Q36132063 | Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping |
Q40831106 | Ejaculatory failure |
Q46823957 | Elastin morphology in normal and obstructed guinea-pig bladders. Localization of elastin to the trigone |
Q89303338 | Elderly patients aged ≥ 75 years with locally advanced prostate cancer may benefit from local treatment: a population-based propensity score-adjusted analysis |
Q54538708 | Electrified urinary drainage bag: an in vitro study. |
Q57469739 | Electroacupuncture for postmenopausal women with stress urinary incontinence: secondary analysis of a randomized controlled trial |
Q92473403 | Electroacupuncture for women with urgency-predominant mixed urinary incontinence: secondary analysis of a randomized noninferiority trial |
Q40599237 | Electrophysiological methods in smooth-muscle physiology. Corpus cavernosum in vitro |
Q73539101 | Electrophysiological recordings during the peripheral nerve evaluation (PNE) test in complete spinal cord injury patients |
Q46608460 | Electrovasogram in patients with obstructive azoospermia and absent vas deferens |
Q41156069 | Elevated plasma aldosterone is an independent risk factor for erectile dysfunction in men. |
Q43298561 | Elevated scrotal temperature, but not varicocele grade, reflects testicular oxidative stress-mediated apoptosis |
Q90046417 | Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate |
Q90264144 | Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC) |
Q93138168 | En bloc greenlight laser enucleation of prostate (GreenLEP): about the first hundred cases |
Q92203342 | En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study |
Q92104329 | En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer |
Q53317396 | En bloc resection of urothelial cancer within the urinary bladder: the upcoming gold standard? : Re: Kramer MW, Wolters M, Cash H, Jutzi S, Imkamp F, Kuczyk MA, Merseburger AS, Herrmann TR. Current evidence of transurethral Ho:YAG and Tm:YAG treatme |
Q35614120 | En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. |
Q35192401 | En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial |
Q92135871 | En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future? |
Q28213791 | Endocrine response to masturbation-induced orgasm in healthy men following a 3-week sexual abstinence |
Q86513460 | Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial |
Q38887630 | Endoscopic description of renal papillary abnormalities in stone disease by flexible ureteroscopy: a proposed classification of severity and type |
Q97907351 | Endoscopic enucleation for prostate larger than 60 mL: comparison between holmium laser enucleation and plasmakinetic enucleation |
Q51362745 | Endoscopic extraperitoneal radical prostatectomy in patients with prostate cancer and previous laparoscopic inguinal mesh placement for hernia repair. |
Q36749905 | Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 1,300 cases |
Q37394652 | Endoscopic inguinal lymph node dissection for penile carcinoma: the developing of a novel technique |
Q89338271 | Endoscopic intact removal of medium-size- or multiple bladder stones with the use of transvesical laparoendoscopic single-site surgery |
Q90895206 | Endoscopic observations as a tool to define underlying pathology in kidney stone formers |
Q74782505 | Endoscopic skin-graft urethroplasty |
Q36011743 | Endothelin receptor antagonists |
Q34041746 | Endourologic management of upper tract transitional cell carcinoma |
Q90569636 | Endourology survey on radiation exposure and post-ureteroscopy US and CT reveals a need for clear guidelines |
Q91778021 | Energy output modalities of shockwave lithotripsy in the treatment of urinary stones: escalating or fixed voltage? A systematic review and meta-analysis |
Q34209753 | Engineering of cells and tissues for treatment of erectile dysfunction |
Q91870890 | Engineering of erectile tissue: the state and future of corporal restoration |
Q99365971 | Enhanced recovery after surgery (ERAS) following radical cystectomy: is it worth implementing for all patients? |
Q48108896 | Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium |
Q95842668 | Enhanced super-mini-PCNL (eSMP): low renal pelvic pressure and high stone removal efficiency in a prospective randomized controlled trial |
Q34005624 | Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC). |
Q42609792 | Enucleation is enucleation is enucleation is enucleation |
Q70803490 | Enucleation procedures in patients with multiple hereditary renal tumors |
Q44702001 | Environmental exposure, chlorinated drinking water, and bladder cancer |
Q28282581 | Epicurus' death |
Q35798770 | Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma |
Q38128732 | Epidemiological gender-specific aspects in urolithiasis |
Q77422103 | Epidemiology and etiology of urinary incontinence in the elderly |
Q54214039 | Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury. |
Q57640122 | Epidemiology and screening for renal cancer |
Q36304503 | Epidemiology of hypospadias in Europe: a registry-based study |
Q88076125 | Epidemiology of prostate cancer |
Q35113800 | Epidemiology of prostatitis: new evidence for a world-wide problem |
Q39141674 | Epidemiology of stone disease across the world |
Q36832297 | Epidemiology of urinary bladder cancer: from tumor development to patient's death |
Q92565915 | Epidemiology of urological infections: a global burden |
Q88956024 | Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art |
Q38948721 | Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). |
Q90933050 | Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer |
Q37928501 | Epidemiology, treatment and prevention of healthcare-associated urinary tract infections |
Q40958225 | Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate |
Q92137478 | Epidural anesthesia may be associated with increased postoperative complications in the elderly population undergoing radical cystectomy: an analysis from the National Surgical Quality Improvement Project (NSQIP) database |
Q86214157 | Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma |
Q36421782 | Equipment and technology in surgical robotics |
Q33208223 | Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors |
Q88564272 | Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies |
Q62778062 | Erectile dysfunction: a global review of intracavernosal injectables |
Q87374744 | Erratum to: Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population |
Q87401719 | Erratum to: En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial |
Q86060268 | Erratum to: Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch |
Q48131290 | Erratum to: Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review. |
Q57582162 | Erratum to: Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications |
Q81597142 | Erythropoietin producing cells for potential cell therapy |
Q115772254 | Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial |
Q98665616 | Essential elements of anaesthesia practice in ERAS programs |
Q47630467 | Establishing and monitoring of urethral sphincter deficiency in a large animal model. |
Q34283851 | Establishment of a protocol for large-scale gene expression analyses of laser capture microdissected bladder tissue. |
Q53647288 | Estimated functional renal parenchymal volume predicts the split renal function following renal surgery. |
Q71696041 | Estimation of urethral resistance by curve fitting in the pressure-flow plot. Theory and experience in normal men and men with benign prostatic hypertrophy |
Q39016578 | Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch |
Q83215417 | Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch |
Q38098399 | Etiology of chronic prostatitis/chronic pelvic pain syndrome: psychoimmunoneurendocrine dysfunction (PINE syndrome) or just a really bad infection? |
Q35139893 | Etiology: where does prostatitis stop and interstitial cystitis begin? |
Q104751042 | Evaluating outcomes of complete supine percutaneous nephrolithotomy for staghorn vs multiple non-staghorn renal stones: a 10-year study |
Q36739758 | Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. |
Q36986295 | Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. |
Q93184861 | Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories |
Q36679097 | Evaluating the efficacy, safety, and cost of lasers for the treatment of benign prostatic hyperplasia. |
Q40178727 | Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT. |
Q97531908 | Evaluation of 30-day complication rates following vaginal anterior compartment repair with and without graft augmentation in a propensity score matched cohort |
Q112586071 | Evaluation of a free 3D software for kidney stones' surgical planning: "kidney stone calculator" a pilot study |
Q129245408 | Evaluation of a novel circulation system for ureteroscopic laser lithotripsy in vitro |
Q45753664 | Evaluation of bladder capacity in Korean children younger than 24 months: a nationwide multicenter study |
Q49670684 | Evaluation of clinical staging of the American Joint Committee on Cancer (eighth edition) for prostate cancer |
Q48608975 | Evaluation of complications in endoscopic extraperitoneal radical prostatectomy in a modular training programme: a multicentre experience |
Q81324003 | Evaluation of early pelvic floor physiotherapy on the duration and degree of urinary incontinence after radical retropubic prostatectomy in a non-teaching hospital |
Q98774275 | Evaluation of efficacy of oxygen-enriched oil-based gel dressing in patients who underwent surgical repair of distal hypospadias: a prospective randomised clinical trial |
Q90330645 | Evaluation of flexible ureteroscope with an omni-directional bending tip, using a JOYSTICK unit (URF-Y0016): an ex-vivo study |
Q79926745 | Evaluation of laparoscopic radical cystectomy for loco-regionally advanced bladder cancer |
Q92887565 | Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy |
Q47221452 | Evaluation of pain perception associated with use of the magnetic-end ureteric double-J stent for short-term ureteric stenting |
Q36020770 | Evaluation of penile perfusion by color-coded duplex sonography in the management of erectile dysfunction |
Q98160253 | Evaluation of pre-operative bladder contractility as a predictor of improved response rate to a staged trial of sacral neuromodulation in patients with detrusor underactivity |
Q60704996 | Evaluation of renal damage by urinary enzyme dosage |
Q35727387 | Evaluation of renal function in patients with a main renal stone larger than 1 cm and perioperative renal functional change in minimally invasive renal stone surgery: a prospective, observational study. |
Q51334121 | Evaluation of sexual function in women at two stages of multiple sclerosis. |
Q96128900 | Evaluation of stone free rates in early versus delayed primary ureteroscopy: time does matter |
Q90569628 | Evaluation of the "Teaching Guide for Basic Laparoscopic Skills" as a stand-alone educational tool for hands-on training sessions: a pilot study |
Q50890262 | Evaluation of the 'Prostate Interdisciplinary Communication and Mapping Algorithm for Biopsy and Pathology' (PIC-MABP). |
Q87479767 | Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis |
Q90026051 | Evaluation of the draft guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women |
Q58564413 | Evaluation of the effect of urethroplasty for anterior urethral strictures by a validated disease-specific patient-reported outcome measure |
Q34317011 | Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach |
Q90101833 | Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients |
Q41116625 | Evaluation of three-dimensional printing for laparoscopic partial nephrectomy of renal tumors: a preliminary report |
Q80565335 | Evaluation of tumor thrombi in the inferior vena cava with intraoperative ultrasound |
Q99554087 | Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease |
Q96643173 | Every ureteral stone deserves conventional management prior to intervention |
Q93132918 | Evidence that surgical performance predicts clinical outcomes |
Q91378940 | Evidence-based approach to active surveillance of prostate cancer |
Q83509043 | Evidence-based medicine in urology |
Q89949504 | Evidence-based medicine in urology |
Q57575135 | Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis |
Q38025912 | Evolution and simplified terminology of natural orifice transluminal endoscopic surgery (NOTES), laparoendoscopic single-site surgery (LESS), and mini-laparoscopy (ML). |
Q53544165 | Evolution from laparoscopic to robotic nephron sparing surgery: a high-volume laparoscopic center experience on achieving 'trifecta' outcomes. |
Q129661604 | Evolution of anxiety management in prostate biopsy under local anesthesia: a narrative review |
Q92237860 | Evolution of definitive external beam radiation therapy in the treatment of prostate cancer |
Q51840634 | Evolution of endoscopic extraperitoneal radical prostatectomy (EERPE)--technical improvements and development of a nerve-sparing, potency-preserving approach. |
Q46084199 | Evolution of health-related quality of life two to seven years after retropubic radical prostatectomy: evaluation by UCLA prostate cancer index |
Q71324649 | Evolution of outcomes with the ileal hydraulic valve continent diversion: reevaluation of the Benchekroun catheterizable stoma |
Q63966583 | Evolution of repeat prostate biopsy strategies incorporating transperineal and MRI–TRUS fusion techniques |
Q88085987 | Evolution of technologies in urology: full steam ahead? |
Q91753406 | Evolution of the surgical sealing patch TachoSil® in Peyronie's disease reconstructive surgery: technique and contemporary literature review |
Q39885213 | Evolution on experimental animal model for upper urothelium carcinogenesis |
Q53216826 | Evolving concepts in muscle-invasive bladder cancer. |
Q31108321 | Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry |
Q101406112 | Evolving robotic surgery training and improving patient safety, with the integration of novel technologies |
Q35102224 | Evolving strategies for prostate cancer chemoprevention trials |
Q33719011 | Examining health-related quality of life in men treated for prostate cancer |
Q89485786 | Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial |
Q37203774 | Exit strategies following percutaneous nephrolithotomy (PCNL): a comparison of surgical outcomes in the Clinical Research Office of the Endourological Society (CROES) PCNL Global Study |
Q38104313 | Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses. |
Q38231245 | Expansion of the role of web-based social networks related to synthetic mesh/tape complications |
Q74068035 | Expectant management as an option for men with stage T1c prostate cancer: a preliminary study |
Q30992073 | Experience on semirigid ureteroscopy and pneumatic lithotripsy in children at a single center |
Q91720064 | Experience with detrusorotomy in children by open and robotic approach |
Q53301305 | Experience with different questionnaires in the management of patients with CP/CPPS: GPSS, IPSS and NIH-CPSI. |
Q36679120 | Experience with the Ultraline and Urolase laser fibers: is there any difference? |
Q73678772 | Experimental and clinical experience using tissue regeneration for urethral reconstruction |
Q37392045 | Experimental animal model and RNA interference: a promising association for bladder cancer research. |
Q40905644 | Experimental basis of shockwave-induced renal trauma in the model of the canine kidney |
Q37222356 | Experimental rat bladder urothelial cell carcinoma models |
Q77617271 | Experimental results on mechanisms of action of electrical neuromodulation in chronic urinary retention |
Q130029622 | Experts’ recommendations in laser use for the treatment of urolithiasis: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training-Research in Urological Surgery and Technology (T.R.U.S.T.)-Group |
Q112683493 | Explainable artificial intelligence (XAI): closing the gap between image analysis and navigation in complex invasive diagnostic procedures |
Q53221039 | Exploratory factor analysis: strategies used by patients to promote health. |
Q39686307 | Expression and clinical significance of hepaCAM and VEGF in urothelial carcinoma |
Q51652607 | Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients. |
Q39097666 | Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage. |
Q51819479 | Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness. |
Q44005162 | Expression of transient receptor potential vanilloid 4 and effects of ruthenium red on detrusor overactivity associated with bladder outlet obstruction in rats |
Q91658935 | Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer |
Q85541913 | Expression of β-tubulin isotypes in urothelial carcinoma of the bladder |
Q47834178 | Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC). |
Q53649230 | Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer. |
Q43836135 | Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines |
Q43668564 | Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? |
Q41288218 | Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis |
Q40933499 | Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years. |
Q91839638 | Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis |
Q41706002 | Extent of pelvic lymph node dissection in penile cancer may impact survival |
Q35196648 | External beam radiation therapy: role of androgen deprivation |
Q96688194 | External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients |
Q41379215 | External vacuum therapy for erectile dysfunction: use and results |
Q83053056 | External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer |
Q92454963 | External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers |
Q92104320 | External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomy |
Q90703113 | External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma |
Q46728739 | External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer |
Q44888718 | External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses |
Q44323809 | External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma |
Q42666935 | External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery |
Q91537265 | Extirpative renal surgery volume in training: different roads to the (same?) destination |
Q47612467 | Extra-anatomical transobturator bypass graft for femoral artery involvement by metastatic carcinoma of the penis: report of five patients |
Q90994439 | Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer |
Q71341493 | Extracellular matrix and integrin composition of the normal bladder wall |
Q84230057 | Extracellular matrix remodeling in the human gubernaculum during fetal testicular descent and in cryptorchidic children |
Q34891752 | Extracorporeal lithotripsy endoscopically controlled by ureterorenoscopy (LECURS): a new concept for the treatment of kidney stones-first clinical experience using digital ureterorenoscopes. |
Q44739814 | Extracorporeal shock wave lithotripsy in children: experience using a mpl-9000 lithotriptor |
Q38815958 | Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain |
Q30590054 | Extracting data from electronic medical records: validation of a natural language processing program to assess prostate biopsy results |
Q83940447 | Extraperitoneal laparo-endoscopic single-site radical prostatectomy: first experience |
Q82967625 | Extraperitoneal laparoscopic adenomectomy for benign prostatic hyperplasia |
Q52908264 | Extraperitoneal radical cystectomy with extraperitonealization of the ileal neobladder: a comparison to the transperitoneal technique. |
Q44294699 | Extraperitoneal robot-assisted laparoscopic radical prostatectomy: a single-center experience beyond the learning curve |
Q43995951 | Extraperitoneal transumbilical laparoendoscopic single-site radical prostatectomy using a homemade single-port device: 20 cases with midterm outcomes |
Q36125670 | Factors affecting complication rates of retrograde flexible ureterorenoscopy: analysis of 1571 procedures-a single-center experience |
Q40680582 | Factors affecting hospital readmission and rehospitalization following percutaneous nephrolithotomy |
Q41575910 | Factors affecting post-pubertal penile size in patients with hypospadias |
Q80565339 | Factors affecting successful outcome from ICSI in men following previous vasectomy |
Q51354932 | Factors associated with non-orthotopic urinary diversion after radical cystectomy. |
Q90293694 | Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy |
Q89424859 | Factors influencing urinary retention after transperineal template biopsy of the prostate: outcomes from a regional cancer centre |
Q53057039 | Factors predicting inguinal node metastasis in squamous cell cancer of penis. |
Q47865504 | Factors that influence lower urinary tract symptom (LUTS)-related quality of life (QoL) in a healthy population |
Q43161348 | Factors that influence the outcome of open urethroplasty for pelvis fracture urethral defect (PFUD): an observational study from a single high-volume tertiary care center |
Q37967386 | Failures and complications in pelvic floor surgery |
Q79190494 | False-positive lesions detected by fluorescence cystoscopy: any association with p53 and p16 expression? |
Q37960826 | Familial risk and familial survival in prostate cancer |
Q30884117 | Familial risk of urological cancers: data for clinical counseling |
Q51308361 | Fascicular anatomy and surgical access of the human pudendal nerve. |
Q52928495 | Fast-track surgery in laparoscopic radical prostatectomy: basic principles. |
Q33404616 | Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate |
Q38203840 | Feasibility and outcomes regarding open and laparoscopic radical prostatectomy in patients with previous synthetic mesh inguinal hernia repair: meta-analysis and systematic review of 7,497 patients |
Q98179248 | Feasibility and relevance of urine culture during stone fragmentation in patients undergoing percutaneous nephrolithotomy and retrograde intrarenal surgery: a prospective study |
Q38808884 | Feasibility and safety of augmented reality-assisted urological surgery using smartglass. |
Q92298726 | Feasibility and safety of laparoscopic living donor nephrectomy in case of right kidney and multiple-renal artery kidney: a systematic review of the literature |
Q97087983 | Feasibility and safety of magnetic-end double-J ureteral stent insertion and removal in children |
Q90084418 | Feasibility of adopting retroperitoneal robotic partial nephrectomy after extensive transperitoneal experience |
Q92735769 | Feasibility of holmium laser enucleation of the prostate as a 1-day surgery |
Q53472993 | Feasibility of performing dynamic sentinel lymph node biopsy as a delayed procedure in penile cancer. |
Q48143698 | Feasibility of radical cystectomy in exclusive spinal and/or epidural anaesthesia |
Q41525911 | Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad® Soluble focal treatment for localized prostate cancer. |
Q51292827 | Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. |
Q43768140 | Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy |
Q34727994 | Female sexual desire disorders: subtypes, classification, personality factors and new directions for treatment |
Q51778031 | Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction. |
Q38508082 | Female stress urinary incontinence and the mid-urethral sling: is obstruction necessary to achieve dryness? |
Q90203145 | Female urethral reconstruction: dorsal buccal mucosa graft onlay |
Q47988035 | Female urethral stricture: a contemporary series. |
Q93232156 | Female urethroplasty: contemporary thinking |
Q50876266 | Feminizing genitoplasty: state of the art. |
Q89282323 | Fertility and sexuality in the spinal cord injury patient |
Q100317226 | Fertility and sexuality issues in congenital lifelong urology patients: female aspects |
Q89749167 | Fertility and sexuality issues in congenital lifelong urology patients: male aspects |
Q72781948 | Fertility considerations in nerve-sparing retroperitoneal lymph-node dissection |
Q70468173 | Fertility in the testicular cancer patient |
Q37437326 | Fertility potential after unilateral and bilateral orchidopexy for cryptorchidism |
Q91416818 | Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy |
Q48145224 | Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement |
Q57032536 | Fiducial markers: can the urologist do better? |
Q39061810 | Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients |
Q40865231 | Final pathohistology after radical prostatectomy in patients eligible for active surveillance (AS). |
Q94555919 | Final results of the PräVAC trial: prevention of wound complications following inguinal lymph node dissection in patients with penile cancer using epidermal vacuum-assisted wound closure |
Q85267995 | First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival |
Q51246503 | First clinical evaluation of a new innovative ureteral access sheath (Re-Trace™): a European study. |
Q40429255 | First clinical evaluation of a new single-use flexible cystoscope dedicated to double-J stent removal (Isiris™): a European prospective multicenter study |
Q39348365 | First clinical evaluation of a new single-use flexible ureteroscope (LithoVue™): a European prospective multicentric feasibility study. |
Q86576893 | First findings of gap junction proteins in human urothelial carcinoma |
Q39185003 | First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy. |
Q36482570 | First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment? |
Q91715918 | Five compelling UTI questions after kidney transplant |
Q37812561 | Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity |
Q30315011 | Five-year experience with the adjustable transobturator male system for the treatment of male stress urinary incontinence: a single-center evaluation |
Q36345613 | Five-year outcomes of thulium vapoenucleation of the prostate for symptomatic benign prostatic obstruction. |
Q88097048 | Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies |
Q33286715 | FlexGuard: a new laser insertion sheath: functional aspects in ureterorenoscopy (URS). |
Q47346791 | Flexible ureterorenoscopy versus miniaturized PNL for solitary renal calculi of 10-30 mm size |
Q99602895 | Flexible ureteroscopy in extreme elderly patients (80 years of age and older) is feasible and safe |
Q96820014 | Floating docking technique: a simple modification to improve the working space of the instruments during single-port robotic surgery |
Q60355496 | Flow cytometric evaluation of bladder cancer: recommendations of the NCI flow cytometry network for bladder cancer |
Q40860531 | Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience |
Q86583810 | Flow matters 2: How to improve irrigation flow in small-calibre percutaneous procedures-the purging effect |
Q84329634 | Flow rate models in renal obstruction |
Q80494824 | Fluid perfused urethral pressure profilometry and Valsalva leak point pressure: a comparative study in a biophysical model of the urethra |
Q44564416 | Fluorescence diagnosis: a novel method to guide radical inguinal lymph node dissection in penile cancer |
Q53636094 | Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy. |
Q63966569 | Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial |
Q38190412 | Fluoroscopy time during uncomplicated unilateral ureteroscopy for urolithiasis decreases with urology resident experience. |
Q49937041 | Fluoroscopy-free ultrasonography-guided percutaneous nephrolithotomy in pediatric patients: a single-center experience |
Q97427012 | Focal HIFU therapy for anterior compared to posterior prostate cancer lesions |
Q96128908 | Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE) |
Q91172262 | Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project |
Q35969717 | Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review |
Q85050865 | Focal therapy in urologic oncology: maximizing organ function and oncologic disease control |
Q88690665 | Follow-up after curative treatment of localised renal cell carcinoma |
Q30829030 | Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project |
Q104582314 | Follow-up in non-muscle invasive bladder cancer: facts and future |
Q38307414 | Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project |
Q39738347 | Follow-up of men obtaining a six-core versus a ten-core benign prostate biopsy 7 years previously |
Q88766160 | Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer? |
Q90264189 | Following the crowd: patterns of crowdsourcing on Twitter among urologists |
Q58614975 | Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when? |
Q51824062 | Four-arm robotic partial nephrectomy for complex renal cell carcinoma. |
Q83627877 | Four-year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes |
Q47389405 | Franz von Paula Gruithuisen (1774-1852): lithotrity pioneer and astronomer. On the 150th anniversary of his death |
Q36679069 | Free-beam and contact laser ablation of benign prostatic hyperplasia with the KTP/Nd:YAG laser: efficacy and versatility |
Q92301274 | From box ticking to the black box: the evolution of operating room safety |
Q92363324 | From indecision to precision: advances in imaging in metastatic prostate cancer |
Q40703727 | From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists |
Q41738380 | From needles to numbers: can noninvasive imaging distinguish benign and malignant adrenal lesions? |
Q34595448 | From proficiency to expert, when does the learning curve for robotic-assisted prostatectomies plateau? The Columbia University experience |
Q48096450 | Fuhrman grading is inappropriate for papillary renal cell carcinoma |
Q89604059 | Functional and perioperative outcomes in elderly men after robotic-assisted radical prostatectomy for prostate cancer |
Q51488985 | Functional conditions of micturition induced by selective sacral anterior root stimulation: experimental results in a canine animal model. |
Q70803485 | Functional electromyostimulation of the corpus cavernosum penis--preliminary results of a novel therapeutic option for erectile dysfunction |
Q89282288 | Functional follow-up after Advance® and Advance XP® male sling surgery: assessment of predictive factors |
Q46323316 | Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the rat. |
Q85168946 | Functional inhibition of erectile process in rats by indomethacin |
Q38461592 | Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer |
Q51273603 | Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing. |
Q41472588 | Functional outcomes of adjustable continence therapy (ACT™) balloons in women aged >80 years and suffering from stress urinary incontinence caused by intrinsic sphincter deficiency |
Q53821289 | Functional outcomes of robot-assisted radical prostatectomy in patients eligible for active surveillance. |
Q85559822 | Functional urology 2015 |
Q34821704 | Fundamentals on the pathology of prostatic carcinoma after brachytherapy |
Q33827811 | Fungal infections of the urinary tract |
Q90857745 | Furthering the external validity of Aquablation and implications for real-world patients |
Q74321131 | Future aspects of TUMT treatment of benign prostatic hypertrophy |
Q34391933 | Future aspects of renal transplantation |
Q48080052 | Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study-Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7. |
Q34648341 | Future drugs for the treatment of benign prostatic hyperplasia |
Q90813508 | Future of kidney stone surgery: will we treat small stones with large-sized PCNL and big stones with RIRS? |
Q33769221 | Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer |
Q48681009 | G. Frank Lydston (1858?1923) revisited: androgen therapy by testicular implantation in the early twentieth century |
Q41153833 | GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder |
Q54346665 | GSTP1 CpG island hypermethylation for DNA-based detection of occult tumor cells in surgical margins after radical prostatectomy. |
Q44523706 | Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence |
Q100309058 | Gap between UAS and ureteroscope predicts renal stone-free rate after flexible ureteroscopy with the fragmentation technique |
Q46306178 | Gastrocystoplasty: is there a consensus? |
Q34317251 | Gastroenterological causes of pelvic pain |
Q34114696 | Gastrointestinal tissue as a substitute for the detrusor |
Q38082382 | Gender differences in benign renal masses |
Q38123712 | Gender differences in bladder control: from babies to elderly |
Q86561539 | Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database |
Q85118708 | Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma |
Q79303327 | Gender discrepancies in the diagnosis of renal cortical tumors |
Q51461507 | Gender effect on renal outcome in patients with urothelial carcinoma. |
Q115388137 | Gender gap at a large European urological congress: still at the beginning |
Q43805333 | Gender in urology |
Q92360639 | Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinoma |
Q47259653 | Gender-dependent cancer-specific survival following radical cystectomy |
Q38080480 | Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity |
Q45362887 | Gender-specific survival following radical cystectomy for pT4 bladder cancer. |
Q46101334 | Gene expressions and mechanical functions of α1-adrenoceptor subtypes in mouse ureter |
Q33943113 | Gene therapy for bladder cancer |
Q33943107 | Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions |
Q45868665 | Gene therapy in urologic oncology |
Q40407411 | Gene therapy on renal-cell carcinoma: magic bullet or tragic insanity? |
Q41536038 | Genes in idiopathic calcium oxalate stone disease |
Q40958215 | Genes involved in testicular development and function |
Q72781961 | Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p |
Q86289606 | Genetic architecture of renal cell carcinoma: Do we have to know? |
Q40568423 | Genetic factors in malignant germ-cell tumors |
Q35597290 | Genetic polymorphisms and prostate cancer risk |
Q45221749 | Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours |
Q57565136 | Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways |
Q39516233 | Genetic variants in RNA-induced silencing complex genes and prostate cancer |
Q33657250 | Genital skin loss: unified reconstructive approach to a heterogeneous entity |
Q103012989 | Genitourinary reconstruction |
Q77422134 | Genitourinary reconstruction. Part II |
Q77877165 | Genitourinary trauma |
Q93020857 | Genomic classification and risk stratification of bladder cancer |
Q90899773 | Genomics and clinical correlates of renal cell carcinoma |
Q35019985 | German urologists under national socialism |
Q48306697 | Getting to know Dr. Paul Sweeney |
Q46386893 | Glanuloplasty by ventral skin interposition in hypospadias repair: preliminary report |
Q44521747 | Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer |
Q50644343 | Gleason underestimation is predicted by prostate biopsy core length. |
Q97088002 | Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic |
Q37953213 | Global concepts of bladder pain syndrome (interstitial cystitis). |
Q44481196 | Glutathione S-transferase isoenzyme profile in non-tumor and tumor human kidney tissue. |
Q130187782 | Glycolate oxidase-1 gene variants influence the risk of hyperoxaluria and renal stone development |
Q40661769 | Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones |
Q72017491 | Glycosaminoglycans and proteoglycans in the urinary tract |
Q40661775 | Glycosaminoglycans and struvite calculi |
Q40626864 | Goethe almost died of urosepsis |
Q55883486 | Gonadotropin-releasing hormone analogues for palliation of carcinoma of the prostate |
Q37513760 | Good-risk-advanced germ cell tumors: historical perspective and current standards of care. |
Q38501631 | Gracilis muscle interposition flap repair of urinary fistulae: pelvic radiation is associated with persistent urinary incontinence and decreased quality of life |
Q41645556 | Gracilis muscle transposition with electrical stimulation for sphincteric incontinence: a new approach |
Q92182731 | Green-laser assisted laparoscopic partial cystectomy for selective muscle-invasive bladder cancer: technique and initial outcome |
Q101232354 | Greenlight laser: a laser for every prostate and every urologist |
Q87952911 | Greenlight® users should move from photoselective vaporization to endoscopic enucleation in larger prostates |
Q41442996 | Growth factors and renal cancer: characterization and therapeutic implications |
Q40958208 | Growth factors as mediators of androgen action during the development of the male urogenital tract |
Q41442987 | Growth factors in bladder cancer |
Q46865315 | Guest editorial: robotic techniques in urologic oncology |
Q37078172 | Guidelines for development of diagnostic markers in bladder cancer |
Q36095818 | Guidelines for the pharmacotherapy of premature ejaculation |
Q40536099 | HAROW: the first comprehensive prospective observational study comparing treatment options in localized prostate cancer |
Q40713928 | HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC). |
Q41533360 | Hand-assisted laparoscopic bladder cuff excision via the same hand port as that used for nephroureterectomy |
Q51418348 | Has blood volume an impact on serum PSA levels? |
Q35043210 | Hatha Yoga therapy management of urologic disorders |
Q37806646 | Health care reform in 2010: transforming the delivery system to improve quality of care. |
Q37848126 | Health services research in urology |
Q90042091 | Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis |
Q91285074 | Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes |
Q100739035 | Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN |
Q45083861 | Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial |
Q33719006 | Health-related quality-of-life studies in urology: conceptual and methodological considerations |
Q48099272 | Healthcare utilization in men with poorer sexual and urinary function recovery following robot-assisted radical prostatectomy |
Q51237319 | Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010. |
Q48909051 | Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients |
Q82693734 | Hemodynamic effects of orally administered delta-ALA during radical prostatectomy |
Q54019591 | Hemodynamic insult by vascular risk factors and pharmacologic erection in men with erectile dysfunction: Doppler sonography study. |
Q35116806 | Herbal and complementary medicine in chronic prostatitis |
Q52572027 | Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. |
Q38202888 | Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations |
Q39267304 | High NF-κB and STAT3 activity in human urothelial carcinoma: a pilot study |
Q73774102 | High dose rate brachytherapy in the treatment of prostate cancer |
Q41730736 | High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec |
Q90442803 | High incidence of urinary tract infections after photoselective laser vaporisation of the prostate: a risk factor analysis of 665 patients |
Q92026659 | High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma |
Q40960782 | High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy |
Q84243463 | High risk NSGCT: case for surveillance |
Q39117263 | High volume is the key for improving in-hospital outcomes after radical prostatectomy: a total population analysis in Germany from 2006 to 2013. |
Q38966419 | High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how. |
Q80874468 | High-flow priapism: colour-Doppler ultrasound-guided supraselective embolization therapy |
Q42097270 | High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance |
Q35131283 | High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction |
Q49642353 | High-power HoLEP: no thanks! |
Q91622620 | High-resolution imaging reveals microbial biofilms on patient urinary catheters despite antibiotic administration |
Q37504781 | High-risk clinical stage I NSGCT: the case for RPLND. |
Q37564083 | High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy |
Q38052445 | High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment |
Q34168382 | High-risk prostate cancer in the United States, 1990-2007 |
Q93041458 | Higher expression of phosphodiesterase type 5 in the anterior fibromuscular stroma of the human prostate |
Q83144914 | Histamine receptors in human detrusor smooth muscle cells: physiological properties and immunohistochemical representation of subtypes |
Q91574400 | Histologic characterization of the post-radiation urethral stenosis in men treated for prostate cancer |
Q37130057 | Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically. |
Q26820469 | Histological outcomes after focal high-intensity focused ultrasound and cryotherapy |
Q41929509 | Histopathological correlations to ureteral lesions visualized during ureteroscopy |
Q53550694 | Histopathology and prognosis of de novo bladder tumors following solid organ transplantation. |
Q48501024 | Histopathology: ditch the slides, because digital and 3D are on show |
Q33287450 | History of lasers |
Q90235561 | Ho:YAG laser lithotripsy in non-contact mode: optimization of fiber to stone working distance to improve ablation efficiency |
Q33534167 | Ho:YAG-laser: treatment of vesicourethral strictures after radical prostatectomy |
Q102055699 | HoLEP after prostate biopsy: does it have any impact? |
Q34666430 | HoLEP has come of age. |
Q88956022 | HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis |
Q34332884 | Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients |
Q35713739 | Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia; is it a realistic endourologic alternative in developing country? |
Q90614496 | Holmium laser enucleation of the prostate for very large benign prostatic hyperplasia (≥ 200 cc) |
Q48091501 | Holmium laser enucleation of the prostate is an effective treatment in patients with concomitant bladder diverticula and outlet obstruction. |
Q90008958 | Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results |
Q96128921 | Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy |
Q33277040 | Holmium laser for stone management |
Q34974642 | Holmium:YAG laser ureteroscopic lithotripsy for ureteric calculi in children: predictive factors for complications and success |
Q74744438 | Homologous acellular matrix graft for vaginal repair in rats: a pilot study for a new reconstructive approach |
Q92226930 | Hope, hype and biology: the current biomarker landscape in bladder cancer |
Q38045234 | Hormone therapy for radiorecurrent prostate cancer |
Q46325754 | Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study |
Q90864284 | Hospital volume in ureterorenoscopic stone treatment: 99 operations per year could increase the chance of a better outcome-results of the German prospective multicentre BUSTER project |
Q84157390 | Hot topics in kidney cancer 2010 |
Q37193741 | How accurate are present risk group assignment tools in penile cancer? |
Q89161189 | How bothersome double-J ureteral stents are after semirigid and flexible ureteroscopy: a prospective single-institution observational study |
Q89096016 | How can a ureteral stone cause pain without hydronephrosis? |
Q36542846 | How do I treat and follow my TUNA patients |
Q95936737 | How do we assess the efficacy of Ho:YAG low-power laser lithotripsy for the treatment of upper tract urinary stones? Introducing the Joules/mm3 and laser activity concepts |
Q97674833 | How early is early? The need for defining "early" intervention in high-grade blunt renal trauma |
Q38105251 | How far is the horizon? From current targets to future drugs in advanced renal cancer. |
Q92984514 | How much energy do we need to ablate 1 mm3 of stone during Ho:YAG laser lithotripsy? An in vitro study |
Q98188203 | How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study |
Q52936532 | How septic is urosepsis? Clinical course of infected hydronephrosis and therapeutic strategies. |
Q48192298 | How to accelerate the upper urinary stone discharge after extracorporeal shockwave lithotripsy (ESWL) for < 15 mm upper urinary stones: a prospective multi-center randomized controlled trial about external physical vibration lithecbole (EPVL). |
Q90046425 | How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies |
Q91498241 | How to implement the requirements of a quality assurance system for prostate cancer |
Q92970919 | How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection |
Q92678937 | How to prevent infectious complications following flexible ureteroscopy? |
Q50931074 | Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups. |
Q71341485 | Human urinary bladder-carcinoma cells are non-osteoinductive |
Q40091515 | Hybrid laparoendoscopic single-site surgery of upper urinary tract with the use of mini-laparoscopic instruments: cosmetic outcome and midterm oncological outcome |
Q41169099 | Hyperfiltration nephropathy as a cause of late graft loss in renal transplantation |
Q38836853 | Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer |
Q45173623 | Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer: methodological issues |
Q54626855 | Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib. |
Q46025657 | Hypoxic pre-conditioning in a rat renal ischemia model: an evaluation of the use of hydralazine. |
Q53505726 | ICUD guidelines for upper tract urothelial carcinoma: a state-of-the-art evidence-based guidance for clinical decisions regarding diagnosis, management and treatment. |
Q90953557 | ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer |
Q39481269 | ID4 is frequently downregulated and partially hypermethylated in prostate cancer |
Q40010150 | IL-10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort |
Q91289264 | Ideal timing of indwelling catheter removal after robot-assisted radical prostatectomy with a running barbed suture technique: a prospective analysis of 425 consecutive patients |
Q93384501 | Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones |
Q47588775 | Identification of key genes and construction of microRNA-mRNA regulatory networks in bladder smooth muscle cell response to mechanical stimuli using microarray expression profiles and bioinformatics analysis |
Q37323468 | Identification of molecular targets in urologic oncology |
Q84199031 | Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancer |
Q92528890 | Identification of ureteral stones at reduced radiation exposure: a pilot study comparing conventional versus digital low-dosage linear slot scanning (Lodox®) radiography |
Q45977418 | Identification of urine PLK2 as a marker of bladder tumors by proteomic analysis. |
Q35901979 | Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation |
Q38609460 | Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy |
Q33724312 | Image guidance for focal therapy of prostate cancer. |
Q38993533 | Image-based monitoring of targeted biopsy-proven prostate cancer on active surveillance: 11-year experience |
Q91959858 | Image-guided therapies for prostate and kidney cancers |
Q35854170 | Imaging for kidney stones |
Q89282310 | Imaging for the diagnosis and response assessment of renal tumours |
Q90703121 | Imaging modalities in synchronous oligometastatic prostate cancer |
Q33574549 | Imaging of advanced renal cell carcinoma |
Q63199172 | Imaging the urologic patient: the utility of intravenous pyelogram in the CT scan era |
Q98879235 | Imbalance of nerve growth factor metabolism in aging women with overactive bladder syndrome |
Q83567882 | Immediate renal Doppler ultrasonography findings (<24 h) and its association with graft survival |
Q101135019 | Immune checkpoint inhibition in upper tract urothelial carcinoma |
Q38612706 | Immune checkpoint inhibitors: a new frontier in bladder cancer |
Q88961952 | Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer |
Q80187307 | Immunocytology in the assessment of patients with asymptomatic hematuria |
Q73622046 | Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer |
Q50090642 | Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer |
Q41169085 | Immunologic tolerance in renal transplantation |
Q33373077 | Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen |
Q87204434 | Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study |
Q91243685 | Immunotherapy for bladder cancer: the fight is on |
Q36087136 | Immunotherapy in metastatic renal cell carcinoma |
Q100563505 | Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions |
Q101237954 | Immunotherapy in prostate cancer: new horizon of hurdles and hopes |
Q37068011 | Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma |
Q44907640 | Immunotherapy with autologous antigen presenting cells for the treatment of androgen independent prostate cancer |
Q41125821 | Impact of 2004 ISUP/WHO classification on bladder cancer grading |
Q98830493 | Impact of COVID-19 on medical education: introducing homo digitalis |
Q40220251 | Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy |
Q92575460 | Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis |
Q51903617 | Impact of body mass index on outcomes after robot assisted radical prostatectomy. |
Q40714046 | Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer. |
Q50070005 | Impact of body mass index on the oncological outcomes of patients treated with radical nephroureterectomy for upper tract urothelial carcinoma |
Q86698424 | Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer |
Q48035948 | Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). |
Q91952780 | Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH |
Q51218981 | Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. |
Q44745044 | Impact of dutasteride on nocturia in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a pooled analysis of three phase III studies |
Q37886832 | Impact of gender on bladder cancer incidence, staging, and prognosis |
Q40183473 | Impact of gender on success and complication rates after ureteroscopy |
Q39968893 | Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis |
Q46987647 | Impact of intermittent catheterization on the quality of life of multiple sclerosis patients |
Q38449513 | Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer |
Q91172266 | Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology |
Q36385759 | Impact of laser fiber tip cleavage on power output for ureteroscopy and stone treatment |
Q46121062 | Impact of marital status in patients undergoing radical cystectomy for bladder cancer |
Q53096084 | Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma. |
Q57111662 | Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy |
Q91390839 | Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer |
Q90293717 | Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy |
Q30315523 | Impact of novel techniques on minimally invasive adrenal surgery: trends and outcomes from a contemporary international large series in urology. |
Q90235588 | Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan |
Q50573770 | Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. |
Q53161917 | Impact of parenchymal loss on renal function after laparoscopic partial nephrectomy under warm ischemia. |
Q82776167 | Impact of patient age on outcome following bladder-preserving treatment for non-muscle-invasive bladder cancer |
Q40701908 | Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011. |
Q86993035 | Impact of positive surgical margins and their locations after radical prostatectomy: comparison of biochemical recurrence according to risk stratification and surgical modality |
Q38009239 | Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term results |
Q33399993 | Impact of preoperative haemoglobin concentrations on the efficiency of KTP-laser vaporization of the prostate |
Q41351075 | Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study |
Q45793333 | Impact of preoperative immunonutrition on morbidity following cystectomy for bladder cancer: a case-control pilot study |
Q92099316 | Impact of previous SWL on ureterorenoscopy outcomes and optimal timing for ureterorenoscopy after SWL failure in proximal ureteral stones |
Q96820025 | Impact of previous transurethral prostate surgery on health-related quality of life after radical prostatectomy: Does the interval between surgeries matter? |
Q93066382 | Impact of previous urethroplasty on the outcome after artificial urinary sphincter implantation: a prospective evaluation |
Q35389743 | Impact of pulse duration on Ho:YAG laser lithotripsy: fragmentation and dusting performance |
Q35567222 | Impact of pulse duration on Ho:YAG laser lithotripsy: treatment aspects on the single-pulse level |
Q92516019 | Impact of routine imaging in the diagnosis of recurrence for patients with localized and locally advanced renal tumor treated with nephrectomy |
Q120633376 | Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center |
Q40908884 | Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma |
Q58092281 | Impact of sodium F-fluoride PET/CT, F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study |
Q39898461 | Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates. |
Q101237955 | Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years' experience from a large Canadian academic center |
Q38086051 | Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival |
Q82606423 | Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors |
Q45270839 | Impact of the type of ultrasound probe on prostate cancer detection rate and characterization in patients undergoing MRI-targeted prostate biopsies using cognitive fusion |
Q89731998 | Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette-Guerin |
Q46874421 | Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer |
Q44964310 | Impact of transplant nephrectomy on retransplantation: a single-center retrospective study. |
Q46222362 | Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation |
Q47390791 | Impact of tumor size on the long-term survival of patients with early stage renal cell cancer |
Q92161316 | Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period |
Q27027443 | Impact of ureteral stenting prior to ureterorenoscopy on stone-free rates and complications |
Q91911984 | Impact of using 29 MHz high-resolution micro-ultrasound in real-time targeting of transrectal prostate biopsies: initial experience |
Q42659867 | Impact of warm versus cold ischemia on renal function following partial nephrectomy |
Q91501133 | Impaired sleep is associated with low testosterone in US adult males: results from the National Health and Nutrition Examination Survey |
Q43334256 | Implantation of anterior sacral root stimulators combined with posterior sacral rhizotomy in spinal injury patients |
Q52594919 | Implementation of medical scribes in an academic urology practice: an analysis of productivity, revenue, and satisfaction. |
Q48504045 | Implementation of minimally invasive percutaneous nephrolithotomy (MIP): comparison of the initial learning curve with the later on clinical routine in a tertiary centre |
Q91613860 | Implementing quality metrics in European Cancer Centers (ECCs) |
Q120633366 | Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer |
Q91071991 | Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer |
Q35875135 | Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. |
Q38781628 | Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy. |
Q91764530 | Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital |
Q44741295 | Improved detection of microbial ureteral stent colonisation by sonication |
Q86113801 | Improved laparoscopic treatment of symptomatic urachal anomalies |
Q39433661 | Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer |
Q51365150 | Improvement of health outcomes after continued implementation of a clinical pathway for radical nephrectomy. |
Q54433936 | Improvement of histopathological classification of adrenal gland tumors by genetic differentiation. |
Q74744393 | Improvement of practice performance in urological surgery via clinical pathway implementation |
Q36606956 | Improving outcomes with radical cystectomy for high-grade invasive bladder cancer |
Q91104079 | In response to "Obstructive sleep apnea syndrome should always be screened in patients complaining of nocturia". World J Urol. 2018 |
Q43184933 | In vitro and in vivo studies on the importance of the soluble guanylyl cyclase α1 subunit in penile erection |
Q73655268 | In vitro crystallisation systems for the study of urinary stone formation |
Q46793410 | In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors |
Q45072727 | In vivo assessment of a novel biodegradable ureteral stent |
Q74142794 | In vivo effect of the lipido-sterolic extract of Serenoa repens (Permixon) on mast cell accumulation and glandular epithelium trophism in the rat prostate |
Q100388130 | Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis |
Q121888200 | Incidence and risk factors for postoperative urinary incontinence after various prostate enucleation procedures: systemic review and meta-analysis of PubMed literature from 2000 to 2021 |
Q40581391 | Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality. |
Q90293688 | Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials |
Q71115774 | Incidence of urethral tumor involvement in 910 men with bladder cancer |
Q73157921 | Incidence of urolithiasis in cystectomy patients after intestinal conduit or continent urinary diversion |
Q88877727 | Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation |
Q90562358 | Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer |
Q49892987 | Incorporation of the fluoroless C-Arm Trainer at the American Urological Association hands on training percutaneous renal access |
Q74142779 | Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men |
Q46518175 | Increased alpha1D adrenergic receptor activity and protein expression in the urinary bladder of aged rats |
Q89396669 | Increased amount and duration of tea consumption may be associated with decreased risk of renal stone disease |
Q73413966 | Increased discrimination between benign prostatic hyperplasia and prostate cancer with equimolar total prostate specific antigen measurement |
Q71341489 | Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate |
Q40571897 | Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis |
Q88840264 | Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy |
Q80442780 | Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients |
Q46307947 | Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms |
Q51251285 | Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. |
Q100402112 | Increasing kidney grafts for transplantation |
Q42277205 | Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates. |
Q49588418 | Increasing the size of ureteral access sheath during retrograde intrarenal surgery improves surgical efficiency without increasing complications |
Q47966967 | Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection |
Q89794823 | Independent risk factors for failure after anterior urethroplasty: a multivariate analysis on prospective data |
Q51406371 | Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC). |
Q96581309 | Inducible nitric oxide synthase promotes differentiation of satellite cells and prevents stress urinary incontinence via HGF-mediated p38/MAPK signaling |
Q42636874 | Induction of apoptosis in human prostate stromal cells by 4-hydroxytamoxifen: an alternative therapy for benign prostate hyperplasia |
Q94504063 | Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infection |
Q40831098 | Infection and pyospermia in male infertility |
Q84744167 | Infections in urology |
Q100468903 | Infections in urology: slow progress reflected in clinical practice |
Q89870875 | Infectious complications of prostate biopsy: winning battles but not war |
Q91376705 | Inferring bladder cancer research prioritization from patient-generated online content |
Q89724128 | Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia |
Q52806944 | Influence of CT-based depth correction of renal scintigraphy in evaluation of living kidney donors on side selection and postoperative renal function: is it necessary to know the relative renal function? |
Q46793404 | Influence of a high-oxalate diet on intestinal oxalate absorption |
Q38374050 | Influence of acetylsalicylic acid and low-molecular weight heparins on the formation of renal hematoma after shock wave lithotripsy. |
Q53156367 | Influence of age on false positive rates of urine-based tumor markers. |
Q93358524 | Influence of biofilms on morbidity associated with short-term indwelling ureteral stents: a prospective observational study |
Q40064903 | Influence of endourological devices on 3D reconstruction image quality using the Uro Dyna-CT. |
Q44441338 | Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau). |
Q43431406 | Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy |
Q44362602 | Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort |
Q92179537 | Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau) |
Q84778062 | Influence of surgeon's experience on fluoroscopy time during endourological interventions |
Q37900190 | Influence of urogenital infections and inflammation on semen quality and male fertility |
Q99236581 | Informative value of histological assessment of tissue acquired during aquablation of the prostate |
Q92834532 | Infrequent use of clinical trials registries in published systematic reviews in urology |
Q86029402 | Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7 |
Q61959698 | Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer |
Q73502997 | Inhibition of uropathogenic biofilm growth on silicone rubber in human urine by lactobacilli--a teleologic approach |
Q35959611 | Initial and long-term management of posterior urethral valves |
Q72781956 | Initial chemotherapy for stage II testicular non-seminoma |
Q46715691 | Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis |
Q73503003 | Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder |
Q51874330 | Initial experience with laparoscopic single-incision triangulated umbilical surgery (SITUS) in simple and radical nephrectomy. |
Q45386615 | Initial experiences with the Hemopatch® as a hemostatic agent in zero-ischemia partial nephrectomy |
Q91278400 | Injury severity score associated with concurrent bladder injury in patients with blunt urethral injury |
Q38146913 | Innovations in diagnostic imaging of localized prostate cancer |
Q80727337 | Innovative imaging: in and around urology |
Q100739032 | Innovative standardized reporting template for prostate mpMRI improves clarity and confidence in the report |
Q39299859 | Insertion of double J stent as a therapeutic test in management of adults presenting with loin pain and equivocal ureteropelvic junction obstruction |
Q36022444 | Insignificant disease among men with intermediate-risk prostate cancer |
Q74497042 | Insulin-like growth factors and prostate cancer |
Q39085006 | Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy |
Q53236222 | Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy: bias in the prediction model. |
Q99554086 | Integration of exome sequencing and metabolic evaluation for the diagnosis of children with urolithiasis |
Q52021051 | Intensive laparoscopic training: the impact of a simplified pelvic-trainer model for the urethrovesical anastomosis on the learning curve. |
Q53709345 | Inter-rater reliability in the radiological classification of renal injuries. |
Q71629437 | Interaction between bacteria and the lumenal bladder surface: modulation by pentosan polysulfate, an experimental and theoretical approach with clinical implication |
Q44815225 | Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone |
Q77422125 | Interdisciplinary care of urinary incontinence in the elderly |
Q92137472 | Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomy |
Q40912174 | Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis |
Q73502981 | Intermittent androgen deprivation (IAD) in patients with biochemical failure after radical retropubic prostatectomy (RRP) for clinically localized prostate cancer |
Q33990896 | Intermittent endocrine treatment |
Q45795876 | Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial |
Q47241204 | Internal Fusion: exact correlation of transrectal ultrasound images of the prostate by detailed landmarks over time for targeted biopsies or follow-up. |
Q89949508 | Internal audit of an enhanced recovery after surgery protocol for radical cystectomy |
Q86066171 | Internal urethrotomy in patients with recurrent urethral stricture after buccal mucosa graft urethroplasty |
Q45009488 | International multi-institutional experience with the vessel-sparing technique to reconstruct the proximal bulbar urethra: mid-term results. |
Q39547712 | International telementoring: a feasible method of instruction |
Q36015351 | Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems |
Q78775381 | Interstitial cystitis, pelvic pain, and the relationship to myofascial pain and dysfunction: a report on four patients |
Q34317241 | Interstitial cystitis: a chronic inflammatory bladder condition |
Q31943468 | Interstitial laser coagulation of the prostate: introduction of a volume-based treatment formula with 12-month follow-up |
Q73896890 | Interstitial laser coagulation technique. Anatomic review |
Q73896892 | Interstitial laser coagulation technique. Bibliography |
Q73896881 | Interstitial laser coagulation technique. Executive summary |
Q30879134 | Interstitial laser coagulation technique: ILC blueprint |
Q30879146 | Interstitial laser coagulation technique: clinical research updates |
Q30879159 | Interstitial laser coagulation technique: considerations for office -based ILC. |
Q30879180 | Interstitial laser coagulation techniques: local anesthesia techniques |
Q43884608 | Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer |
Q74443260 | Interventional uroradiology |
Q46800532 | Intestinal oxalate absorption in patients with continent urinary diversion |
Q92575453 | Intra- and inter-resting-state networks abnormalities in overactive bladder syndrome patients: an independent component analysis of resting-state fMRI |
Q84945538 | Intra-operative erythropoietin during laparoscopic partial nephrectomy is not renoprotective |
Q53554843 | Intra-operative inferior vena cava syndrome in a patient with autosomal dominant polycystic kidney disease. |
Q40914143 | Intracavernous pharmacotherapy |
Q96766463 | Intranasal ketamine versus intravenous morphine for pain management in patients with renal colic: a double-blind, randomized, controlled trial |
Q37164097 | Intraoperative complications of laparoscopic adrenalectomy |
Q41649301 | Intraoperative frozen section monitoring during nerve-sparing radical prostatectomy: evaluation of partial secondary resection of neurovascular bundles and its effect on oncologic and functional outcome |
Q53258757 | Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: initial experience in 20 patients |
Q52353445 | Intraoperative utilization of advanced imaging modalities in a complex kidney stone case: a pilot case study. |
Q81504740 | Intratesticular varicocele: evaluation using grey scale and color Doppler ultrasound |
Q41583027 | Intratubular crystallization events |
Q39232286 | Intratumoral acetic acid injection eradicates human prostate cancer tumors in a murine model |
Q45405062 | Intratumoral inflammation is associated with more aggressive prostate cancer |
Q41741527 | Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex |
Q89113809 | Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer |
Q24648407 | Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo working party |
Q57565102 | Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study |
Q41062013 | Intravesical suramin: a novel agent for the treatment of superficial transitional-cell carcinoma of the bladder. |
Q94476907 | Intravesical therapy for bladder cancer in the pandemic of Covid-19 |
Q48256274 | Introducing new technology safely into urological practice |
Q90377439 | Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database |
Q57176678 | Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations |
Q37584118 | Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experience |
Q53423591 | Involved intrinsic apoptotic pathway of testicular tissues in varicocele-induced rats. |
Q38874052 | Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury |
Q51551569 | Iridium 192 high-dose-rate brachytherapy--a useful alternative therapy for localized prostate cancer? |
Q52709510 | Irreversible electroporation of small renal masses: suboptimal oncologic efficacy in an early series. |
Q45119450 | Is a return to baseline sexual function possible? An analysis of sexual function outcomes following laparoscopic radical prostatectomy |
Q87146343 | Is a wider angle of the membranous urethra associated with incontinence after radical prostatectomy? |
Q95276188 | Is electronic follow-up using a mobile phone application after mid-urethral sling placement feasible and efficient? |
Q53464860 | Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging. |
Q38097354 | Is gender becoming relevant in uro-oncological research? A bibliographical analysis |
Q50985724 | Is in vivo analysis of urinary stone composition feasible? Evaluation of an experimental setup of a Raman system coupled to commercial lithotripsy laser fibers. |
Q87618943 | Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy? |
Q42554415 | Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL? |
Q92898586 | Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review |
Q38125938 | Is larger tumor size a contraindication to retroperitoneal laparoscopic adrenalectomy? |
Q89161184 | Is loss of power output due to laser fiber degradation still an issue during prostate vaporization using the 180 W GreenLight XPS laser? |
Q49948767 | Is mini-percutaneous nephrolithotomy a safe alternative to extracorporeal shockwave lithotripsy in pediatric age group in borderline stones? a randomized prospective study |
Q38555382 | Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons |
Q98781078 | Is multiple tract percutaneous nephrolithotomy a safe approach for staghorn calculi? |
Q52691240 | Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients. |
Q39677795 | Is overactive bladder a nervous or bladder disorder? Autonomic imaging in patients with overactive bladder via dynamic pupillometry |
Q96162500 | Is pre-operative urodynamic bladder function the true predictor of outcome of male sling for post prostatectomy incontinence? |
Q42260736 | Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men? |
Q97877834 | Is regenerative medicine the future of urology? |
Q91179580 | Is remote live urologic surgery a reality? Evidences from a systematic review of the literature |
Q87732192 | Is retrograde intrarenal surgery a viable treatment option for renal stones in patients with solitary kidney? |
Q38647825 | Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care? |
Q38086731 | Is stone diameter a variable in the decision process of employing a ureteral stent in patients undergoing uncomplicated ureterorenoscopy and associated intracorporeal lithotripsy? |
Q48248080 | Is the laser mightier than the sword? A comparative study for the urethrotomy. |
Q47891665 | Is the robotic approach feasible for repair of iatrogenic injuries of the lower ureter? |
Q98772612 | Is there a clinical benefit from prostate cancer center certification? An evaluation of functional and oncologic outcomes from 22,649 radical prostatectomy patients |
Q47363329 | Is there a correlation |
Q43522374 | Is there a difference in percutaneous nephrolithotomy outcomes among various types of pelvicaliceal system? |
Q90785279 | Is there a need for endoscopic evaluation in symptomatic boys with an unsuspicious urethra on VCUG? A consideration of secondary radiologic signs of posterior urethral valves |
Q88027591 | Is there a peripheral site of action contributing to the voiding effects of α₂-adrenoceptor agonists and antagonists? |
Q91243680 | Is there a place for indwelling transurethral catheterization in women with febrile urinary tract infection? A prospective randomized trial |
Q53395365 | Is there a place for virtual reality simulators in assessment of competency in percutaneous renal access? |
Q87978836 | Is there a role for extracorporeal shock wave therapy for erectile dysfunction unresponsive to phosphodiesterase type 5 inhibitors? |
Q53130316 | Is there a role for salvage lymphadenectomy as second-line therapy post-robotic radical prostatectomy? |
Q42629842 | Is there a volume-outcome relationship for partial nephrectomy? |
Q53064304 | Is there always a need for invasive treatment of limited liver metastases in renal cell cancer or other solid tumors? |
Q39217798 | Is there an anti-androgen withdrawal syndrome for enzalutamide? |
Q92505441 | Is there enough evidence to support sacral neuromodulation as a viable treatment option in children and adolescents with neurogenic lower urinary tract dysfunction? |
Q45013439 | Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers |
Q38765727 | Is there room for behavioral and modifiable health-related targets in the lower urinary tract symptoms' scenario |
Q46696128 | Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database. |
Q93358530 | Is time from diagnosis to radical prostatectomy associated with oncological outcomes? |
Q33904157 | Is ureteral stenting really necessary after ureteroscopic lithotripsy with balloon dilatation of ureteral orifice? A multi-institutional randomized controlled study. |
Q89004430 | Is urodynamics necessary to identify occult stress urinary incontinence? |
Q51030385 | Is vaginal mucosal graft the excellent substitute material for urethral reconstruction in female-to-male transsexuals? |
Q84074575 | Is ¹⁵³Samarium-ethylene-diamine-tetramethyl-phosphonate (EDTMP) bone uptake influenced by bisphosphonates in patients with castration-resistant prostate cancer? |
Q72608639 | Isolated necrotizing granulomatous vasculitis of the epididymis and spermatic cords |
Q41062002 | Isolated perfusion of the kidney with tumor necrosis factor for localized renal-cell carcinoma. |
Q33827799 | Issues in urinary tract infections in the elderly |
Q33827805 | Issues surrounding the prevention and management of device-related infections |
Q48537906 | Johann Anton von Mikulicz-Radecki (1850-1905)--a pioneer of gastroscopy and modern surgery: his credit to urology |
Q34544655 | Julius Bruck (1840-1902) and his influence on the endoscopy of today |
Q46033293 | Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. |
Q40958243 | Keratinocyte growth factor: an androgen-regulated mediator of stromal-epithelial interactions in the prostate |
Q36920156 | Key clinical issues in renal cancer: a challenge for proteomics |
Q33146307 | Key issues from the clinical trials of apomorphine SL. |
Q37130033 | Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability |
Q41189196 | Kidney cancer focal cryoablation trend: does location or approach matter? |
Q91157240 | Kidney regeneration approaches for translation |
Q38281436 | Kidney stone analysis: "Give me your stone, I will tell you who you are!". |
Q38262687 | Kidney stones and imaging: what can your radiologist do for you? |
Q41169104 | Kidney transplantation in Saudi Arabia: a unique experience |
Q41169081 | Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols |
Q45225843 | Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential? |
Q38860996 | Knockdown of BAG3 sensitizes bladder cancer cells to treatment with the BH3 mimetic ABT-737. |
Q88197342 | Knowledge of smoking as a risk factor for disease among urology clinic patients in Australia |
Q38638510 | Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience |
Q114229790 | LC–MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer |
Q39831515 | LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer |
Q40831111 | Laboratory testing in the evaluation of male infertility. A rational approach |
Q71951415 | Lack of correlation between prostate-specific antigen density and prostatic shrinkage in response to finasteride therapy |
Q70485132 | Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pTa vs pT1): recommended approach. Pathologists of the French Association of Urology Cancer Committee |
Q86433014 | Landscape of chromosome number changes in prostate cancer progression |
Q42662220 | Laparoendoscopic partial nephrectomy in single-incision triangulated umbilical surgery (SITUS) technique: early experience |
Q37868977 | Laparoendoscopic single site (LESS) adrenalectomy: technique and outcomes |
Q30317929 | Laparoendoscopic single-site versus conventional laparoscopic radical nephrectomy for renal cell cancer in patients with increased comorbidities and previous abdominal surgery: preliminary results of a single-centre retrospective study |
Q35537288 | Laparoscopic adenomectomy versus Eraser laser enucleation of the prostate |
Q46855853 | Laparoscopic and robotic partial nephrectomy without renal ischaemia for tumours larger than 4 cm: perioperative and functional outcomes |
Q90293708 | Laparoscopic and robotic-assisted repair of retrocaval ureter in children: a multi-institutional comparative study with open repair |
Q30318878 | Laparoscopic dismembered pyeloplasty: technique and results in 105 patients |
Q53860322 | Laparoscopic evaluation of testicular mobility as a guide to management of intra-abdominal testes. |
Q34114712 | Laparoscopic lower urinary tract reconstruction |
Q37980041 | Laparoscopic management of complicated urachal remnants in adults |
Q35987362 | Laparoscopic management of hydronephrosis in children |
Q34041772 | Laparoscopic management of renal cystic disease |
Q50544892 | Laparoscopic nephrectomy for polycystic kidney: comparison of the transperitoneal and retroperitoneal approaches. |
Q37702837 | Laparoscopic partial nephrectomy for large renal masses: results of a European survey |
Q43988378 | Laparoscopic partial nephrectomy: risk stratification according to patient and tumor characteristics |
Q34041753 | Laparoscopic radical and partial nephrectomy |
Q37961481 | Laparoscopic radical and partial nephrectomy: technical issues and outcome |
Q57110953 | Laparoscopic radical cystectomy with extracorporeal ileal neobladder for muscle-invasive urothelial carcinoma of the bladder: technique and short-term outcomes |
Q42660056 | Laparoscopic radical cystectomy: initial experience using the single-incision triangulated umbilical surgery (SITUS) technique |
Q40396879 | Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma |
Q34041779 | Laparoscopic radical prostatectomy |
Q92672812 | Laparoscopic retroperitoneal approach for retrocaval ureter in children |
Q35701242 | Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma |
Q101567670 | Laparoscopic simple prostatectomy vs bipolar plasma enucleation of the prostate in large benign prostatic hyperplasia: a two-center 3-year comparison |
Q88651506 | Laparoscopic single-incision triangulated umbilical surgery (SITUS) pyeloplasty: a description of the first 32 cases |
Q34041759 | Laparoscopic tissue approximation |
Q37541838 | Laparoscopic ureteral reimplantation: prospective evaluation of medium-term results and current developments. |
Q34114707 | Laparoscopic urinary diversion |
Q30317884 | Laparoscopic versus open bilateral intrafascial nerve-sparing radical prostatectomy after TUR-P for incidental prostate cancer: surgical outcomes and effect on postoperative urinary continence and sexual potency. |
Q48074557 | Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life |
Q40162609 | Laparoscopic vesico-ureteral reimplantation with Lich-Gregoir approach in children: medium term results of 159 renal units in 117 children |
Q61917195 | Laparoscopic “single knot–single running” suture vesico-urethral anastomosis with posterior musculofascial reconstruction |
Q92762662 | Laparoscopy versus robotic-assisted pyeloplasty in children: preliminary results of a pilot prospective randomized controlled trial |
Q34041766 | Laposcopic retroperitoneal lymph node dissection: evolution of a new technique |
Q35269845 | Laser endoureterotomy and endopyelotomy: an update |
Q89612244 | Laser enucleation of the prostate versus transurethral resection of the prostate: perioperative outcomes from the ACS NSQIP database |
Q90976563 | Laser fibre, rather than the stone, may harm the scope: retrospective monocentric analysis of 26 pre- and intraoperative factors of flexible ureteroscope (fURS) damage |
Q33503696 | Laser fragmentation of foreign bodies in the urinary tract: an in vitro study and clinical application |
Q103828237 | Laser procedures in the treatment of BPH: a bibliometric study |
Q36679088 | Laser prostatectomy for patients with benign prostatic hyperplasia: a prospective randomized study comparing two different techniques using the Prolase-II fiber |
Q33285831 | Laser treatment of benign prostatic hyperplasia |
Q33235539 | Laser treatment of symptomatic benign prostatic hyperplasia |
Q34185188 | Laser-guided percutaneous kidney access with the Uro Dyna-CT: first experience of three-dimensional puncture planning with an ex vivo model |
Q99602893 | Laser-guided real-time automatic target identification for endoscopic stone lithotripsy: a two-arm in vivo porcine comparison study |
Q83189459 | Lasers for every organ |
Q33280425 | Lasers in clinical urology: state of the art and new horizons |
Q33458451 | Lasers in percutaneous renal procedures |
Q33287353 | Lasers in the upper urinary tract for non-stone disease |
Q80463766 | Lasers in urology |
Q92828040 | Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies |
Q98197076 | Late complications of robot-assisted radical cystectomy with totally intracorporeal urinary diversion |
Q80244771 | Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience |
Q37448250 | Late relapse of germ cell tumors |
Q35738500 | Late relapse of testicular cancer |
Q33545997 | Lateral transperitoneal laparoscopic adrenalectomy |
Q101210879 | Learning benefits of live surgery and semi-live surgery in urology-informing the debate with results from the International Meeting of Reconstructive Urology (IMORU) VIII |
Q36170156 | Learning curves and perioperative outcomes after endoscopic enucleation of the prostate: a comparison between GreenLight 532-nm and holmium lasers |
Q40995871 | Leiomyosarcoma of the spermatic cord: report of two cases and review of the literature |
Q92190360 | Lessons learned from clinical outcome and tumor features of patients underwent selective artery embolization due to postoperative bleeding following 2076 partial nephrectomies: propensity scoring matched study |
Q40197726 | Lessons learned from the CROES percutaneous nephrolithotomy global study. |
Q92576266 | Letter to editor for the article "The effect of short-term preoperative ureteral stenting on the outcomes of retrograde intrarenal surgery for renal stones" |
Q120633367 | Letter to the Editor on the systematic review “Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer” |
Q90019580 | Letter to the Editor regarding the article "A contemporary lower pole approach for complete staghorn calculi: outcomes and efficacy" |
Q92565931 | Letter to the Editor regarding the article "Comparison of intra- and postoperative analgesia and pain perception in robot-assisted vs. open radical prostatectomy" |
Q91303650 | Letter to the Editor regarding the article "Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors" |
Q93066375 | Letter to the Editor regarding the article "Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors" |
Q92528909 | Letter to the Editor regarding the article "Radical prostatectomy after previous transurethral resection of the prostate: oncological, surgical and functional outcomes-a meta-analysis" |
Q48096460 | Letter to the Editor: A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy. |
Q91753416 | Letter to the Editor: Does intermittent catheterization result in fewer infections? |
Q91613848 | Letter to the editor |
Q88108500 | Letter to the editor regarding the article "Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study" |
Q88646226 | Letter to the editor regarding the article "Evaluation of pain perception associated with use of the magnetic-end ureteric double-J stent for short-term ureteric stenting" |
Q83730922 | Letter to the editor regarding the article "experience on semirigid ureteroscopy and pneumatic lithotripsy in children at a single center" |
Q89407239 | Letter to the editor regarding the article 'The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome' |
Q98390921 | Letter to the editor regarding: comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis |
Q90434785 | Letter to the editor: considering the effects of deep neuromuscular blockade on endoscopic surgical conditions during transurethral resection of a bladder tumor (TURB) |
Q73157907 | Levator ani muscle: new physioanatomical aspects and role in the micturition mechanism |
Q92059066 | Level of knowledge on radiation exposure and compliance to wearing protective equipment: where do endourologists stand? An ESUT/EULIS survey |
Q92785767 | Leydig-cell tumour of the testis: retrospective analysis of clinical and therapeutic features in 204 cases |
Q38103197 | Lichen sclerosus in men is associated with elevated body mass index, diabetes mellitus, coronary artery disease and smoking |
Q34558141 | Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment |
Q35607173 | Lifestyle issues and genitourinary tumours |
Q38886709 | Ligation-free technique for dorsal vascular complex control during laparoscopic radical prostatectomy: a single-center experience from China |
Q94497410 | Limitations of abdominopelvic CT and multiparametric MR imaging for detection of lymph node metastases prior to radical prostatectomy |
Q90953567 | Limited sensitivity and size over measurements of ultrasound affect medical decisions for ureteral stone compared to non-contrasted computed tomography |
Q35887804 | Linear growth after enterocystoplasty in children and adolescents: a review |
Q81121925 | Lingual mucosal graft substitution urethroplasty for anterior urethral strictures: our technique of graft harvesting |
Q92597296 | Liquid buccal mucosa graft endoscopic urethroplasty: a validation animal study |
Q91182568 | Liquid chromatography-mass spectrometry identification of serum biomarkers for nocturia in aged men |
Q91523788 | Live surgery in reconstructive urology: evaluation of the surgical outcome and educational benefit of the international meeting on reconstructive urology (IMORU) |
Q46472548 | Live surgery: highly educational or harmful? |
Q53904704 | Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. |
Q87402389 | Livin, Survivin and Caspase 3 as early recurrence markers in non-muscle-invasive bladder cancer |
Q48762585 | Local anesthesia for transurethral manipulations: is a transrectal periprostatic nerve block effective? |
Q44044026 | Local antiseptic therapy for non-gonococcal urethritis: phase II study with Instillagel |
Q89604072 | Local delivery of vasodilators for the reduction of ureteral contractions: limited but promising |
Q88431867 | Local staging with multiparametric MRI in daily clinical practice: diagnostic accuracy and evaluation of a radiologic learning curve |
Q71721260 | Localized renal-cell carcinoma: detection of abnormal cells in peritumoral tissue. A cytophotometry and immunocytochemistry study |
Q87133272 | Location, extent, and multifocality of positive surgical margins for biochemical recurrence prediction after radical prostatectomy |
Q92565925 | Long short-term memory artificial neural network model for prediction of prostate cancer survival outcomes according to initial treatment strategy: development of an online decision-making support system |
Q46483126 | Long-term PSA-free survival and castration-free survival with delayed antiandrogen therapy in patients with one versus two or more positive nodes at prostatectomy |
Q43717587 | Long-term angiogenic activity of free grafts and pedicle flap in a rabbit urethroplasty model |
Q51527942 | Long-term biochemical evaluation of the androgen receptor pathway in males with disorders of sex development. |
Q33463777 | Long-term bowel disorders following radial cystectomy: an underestimated issue? |
Q53272579 | Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial. |
Q47998499 | Long-term efficacy of the trans-obturator and retropubic mid-urethral slings for stress urinary incontinence: update from a randomized clinical trial |
Q42640085 | Long-term evaluation of oncologic and functional outcomes after laparoscopic open-assisted radical cystectomy: a matched-pair analysis. |
Q54076882 | Long-term experience with early single mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial. |
Q58614978 | Long-term follow-up after cystectomy for bladder pain syndrome: pain status, sexual function and quality of life |
Q44574433 | Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy |
Q50890026 | Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms. |
Q71691027 | Long-term follow-up of kidneys transplanted from elderly cadaveric donors |
Q91237219 | Long-term follow-up of neurogenic bladder patients after bladder augmentation with small intestinal submucosa |
Q82690459 | Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients |
Q90155622 | Long-term functional outcomes after robotic vs. retropubic radical prostatectomy in routine care: a 6-year follow-up of a large German health services research study |
Q35655453 | Long-term functional outcomes following non-radiated urethrovaginal fistula repair |
Q77422164 | Long-term metabolic effects in patients with urinary diversion |
Q92692214 | Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study |
Q86414834 | Long-term oncological and functional results of extraperitoneal laparoscopic radical prostatectomy: one surgical team's experience on 1,600 consecutive cases |
Q50090653 | Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study |
Q38614824 | Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment. |
Q35095090 | Long-term outcome following Thulium VapoEnucleation of the prostate |
Q36416273 | Long-term outcome following hypospadias repair |
Q87258499 | Long-term outcome following radical prostatectomy for Gleason 8-10 prostatic adenocarcinoma |
Q37015313 | Long-term outcome of home dipstick testing for hematuria. |
Q71951430 | Long-term outcome of kidneys with initially poor drainage or no drainage following pyeloplasty |
Q36416270 | Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer |
Q100402115 | Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study |
Q91537255 | Long-term outcomes of anastomotic urethroplasty for radiation-induced strictures |
Q37813081 | Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer. |
Q37744804 | Long-term outcomes of salvage radiotherapy for PSA-recurrent prostate cancer: validation of the Stephenson nomogram |
Q36396748 | Long-term outcomes of the surgical management of renal cell carcinoma |
Q51058634 | Long-term outcomes of transobturator tension-free vaginal tapes as secondary continence procedures. |
Q91748088 | Long-term outcomes of ultrasound-guided percutaneous nephrolithotomy in patients with solitary kidneys: a single-center experience |
Q90291461 | Long-term outcomes of urethral catheterisation injuries: a prospective multi-institutional study |
Q91501138 | Long-term results of ProACT primary and repeat implantation for treatment of stress urinary incontinence in men |
Q36463101 | Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer |
Q51166428 | Long-term results of standard procedures in urology: the ileal neobladder. |
Q35501374 | Long-term results of thulium laser resection of the prostate: a prospective study at multiple centers |
Q36861195 | Long-term subjective continence status and use of alternative treatments by women with stress urinary incontinence after collagen injection therapy |
Q44836523 | Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder |
Q34786513 | Long-term urinary adverse effects of pelvic radiotherapy |
Q52352165 | Longer length improvement and more covert incision: a single-center, prospective study of two innovative surgical methods "one stitch" and "four stitch" for pediatric buried penis. |
Q102055697 | Longitudinal analysis of trifecta outcome in Japanese patients with prostate cancer following robot-assisted laparoscopic radical prostatectomy |
Q87239694 | Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancer |
Q53319777 | Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival. |
Q45049691 | Low amplitude rhythmic contraction frequency in human detrusor strips correlates with phasic intravesical pressure waves |
Q41413983 | Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot |
Q46673575 | Low serum testosterone levels are predictive of prostate cancer |
Q39994345 | Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy. |
Q36844876 | Low yield of surveillance imaging after surgery for T1 kidney cancer. |
Q71341500 | Low-angle X-ray scattering signatures of urinary calculi |
Q54172830 | Low-expressed testis-specific calcium-binding protein CBP86-IV (CABYR) is observed in idiopathic asthenozoospermia. |
Q42818636 | Low-molecular-weight inhibitor of in vitro fibroblast colony formation from human urine |
Q48298978 | Low-pressure monopolar electroresection of the prostate for glands sized > 70 vs. < 70 cc performed with continuous irrigation and suprapubic suction: perioperative and long-term outcome |
Q90434759 | Low-risk prostate cancer selected for active surveillance with negative MRI at entry: can repeat biopsies at 1 year be avoided? A pilot study |
Q45819154 | Lower pole stones: prone PCNL versus supine PCNL in the International Cooperation in Endourology (ICE) group experience. |
Q57292773 | Lower urinary tract dysfunction in chronic Chagas disease: clinical and urodynamic presentation |
Q53101397 | Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study. |
Q53090397 | Lower urinary tract symptoms in patients with liver cirrhosis. |
Q39162041 | Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study |
Q64806303 | Lower urinary tract symptoms treatment constraints assessment (LUTS-TCA): a new tool for a global evaluation of neurogenic bladder treatments |
Q83318592 | Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: real life experience in Austria |
Q41738416 | Lower urinary tract trauma |
Q36839032 | Lower urinary-tract symptoms and testosterone in elderly men |
Q73157910 | Lower-energy thermotherapy in the treatment of benign prostatic hyperplasia: long-term follow-up results of a multicenter international study |
Q43618040 | Ludwig Rehn (1849-1930)--pioneering findings on the aetiology of bladder tumours |
Q46092423 | Lymph node dissection in bladder cancer: Where do we stand? |
Q89391627 | Lymph node dissection in urological cancers: one topic, many controversies |
Q53243465 | Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion. |
Q83318595 | Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes |
Q84218618 | Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? |
Q91131477 | M0CRPC overview of management options |
Q36107860 | MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging |
Q57105670 | MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature |
Q83932123 | MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy |
Q91319030 | MRI-targeted biopsies: What's next? |
Q34419228 | Macroscopic and microsurgical varicocelectomy: what's the intraoperative difference? |
Q35858464 | Magnetic resonance imaging and ultrasound evaluation of penile and testicular masses |
Q48137514 | Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF-III renal cysts: a multicenter study. |
Q40859798 | Magnetic resonance imaging of renal masses |
Q91810723 | Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters |
Q35560402 | Magnitude-dependent proliferation and contractility modulation of human bladder smooth muscle cells under physiological stretch |
Q42606500 | Major urological oncological surgeries can be performed using minimally invasive robotic or laparoscopic methods with similar early perioperative outcomes compared to conventional open methods |
Q96306206 | Making a case "against" focal therapy for intermediate-risk prostate cancer |
Q91777644 | Making surgery safer by centralization of care: impact of case load in penile cancer |
Q91747566 | Making surgery safer in an increasingly digital world: the internet-friend or foe? |
Q91623974 | Making surgery safer through adequate communication with the stakeholders: vaginal slings |
Q92318198 | Male CP/CPPS: where do we stand? |
Q38105250 | Male chronic pelvic pain syndrome and the role of interdisciplinary pain management |
Q28237994 | Male circumcision and HIV infection risk |
Q44625648 | Male contraception: mechanical, hormonal and non-hormonal methods |
Q89799736 | Male genital trauma at a level 1 trauma center |
Q51955417 | Male genital tuberculosis in Siberians. |
Q37878399 | Male genital tuberculosis: epidemiology and diagnostic |
Q38121826 | Male urogenital infections: impact of infection and inflammation on ejaculate parameters |
Q57109819 | Malignant invasion of the central nervous system: the hidden face of a poorly understood outcome of prostate cancer |
Q70803471 | Malignant peripheral neuroectodermal tumors in urology |
Q43557274 | Malondialdehyde and CA II autoantibody levels are elevated in children with undescended testes |
Q37728946 | Management and prevention of renal ablative therapy complications. |
Q35718994 | Management of BPH Larger Than 100 mL: Simple Prostatectomy Versus Laser Transurethral Surgery |
Q95790101 | Management of Peyronie's disease - a review |
Q92059049 | Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase |
Q31971733 | Management of Peyronie's disease--a review |
Q48311101 | Management of biochemically recurrent prostate cancer: molecular imaging perspective |
Q46523645 | Management of bladder cancer and urinary tract reconstruction : dedicated to the memory of John P. Stein, 14 June 1962-11 April 2008. |
Q52594077 | Management of bladder exstrophy epispadias complex in adults: is abdominal closure possible without osteotomy? |
Q38097352 | Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact |
Q40905631 | Management of complex renal calculi |
Q53019594 | Management of contralateral testicular intraepithelial neoplasia in patients with testicular germ-cell tumor. |
Q36640986 | Management of ejaculatory duct obstruction: etiology, diagnosis, and treatment |
Q36752749 | Management of erectile dysfunction after radical prostatectomy in 2007. |
Q94522410 | Management of highly recurrent bladder neck contractures via transurethral resection combined with intra- and post-operative triamcinolone acetonide injections |
Q33545983 | Management of incidentally discovered adrenal masses |
Q34798525 | Management of locally advanced bladder cancer: early vs deferred chemotherapy |
Q33990907 | Management of locally advanced prostate cancer. 1. Staging, natural history, and results of radical surgery |
Q33990914 | Management of locally advanced prostate cancer. 2. Radiotherapy, neoadjuvant endocrine treatment, update 1997-1999. |
Q85410469 | Management of low- and intermediate-risk prostate cancer |
Q82022765 | Management of low-risk prostate cancer |
Q90185194 | Management of low-risk prostate cancer in patients with enlarged glands and lower urinary tract symptoms: robotic total prostatectomy, a novel technique |
Q36256764 | Management of neobladder-vaginal fistula and stress incontinence following radical cystectomy in women: a review |
Q36513850 | Management of non-complicated BPH: proposition of a renewed decision tree |
Q37423978 | Management of non-germinal testicular tumors |
Q91815652 | Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations |
Q93001646 | Management of pelvic fracture urethral injuries in the developing world |
Q91862785 | Management of post TURP strictures |
Q37448244 | Management of post-chemotherapy extra-retroperitoneal residual masses |
Q33158881 | Management of renal artery pseudoaneurysm after partial nephrectomy |
Q50067131 | Management of renal transplant urolithiasis: a multicentre study by the French Urology Association Transplantation Committee |
Q33533586 | Management of small renal masses: a review |
Q37748548 | Management of sunitinib-related adverse events: an evidence- and expert-based consensus approach |
Q37448256 | Management of the contralateral testicle in patients with unilateral testicular cancer |
Q45929050 | Management of the post chemotherapy subcentimeter residual mass: the case for observation. |
Q96688421 | Management of urinary extravasation after renal trauma: the need for multi-institutional prospective trials |
Q43995084 | Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions |
Q92259167 | Managing complications of collagenase Clostridium histolyticum (CCH) injection |
Q90664568 | Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort |
Q91566362 | Manganese dioxide coating reduces bacterial adhesion and infection in silicon implants in animal model |
Q37428681 | Manual versus automatic bladder wall thickness measurements: a method comparison study |
Q31007069 | Manufacturers' data show increasing implanted cylinder sizes and measured corporal lengths in inflatable penile implants |
Q36907584 | Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens |
Q40066986 | Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1-2 N0 M0 renal cell carcinoma |
Q39723171 | Maspin modulates adhesion of bladder carcinoma cells to vascular endothelium |
Q30444285 | Mass spectrometry based proteomics in urine biomarker discovery |
Q42647426 | Matched comparison of outcomes following open and minimally invasive radical prostatectomy for high-risk patients |
Q51776076 | Matched comparison of primary versus salvage laparoscopic pyeloplasty. |
Q42661858 | Matched comparison of robot-assisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients |
Q38197539 | Matched pair analysis of laparoscopic versus open radical nephrectomy for the treatment of T3 renal cell carcinoma. |
Q42690014 | Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer |
Q38846463 | Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer. |
Q53518058 | May antioxidant therapy improve sperm parameters of men with persistent oligospermia after retrograde embolization for varicocele? |
Q37587788 | Measuring urgency in clinical practice |
Q91073429 | Mechanical and functional validation of a perfused, robot-assisted partial nephrectomy simulation platform using a combination of 3D printing and hydrogel casting |
Q70708787 | Mechanical testing of urinary calculi |
Q34694708 | Mechanism of microwave thermotherapy |
Q40860538 | Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer |
Q77617306 | Mechanisms of bladder smooth-muscle hypertrophy and decompensation: lessons from normal development and the response to outlet obstruction |
Q35109762 | Mechanisms of pain in chronic pelvic pain syndrome: influence of prostatic inflammation |
Q37947091 | Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives |
Q36072079 | Mechanisms of the development of androgen independence in prostate cancer |
Q41111871 | Mechanisms of tumor invasion and metastasis |
Q34728010 | Mediators of the female sexual response: pharmacotherapeutic implications |
Q91959850 | Medical dissolution therapy for the treatment of uric acid nephrolithiasis |
Q88867948 | Medical impulsive therapy (MIT): the impact of 1 week of preoperative tamsulosin on deployment of 16-French ureteral access sheaths without preoperative ureteral stent placement |
Q38902490 | Medical students faced with related and unrelated living kidney donation: a stratified and multicentre study in Spain. |
Q91143481 | Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis |
Q77422121 | Medical treatment and medical side effects in urinary incontinence in the elderly |
Q47600543 | Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy. |
Q33719034 | Mental health, psychosocial functioning, and quality of life in patients with bladder exstrophy and epispadias - an overview |
Q62778071 | Men’s health on the web: an analysis of current resources |
Q52676343 | Mesenchymal stem cells inhibit hypoxia-induced inflammatory and fibrotic pathways in bladder smooth muscle cells. |
Q41205942 | Mesenchymal-epithelial interactions in the bladder |
Q90905332 | Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors |
Q38388882 | Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients |
Q80428023 | Metabolic and functional consequences of urinary diversion through intestinal segments |
Q93089896 | Metabolic changes with degarelix vs leuprolide plus bicalutamide in patients with prostate cancer: a randomized clinical study |
Q85251854 | Metabolic disorders: stones as first clinical manifestation of significant diseases |
Q94522409 | Metabolic effects of cholecalciferol supplementation in patients with calcium nephrolithiasis and vitamin D deficiency |
Q38270121 | Metabolic evaluation of urinary lithiasis: what urologists should know and do. |
Q92835119 | Metagenomics in diagnosis and improved targeted treatment of UTI |
Q44884296 | Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignancies. |
Q79660615 | Metallothionein in bladder cancer: correlation of overexpression with poor outcome after chemotherapy |
Q92287932 | Metastasectomy for visceral and skeletal oligorecurrent prostate cancer |
Q92287924 | Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study |
Q96688417 | Metastatic hormone sensitive prostate cancer: local treatment strategies |
Q42661991 | Methicillin-resistant Staphylococcus aureus (MRSA) in an Austrian urological department: 10 years experience covering 95.161 patients |
Q47569619 | MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1. |
Q47548874 | Micro-ureteroscopy vs. ureteroscopy: effects of miniaturization on renal vascularization and intrapelvic pressure |
Q46560161 | Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation |
Q33353146 | Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle? |
Q96173049 | Microbiological diagnosis in urogenital tuberculosis: the Holy Grail still Eludes |
Q44008181 | Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria |
Q47599375 | Microbubbles improve the ablation efficiency of extracorporeal high intensity focused ultrasound against kidney tissues. |
Q88766157 | Microcirculatory effects of sildenafil in experimental testicular torsion in rats |
Q91857347 | Microlocalization and clinical significance of stabilin-1+ macrophages in treatment-naïve patients with urothelial carcinoma of the bladder |
Q130040352 | Microstructural white matter abnormalities in overactive bladder syndrome evaluation with diffusion kurtosis imaging tract-based spatial statistics analysis |
Q82594263 | Microvessel density estimate: friend or foe in the light of prostate vascular system complexity? |
Q38113950 | Midterm oncological outcome and clinicopathological characteristics of anterior prostate cancers treated by endoscopic extraperitoneal radical prostatectomy. |
Q90873509 | Mind the gap: management of benign prostatic obstruction (BPO) surgical candidates on antithrombotics |
Q47585870 | Mini-laparoscopic live donor nephrectomy with the use of 3-mm instruments and laparoscope |
Q91778029 | Mini-percutaneous nephrolithotomy versus retrograde intrarenal surgery for the treatment of 10-20 mm lower pole renal stones: a systematic review and meta-analysis |
Q49948738 | Miniaturised percutaneous nephrolithotomy versus flexible ureteropyeloscopy: a systematic review and meta-analysis comparing clinical efficacy and safety profile |
Q85226372 | Minilaparoscopy in urology: initial results after 32 cases |
Q77740474 | Minilaparotomy staging pelvic lymphadenectomy follow-up: a safe alternative to standard and laparoscopic pelvic lymphadenectomy |
Q47825102 | Minimal incision living donor nephrectomy compared to the hand-assisted laparoscopic living donor nephrectomy. |
Q77740449 | Minimally invasive approaches in urology |
Q50665147 | Minimally invasive cytoreductive nephrectomy: a multi-institutional experience. |
Q58099615 | Minimally invasive management of ureteral strictures: a 5-year retrospective study |
Q48245875 | Minimally invasive percutaneous nephrolithotomy under peritubal local infiltration anesthesia |
Q46229615 | Minimally invasive percutaneous nephrolithotomy: an alternative to retrograde intrarenal surgery and shockwave lithotripsy |
Q57042582 | Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years |
Q92283626 | Minimally invasive robotic versus conventional open living donor kidney transplantation |
Q72988889 | Minimally invasive surgery and technology: future directions |
Q74744383 | Minimally invasive therapies for benign prostatic hyperplasia |
Q35592682 | Minimally invasive treatment of renal transplant nephrolithiasis |
Q38494146 | Minimally invasive vas surgery using a newly designed double-ringed clamp |
Q40212944 | Minimally invasive vs open nephrectomy in the modern era: does approach matter? |
Q53581835 | Minimum 6 mm core length is strongly predictive for the presence of glandular tissue in transrectal prostate biopsy. |
Q52647309 | Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis. |
Q93384498 | Mitochondrial PIWI-interacting RNAs are novel biomarkers for clear cell renal cell carcinoma |
Q87642674 | Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome |
Q89282314 | Modeling human bladder cancer |
Q51614157 | Modification of the penile block. |
Q54121157 | Modifications of and extended indications for the Pippi Salle procedure. |
Q91119687 | Modifications to Botulinum toxin A delivery in the management of detrusor overactivity recalcitrant to initial injections: a review |
Q50017034 | Modified York Mason technique for repair of iatrogenic recto-urinary fistula: 20 years of the Montsouris experience |
Q83940454 | Modified concept for radioisotope-guided sentinel lymph node dissection in prostate cancer |
Q74377434 | Modified pump-driven venous bypass in surgery for renal cell carcinoma (RCC) involving the inferior vena cava (IVC) |
Q87282821 | Modified single-port minilaparoscopic extraperitoneal repair for pediatric hydrocele: a single-center experience with 279 surgeries |
Q43057663 | Modular therapy approach in metastatic castration-refractory prostate cancer |
Q35196655 | Molecular and genetic prognostic factors of prostate cancer |
Q41465655 | Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer |
Q83575589 | Molecular aspects of prostate cancer |
Q40392526 | Molecular biologic investigations of proto-oncogenes and growth factors in human testicular tumors |
Q41111921 | Molecular biology of dissemination in bladder cancer--laboratory findings and clinical significance |
Q72191279 | Molecular biology of genitourinary cancer |
Q71766929 | Molecular biology of prostate cancer |
Q36680336 | Molecular cytogenetics: unraveling of the genetic composition of individual cells by fluorescence in situ hybridization and digital imaging microscopy. |
Q41205937 | Molecular determinants of sexual differentiation |
Q91794064 | Molecular markers in bladder cancer |
Q36634023 | Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas |
Q41205980 | Molecular mechanisms of testicular carcinogenesis |
Q58107960 | Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer |
Q52942124 | Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different? |
Q72691766 | Molecular prognostic factors in bladder cancer |
Q37189400 | Molecular prognostic factors in penile cancer |
Q33276580 | Molecular staging of prostate cancer in the year 2007. |
Q37336643 | Molecular targets and targeted therapies in bladder cancer management. |
Q89282291 | Molecularly-driven precision medicine for advanced bladder cancer |
Q92958907 | Monopolar enucleation versus transurethral resection of the prostate for small- and medium-sized (< 80 cc) benign prostate hyperplasia: a prospective analysis |
Q50249673 | Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer |
Q120633374 | Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approach |
Q80559759 | Morphologic findings and blood flow parameters of penile vasculature in patients with erectile dysfunction |
Q71721263 | Morphological classification of renal cancer |
Q44043492 | Morphology and dynamics of the male pelvic floor before and after retrourethral transobturator sling placement: first insight using MRI. |
Q38554146 | Mortality and flexible ureteroscopy: analysis of six cases |
Q91170749 | Mortality from kidney stone disease (KSD) as reported in the literature over the last two decades: a systematic review |
Q98165510 | Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review |
Q35854191 | Mucus production after transposition of intestinal segments into the urinary tract |
Q84060147 | Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses |
Q53082540 | Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy. |
Q37724029 | Multi-modal treatment for metastatic renal cancer: the role of surgery |
Q92389193 | Multicenter analysis of posterior urethroplasty complexity and outcomes following pelvic fracture urethral injury |
Q50090635 | Multicenter evaluation of guideline adherence for pelvic lymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer. |
Q86047329 | Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence? |
Q36288029 | Multicenter international experience of 532 nm-laser photo-vaporization with Greenlight XPS in men with large prostates (prostate volume > 100 cc). |
Q82082555 | Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy |
Q91157243 | Multidimensional outcomes of suburethral synthetic midurethral sling removal |
Q34182566 | Multimodality therapy in penile cancer: when and which treatments? |
Q86268475 | Multiparametric MRI of the prostate at 3 T: limited value of 3D (1)H-MR spectroscopy as a fourth parameter |
Q39245393 | Multiparametric magnetic resonance imaging for prostate cancer-a comparative study including radical prostatectomy specimens |
Q28086868 | Multiparametric ultrasound in the detection of prostate cancer: a systematic review |
Q48170023 | Multiparametric ultrasound-targeted biopsy compares favorably to multiparametric MRI-transrectal ultrasound fusion-targeted biopsy on initial biopsy of men at risk for prostate cancer |
Q73522353 | Multiple primary tumors: 17 cases of renal-cell carcinoma associated with primary tumors involving different steroid-hormone target tissues |
Q41379184 | Multiple types of ion channels in cavernous smooth muscle |
Q95648697 | Multiple-tract percutaneous nephrolithotomy as a day surgery for the treatment of complex renal stones: an initial experience |
Q92345413 | Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions |
Q46532573 | Muscarinic receptor expression increases following exposure to intravesical pressures of < or =40 cm-H2O: a possible mechanism for pressure-induced cell proliferation |
Q37159308 | Muscle derived stem cell therapy for stress urinary incontinence |
Q89251151 | Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis |
Q91182563 | Musculocutaneous latissimus dorsi flap for phalloplasty in female to male gender affirmation surgery |
Q47993851 | Mutational analysis of proto-oncogene Dbl on Xq27 in testicular germ cell tumors reveals a rare SNP in a patient with bilateral undescended testis |
Q91558578 | Mutations in CDKN2A and the FGFR3 genes on bladder cancer diagnosis: a systematic review and meta-analysis |
Q40769771 | Myoblast therapy for stress urinary incontinence and bladder dysfunction |
Q46779675 | N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pediatric patients with urolithiasis |
Q37956492 | NF-κB signaling in prostate cancer: a promising therapeutic target? |
Q53544163 | Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial. |
Q89277732 | Nanomaterials: Friend or foe to male fertility? |
Q35127220 | Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate |
Q93024853 | Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy |
Q39287434 | National economic and development indicators and international variation in prostate cancer incidence and mortality: an ecological analysis. |
Q77422129 | National public health policies for prevention and care in urinary incontinence in the elderly |
Q38787880 | National trends and differences in morbidity among surgical approaches for radical prostatectomy in Germany |
Q96610765 | National trends in the management of patients with positive surgical margins at radical prostatectomy |
Q95655530 | National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men |
Q54509886 | Nationwide practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomy. |
Q41465615 | Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients |
Q33955500 | Natural orifice (NOTES) transurethral sutureless radical prostatectomy with thulium laser support: first patient report. |
Q92385514 | Navigating systemic therapy for metastatic castration-naïve prostate cancer |
Q93001643 | Necessity of differentiating small (< 10 mm) and large (≥ 10 mm) PI-RADS 4 |
Q91880378 | Negative impact of being underweight on the outcomes of single-session shockwave lithotripsy in patients with upper urinary tract calculi: a retrospective cohort study |
Q34262384 | Neo-adjuvant chemotherapy in invasive bladder cancer |
Q33990889 | Neoadjuvant and adjuvant hormone therapy for prostate cancer |
Q79370791 | Neoadjuvant chemotherapy for bladder cancer |
Q50246619 | Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancer |
Q53422101 | Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin. |
Q46162075 | Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery |
Q63966810 | Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful? |
Q87423524 | Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report |
Q47227096 | Neobladder formation after pelvic irradiation |
Q45134375 | Nephrectomy as a cause of chronic kidney disease in the treatment of urolithiasis: a case-control study |
Q47323296 | Nephrectomy in patients with autosomal dominant polycystic kidney disease, does size matter? |
Q44762959 | Nephrolithiasis during pregnancy: characteristics, complications, and pregnancy outcome |
Q80848647 | Nephron sparing surgery for renal cell carcinoma in a solitary kidney |
Q48113926 | Nephron sparing surgery for renal cell carcinoma up to 7 cm in the context of guideline development: a contribution of healthcare research. |
Q53671796 | Nephron-sparing surgery in multiple bilateral angiomyolipomas. |
Q40271159 | Nephrostomy in percutaneous nephrolithotomy (PCNL): does nephrostomy tube size matter? Results from the Global PCNL Study from the Clinical Research Office Endourology Society |
Q51646090 | Nerve-sparing technique and urinary control after robot-assisted laparoscopic prostatectomy |
Q38916208 | Neural supply of the male urethral sphincter: comprehensive anatomical review and implications for continence recovery after radical prostatectomy |
Q49097054 | Neurapraxic complications in operations performed in the lithotomy position |
Q70803479 | Neuroblastoma |
Q89303345 | Neurogenic bowel management for the adult spinal cord injury patient |
Q34317263 | Neurogenic inflammation and chronic pelvic pain |
Q128608430 | Neurological sphincter deficiency: is there a place for artificial urinary sphincter? |
Q27003164 | Neuromodulation in male chronic pelvic pain syndrome: rationale and practice |
Q77617264 | Neuromodulation/neurostimulation |
Q41379140 | Neurotransmission and the contraction and relaxation of penile erectile tissues |
Q33520804 | New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device |
Q79750068 | New approaches in the modulation of bladder smooth muscle cells on viable detrusor constructs |
Q41465688 | New approaches in the treatment of metastatic transitional-cell cancer of the bladder |
Q40913104 | New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder |
Q98283892 | New computed tomographic predictors of complicated perioperative course of 17.5F mini-percutaneous nephrolithotomy (mini-PNL) |
Q86608134 | New developed urological protocols for the Uro Dyna-CT reduce radiation exposure of endourological patients below the levels of the low dose standard CT scans |
Q34798504 | New drugs and new approaches for the treatment of metastatic urothelial cancer |
Q50230032 | New ex vivo organ model for percutaneous renal surgery using a laparoendoscopic training box: the sandwich model |
Q36653218 | New imaging modalities in bladder cancer |
Q33200142 | New insights into the pathology and molecular biology of human germ cell tumors. |
Q35556839 | New long-acting androgens |
Q91694742 | New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the details |
Q44829642 | New standardization of checking the vesicourethral anastomosis for tightness following radical prostatectomy with dynamic transrectal ultrasound: can this new technique replace the traditional postoperative cystogram? |
Q91656779 | New study suggests patients with advanced prostate cancer on androgen deprivation therapy need more dialogue with health care provider, especially around cardiovascular risk |
Q51136178 | New technique for prostate volume assessment. |
Q37599548 | New therapies for non-muscle-invasive bladder cancer |
Q51220033 | New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. |
Q37784735 | New trends in minimally invasive urological surgery: what is beyond the robot? |
Q47612379 | Newborn exstrophy closure and epispadias repair |
Q91215993 | Next-day discharge after minimally invasive partial nephrectomy: an analysis of the US National Surgical Quality Improvement Program |
Q28397784 | Nighttime kidney transplantation is associated with less pure technical graft failure |
Q40397945 | Nitric oxide synthase and nitric oxide-mediated effects in lower urinary tract smooth muscles. |
Q36311552 | Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract--is there a basis for pharmacological targeting of cGMP? |
Q48194331 | No convincing evidence on differences in metabolic effects of medical and surgical castration in the treatment of prostate cancer |
Q100528773 | No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance |
Q43773020 | No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer |
Q90291492 | No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study |
Q85323981 | No matter which way: IS 10 or 11/12 FRENCH access the rising new standard in kidney stone surgery 2015? |
Q52895289 | No need for systemic heparinization during laparoscopic donor nephrectomy with short warm ischemia time. |
Q97867836 | No need to say goodbye to transrectal biopsies in the diagnostic work-up for prostate cancer |
Q53701069 | No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study. |
Q36230948 | Nobel Prize nominees and the rise of urology in Europe around 1900. |
Q48068907 | Nocturia and its impact on health-related quality of life and health care seeking behaviour in German community-dwelling men aged 50 years or older |
Q46131315 | Nocturia improvement in the combination of Avodart(®) and tamsulosin (CombAT) study |
Q48030634 | Nocturia: state of the art and critical analysis of current assessment and treatment strategies |
Q100468916 | Nomenclature and treatment of secondary urethral strictures following primary hypospadias repair: weighing up academic principles and clinical pragmatism |
Q48590429 | Nomenclature in PCNL or The Tower Of Babel: a proposal for a uniform terminology |
Q114229788 | Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer |
Q43906056 | Nomograms to predict late urinary toxicity after prostate cancer radiotherapy |
Q96023577 | Non papillary mini-percutaneous nephrolithotomy: early experience |
Q40397938 | Non-adrenergic, non-cholinergic control of the urinary bladder |
Q101477059 | Non-contrast computed tomography characteristics in a large cohort of cystinuria patient |
Q37205040 | Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer |
Q33294284 | Non-invasive markers of ureteropelvic junction obstruction |
Q38779039 | Non-metastatic castrate-resistant prostate cancer: a call for improved guidance on clinical management |
Q96766456 | Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group |
Q92359169 | Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future |
Q34150546 | Non-squamous cell carcinoma of the penis: single-center, 15-year experience |
Q90550303 | Non-surgical urologic management of neurogenic bladder after spinal cord injury |
Q90140781 | Non-technical skills: a review of training and evaluation in urology |
Q91680247 | Non-transecting bulbar urethroplasty is favored over transecting techniques |
Q41738372 | Noncontrast helical CT for ureteral stones |
Q34262363 | Nonfunctioning malignant pheochromocytoma associated with dermatomyositis: case report and literature review |
Q36026873 | Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment? |
Q74068024 | Nonpalpable prostate cancer detected in the prostate-specific antigen era |
Q46106944 | Not only surgical technique, but also anesthetic concerns. |
Q53474740 | Novel AR-V7 detection in whole blood samples in patients with prostate cancer: not as simple as it seems. |
Q97531889 | Novel PET imaging methods for prostate cancer |
Q34409187 | Novel approaches in the therapy of metastatic renal cell carcinoma. |
Q38656611 | Novel contrast-enhanced ultrasound imaging in prostate cancer |
Q36410973 | Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy. |
Q61917182 | Novel kidney segmentation system to describe tumour location for nephron-sparing surgery |
Q91606360 | Novel laser positioning navigation to aid puncture during percutaneous nephrolithotomy: a preliminary report |
Q90394282 | Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system |
Q37958741 | Novel options for the treatment of castration-resistant prostate cancer |
Q34209746 | Novel pharmacological approaches in the treatment of erectile dysfunction |
Q84809453 | Novel strategies in imaging |
Q47710564 | Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligands |
Q35200626 | Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy |
Q90111413 | Novices in MRI-targeted prostate biopsy benefit from structured reporting of MRI findings |
Q71721283 | Nucleolar organizer regions in low- and high-grade carcinomas of the prostate |
Q37240903 | Nutritional predictors of complications following radical cystectomy |
Q84897016 | Nutritional supplementation with L-arginine prevents pelvic radiation-induced changes in morphology, density, and regulating factors of blood vessels in the wall of rat bladder |
Q52677839 | Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients. |
Q91022044 | Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic study |
Q73146060 | Objective measurement of the different collagen types in the corpus cavernosum of potent and impotent men: an immunohistochemical staining with computerized-image analysis |
Q95648708 | Observation vs. early drainage for grade IV blunt renal trauma: a multicenter study |
Q53215676 | Observations and outcomes of urethroplasty for bulbomembranous stenosis after radiation therapy for prostate cancer. |
Q38876862 | Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically. |
Q57806104 | Obstructive sleep apnea syndrome should always be screened in patients complaining of nocturia |
Q35810093 | Obstructive ureterocele-an ongoing challenge. |
Q35597288 | Occupational exposure and urological cancer |
Q81141835 | Occupational risk factors for kidney cancer: a cohort study in Sweden |
Q91839632 | Occupational traumatic injuries rarely affect genitourinary organs: a retrospective, comparative study |
Q31943479 | Office-based surgery and anesthesia: where are we now? |
Q91469061 | Old wine in new bottles? |
Q40897976 | Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy. |
Q56383213 | Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row |
Q47701123 | OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results |
Q97548720 | Oncocytoma: risk of promoting unnecessary surgery |
Q37665813 | Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma |
Q50248508 | Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer |
Q115201922 | Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review |
Q37494500 | Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience |
Q34582467 | Oncologic outcome of 132 cases of laparoscopic radical nephrectomy with intact specimen removal for T1-2N0M0 renal cell carcinoma |
Q44096432 | Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy |
Q93047468 | Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis |
Q42640080 | Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis |
Q84778546 | Oncologic outcomes following radical prostatectomy with intraoperative cell salvage |
Q38055429 | Oncologic outcomes obtained after laparoscopic, robotic and/or single port nephroureterectomy for upper urinary tract tumours. |
Q38051010 | Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review |
Q52371831 | Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience. |
Q85302470 | Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: multicenter experience in Turkey including 1,499 patients |
Q48729142 | Oncologic surveillance following radical cystectomy: an individualized risk-based approach |
Q96347726 | Oncological and functional outcomes in patients over 70 years of age treated with robotic radical prostatectomy: a propensity-matched analysis |
Q36758391 | Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter? |
Q90857749 | Oncological long-term outcome of whole gland HIFU and open radical prostatectomy: a comparative analysis |
Q91048412 | Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse |
Q38245360 | Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy |
Q61917175 | Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis |
Q51192093 | Oncological outcomes of robotic-assisted radical prostatectomy after more than 5 years. |
Q37330112 | Oncological risk of laparoscopic surgery in urothelial carcinomas |
Q100507638 | Oncological safety and functional outcomes of testosterone replacement therapy in symptomatic adult-onset hypogonadal prostate cancer patients following robot-assisted radical prostatectomy |
Q88564262 | Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial |
Q40983333 | Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy. |
Q92597306 | One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis |
Q90140776 | One-stop biparametric MRI and MRI/ultrasound fusion-guided biopsy: can we include the histopathology result and our treatment recommendations in our diagnostic pathway? |
Q99412197 | Online interest in surgical treatment for benign prostatic hyperplasia using Google trends |
Q34538448 | Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder |
Q90457562 | Open partial nephrectomy when a non-flank approach is required: indications and outcomes |
Q38639574 | Open radical cystectomy: still the gold standard for muscle invasive bladder cancer |
Q45849222 | Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project). |
Q42612077 | Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications |
Q48048242 | Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH. |
Q89986158 | Operative time comparison of aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP |
Q100468898 | Operator-assisted vs self-achieved basketing during ureteroscopy: results from an in vitro preference study |
Q98188204 | Opiates prescribed for acute renal colic are associated with prolonged use |
Q92835129 | Optimal non-invasive treatment of 1-2.5 cm radiolucent renal stones: oral dissolution therapy, shock wave lithotripsy or combined treatment-a randomized controlled trial |
Q48157760 | Optimal screening interval for men with low baseline prostate-specific antigen levels (≤1.0 ng/mL) in a prostate cancer screening program. |
Q91413047 | Optimal sequencing strategy using docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant prostate cancer: utilization of neutrophil-to-lymphocyte ratio |
Q36749363 | Optimal treatment of locally advanced prostate cancer |
Q33581007 | Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III |
Q120642557 | Optimizing full-dose radiation therapy in the successful bladder-sparing management of patients with invasive bladder carcinoma |
Q84568622 | Optimizing imaging quality in endourology with the Uro Dyna-CT: contrast agent dilution matters |
Q91343844 | Optimizing male fertility: oxidative stress and the use of antioxidants |
Q53515170 | Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. |
Q41738360 | Optimizing urography |
Q34209758 | Oral alpha adrenoceptor blockade as a treatment of erectile dysfunction |
Q83341460 | Oral mucosal grafts urethroplasty for the treatment of long segmented anterior urethral strictures |
Q89184332 | Oral quality of life after buccal mucosal graft harvest for substitution urethroplasty. More than a bite? |
Q43608208 | Orchialgia after laproscopic renal surgery: a common problem with questionable etiology. Are there any predictors? |
Q38104311 | Orchialgia and the chronic pelvic pain syndrome |
Q44846317 | Organ-sparing surgery is the treatment of choice in benign testicular tumors |
Q64983420 | Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival. |
Q41730298 | Organ-specific acellular matrix for reconstruction of the urinary tract |
Q35640762 | Organ-specific matrix self-assembled by mesenchymal cells improves the normal urothelial differentiation in vitro |
Q92135866 | Original manuscript by Lebdai et al.: do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment |
Q90976560 | Original manuscript by Yu et al.: Antibiotic prophylaxis in perioperative period of percutaneous nephrolithotomy: a systematic review and meta‑analysis of comparative studies |
Q95937764 | Orthotopic robot-assisted kidney transplantation: first case report |
Q38593856 | Orthotopic urinary diversion in the elderly |
Q46069245 | Orthotopic urinary diversion: the Kock ileal neobladder |
Q30305741 | Osteocalcin-directed gene therapy for prostate-cancer bone metastasis |
Q36482565 | Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxin |
Q47095143 | Outcome from 5-year live surgical demonstrations in urinary stone treatment: are outcomes compromised? |
Q95274137 | Outcome groups and a practical tool to predict success of shock wave lithotripsy in daily clinical routine |
Q35581828 | Outcome measures for stress urinary incontinence treatment: can we minimally agree? |
Q47246812 | Outcome of expanded criteria donor kidneys that were transplanted at other Eurotransplant centers after being rejected by our institution. |
Q44855054 | Outcome of female urethral reconstruction: a 12-year experience |
Q88673193 | Outcome of flexible ureteroscopy for renal stone with overnight ureteral catheterization: a propensity score-matching analysis |
Q34096971 | Outcome of laser-assisted laparoscopic partial nephrectomy without ischaemia for peripheral renal tumours |
Q90070437 | Outcome of patients with newly diagnosed prostate cancer with low metastatic burden treated with radical prostatectomy: a comparison to STAMPEDE arm H |
Q43220147 | Outcome of preemptive penile rehabilitation before bilateral cavernosal nerve injury in rats |
Q46669909 | Outcome of repeated prostatic biopsy during active surveillance: implications for focal therapy |
Q90675775 | Outcome of simultaneous thulium laser enucleation of bladder tumor and prostate in patients with non-muscle invasive bladder tumor and benign prostatic hyperplasia: a matched-pair comparison with a long-term follow-up |
Q82776173 | Outcome of treatment of bladder cancer: a comparison between low-volume hospitals and an oncology centre |
Q44893752 | Outcome profiles of locoregional disease after radical prostatectomy and radiotherapy |
Q91795789 | Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study |
Q42692893 | Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy |
Q35989759 | Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia |
Q37848701 | Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy |
Q85377312 | Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis |
Q92669389 | Outcomes for urologic oncology procedures: are there differences between academic and community hospitals? |
Q90096046 | Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success |
Q89689143 | Outcomes of artificial urinary sphincter in female with neurological stress urinary incontinence: a long-term follow-up |
Q93259960 | Outcomes of magnetic resonance imaging fusion-targeted biopsy of prostate imaging reporting and data system 3 lesions |
Q35176884 | Outcomes of minimally invasive simple prostatectomy for benign prostatic hyperplasia: a systematic review and meta-analysis |
Q46120103 | Outcomes of patients with clinical CIS-only disease treated with radical cystectomy |
Q85524473 | Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry |
Q47813874 | Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors |
Q92240661 | Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis |
Q85219958 | Outcomes of two different incision techniques for surgical treatment of stress urinary incontinence with concomitant anterior vaginal wall prolapse |
Q92465230 | Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management |
Q92865749 | Outcomes of ureteroscopy (URS) for stone disease in the paediatric population: results of over 100 URS procedures from a UK tertiary centre |
Q92126594 | Outcomes of ureteroscopy for stone disease in anomalous kidneys: a systematic review |
Q82680189 | Outcomes research in urology |
Q86484978 | Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation |
Q73231153 | Overactive bladder inhibition in response to pelvic floor muscle exercises |
Q91131495 | Overactive bladder symptoms in patients undergoing rigid and flexible cystoscopy |
Q88646235 | Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy |
Q36761279 | Overdiagnosis and overtreatment of early detected prostate cancer |
Q40967704 | Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer |
Q40816684 | Overview of the current status of total androgen deprivation in metastasized prostate cancer. |
Q46800533 | Oxalate and its handling in a low stone risk vs a stone-prone population group |
Q34473215 | Oxybutynin and the overactive bladder |
Q44481190 | Oxytocin plasma levels in the systemic and cavernous blood of healthy males during different penile conditions |
Q53475443 | P53 accumulation in precursor lesions and early stages of bladder cancer. |
Q38656531 | PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols |
Q85789795 | PCNL in the twenty-first century: role of Microperc, Miniperc, and Ultraminiperc |
Q112576412 | PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers |
Q97529885 | PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment |
Q101212513 | PD-L1 testing in urothelial bladder cancer: essentials of clinical practice |
Q51581882 | PDE-5 and NOS II mRNA expression in menopausal women: a molecular biology study. |
Q54472343 | PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection? |
Q35926932 | PET and prostate cancer |
Q38983526 | PET imaging for lymph node dissection in prostate cancer. |
Q85635126 | PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance |
Q41205929 | POU-domain gene expression during spermatogenesis |
Q41288229 | PREDICT: model for prediction of survival in localized prostate cancer. |
Q63966592 | PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapy |
Q49921146 | PSA kinetics following primary focal cryotherapy (hemiablation) in organ-confined prostate cancer patients. |
Q47203358 | PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study |
Q95842677 | PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions |
Q98197075 | PSA-based machine learning model improves prostate cancer risk stratification in a screening population |
Q47810828 | PSA-nadir at 1 year as a sound contemporary prognostic factor for low-dose-rate iodine-125 seeds brachytherapy |
Q58107966 | PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics |
Q57113710 | PSMA-PET guided hook-wire localization of nodal metastases in prostate cancer: a targeted approach |
Q91656786 | Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines |
Q44701998 | Pain during transrectal ultrasonography guided prostate biopsy: a randomized prospective trial comparing periprostatic infiltration with lidocaine with the intrarectal instillation of lidocaine-prilocain cream |
Q88209404 | Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy |
Q114229792 | Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores |
Q50129958 | Papillary puncture: no way! |
Q57473510 | Papillary puncture: still a good practice |
Q40488778 | Paracrine factors and the regulation of spermatogenesis |
Q84346208 | Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome |
Q35935723 | Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy |
Q40926926 | Paratesticular rhabdomyosarcoma |
Q92946832 | Paravertebral block for percutaneous nephrolithotomy: a prospective, randomized, double-blind placebo-controlled study |
Q88209341 | Parental awareness of testicular torsion amongst Irish parents |
Q40984665 | Partial nephrectomy driven by cavitron ultrasonic surgical aspirator under zero ischemia: a pilot study |
Q37172912 | Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics. |
Q52982574 | Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting. |
Q42666668 | Partial nephrectomy: is there an advantage of the self-retaining barbed suture in the perioperative period? A matched case-control comparison |
Q117042055 | Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group |
Q92774222 | Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) |
Q43589581 | Partners agree that the treatment of LUTS reduces patients' bother and improves their quality of life: prospective 12 years follow-up study |
Q53545691 | Patent medicines for the treatment of genitourinary diseases. |
Q33827816 | Pathogenesis and management of recurrent urinary tract infections in women |
Q43456104 | Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens |
Q88673185 | Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort |
Q37808973 | Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre study |
Q81355279 | Pathophysiology of renal function and its effect on isotope studies in the workup of hydronephrosis |
Q41214898 | Patient and disease-specific factors and their influence on urinary reconstruction choice at a referral center |
Q85225385 | Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions |
Q91072953 | Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study |
Q98281387 | Patient-reported outcomes for typical single cheek harvesting vs atypical lingual, labial or bilateral cheeks harvesting: a single-center analysis of more than 800 patients |
Q129182176 | Patients and general practitioner knowledge and perception of testicular self-examination for cancer |
Q92566544 | Patients choose certainty over burden in bladder cancer surveillance |
Q63367559 | Patients knowledge and experience with urinary and peripheral intravenous catheters |
Q88945778 | Patients with disorders of sex development and proximal hypospadias are at high risk for reoperation |
Q51352697 | Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control. |
Q92078048 | Pattern of metastatic deposit in recurrent prostate cancer: a whole-body MRI-based assessment of lesion distribution and effect of primary treatment |
Q49380161 | Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature. |
Q48137505 | Patterns and timing of artificial urinary sphincter failure |
Q84916976 | Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer |
Q38035794 | Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review |
Q53553047 | Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians. |
Q35805467 | Pediatric MRU--its potential and its role in the diagnostic work-up of upper urinary tract dilatation in infants and children |
Q46013518 | Pediatric enterocystoplasty: long-term complications and controversies. |
Q70803455 | Pediatric urological cancer |
Q41738396 | Pediatric uroradiology--1997. |
Q51450700 | Pelvic floor disorders: role of new ultrasonographic techniques. |
Q40228647 | Pelvic floor muscle function is an independent predictor of outcome after retrourethral transobturator male sling procedure |
Q37943783 | Pelvic floor muscle training in treatment of female stress urinary incontinence, pelvic organ prolapse and sexual dysfunction |
Q52357997 | Pelvic floor ultrasound in the diagnosis of sling complications. |
Q33657209 | Pelvic fracture injuries of the posterior urethra |
Q96110389 | Pelvic lymph node distribution and metastases of prostate and bladder cancer: a systematic literature review and template proposal |
Q48428159 | Penile block is associated with less urinary retention than caudal anesthesia in distal hypospadia repair in children |
Q34012647 | Penile cancer: epidemiology, pathogenesis and prevention |
Q83183744 | Penile cancer: incremental insights into etiology, diagnosis, staging, and management |
Q101218260 | Penile cancer: potential target for immunotherapy? |
Q33657229 | Penile fracture and testicular rupture |
Q97646936 | Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial |
Q37219563 | Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience |
Q43761707 | Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures |
Q87916430 | Penoscrotal versus minimally invasive infrapubic approach for inflatable penile prosthesis placement: a single-center matched-pair analysis |
Q41442978 | Peptide growth factors in normal and hypertrophied bladder |
Q70949772 | Peptide growth factors in urology |
Q77740478 | Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro |
Q90562377 | Perceptions of dietary factors promoting and preventing nephrolithiasis: a cross-sectional survey |
Q40219811 | Percutaneous nephrolithotomy for staghorn stones: Which nomogram can better predict postoperative outcomes? |
Q51462107 | Percutaneous nephrolithotomy in children: does age matter? |
Q39194000 | Percutaneous nephrolithotomy in children: experience with 138 cases in a developing country |
Q99545553 | Percutaneous nephrolithotomy in patients with spinal cord injury: should all these patients be automatically assigned a Guy's stone score of 4? |
Q44079060 | Percutaneous nephrolithotomy under combined sonographic/radiologic guided puncture: results of a learning curve using the modified Clavien grading system |
Q53547016 | Percutaneous nephrolithotomy: technique. |
Q36761288 | Percutaneous radiotherapy for low-risk prostate cancer: options for 2007. |
Q44234296 | Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer |
Q36100707 | Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results. |
Q91818110 | Performance of SOFA, qSOFA and SIRS to predict septic shock after percutaneous nephrolithotomy |
Q92735758 | Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance |
Q38954368 | Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study |
Q40212465 | Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate. |
Q84382334 | Periarterial papaverine improves early postoperative renal function after retroperitoneoscopic partial nephrectomy |
Q54255623 | Perineal midline vertical incision verses inverted-U incision in the urethroplasty: which is better? |
Q45946964 | Perioperative analgesia strategies in fast-track pediatric surgery of the kidney and renal pelvis: lessons learned. |
Q98165508 | Perioperative and 1-year patient-reported outcomes of Freyer versus Millin versus Madigan robot-assisted simple prostatectomy |
Q50977271 | Perioperative and long-term renal functional outcomes of robotic versus laparoscopic partial nephrectomy: a multicenter matched-pair comparison. |
Q58564405 | Perioperative and long-term results of retroperitoneal laparoscopic pyelolithotomy versus percutaneous nephrolithotomy for staghorn calculi: a single-center randomized controlled trial |
Q39668775 | Perioperative and renal functional outcomes of laparoscopic partial nephrectomy (LPN) for renal tumours of high surgical complexity: a single-institute comparison between clampless and clamped procedures |
Q57169574 | Perioperative antibiotic prophylaxis in renal transplantation: a single-center comparison between two regimens and a brief survey among the Eurotransplant renal transplantation centers |
Q92649036 | Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines |
Q39078873 | Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review. |
Q91373745 | Perioperative management of direct oral anticoagulants in patients undergoing radical prostatectomy: results of a prospective assessment |
Q50893132 | Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors. |
Q51027422 | Perioperative outcome and female sexual function after laparoscopic transvaginal NOTES-assisted nephrectomy. |
Q88621745 | Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study |
Q98179246 | Perioperative outcomes and safety of robotic vs open cystectomy: a systematic review and meta-analysis of 12,640 cases |
Q48348085 | Perioperative patient education improves long-term satisfaction rates of low-risk prostate cancer patients after radical prostatectomy |
Q92163902 | Perioperative venous thromboembolism prophylaxis in prostate cancer surgery |
Q53334318 | Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma. |
Q34255328 | Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness |
Q110662364 | Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG) |
Q84198756 | Peritoneal cavity as bioreactor to grow autologous tubular urethral grafts in a rabbit model |
Q41645544 | Periurethral collagen injection for male and female sphincteric incontinence: indications, techniques, and result |
Q30311133 | Permanent interstitial brachytherapy for prostate cancer: a current review |
Q40568427 | Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis. |
Q94504067 | Persistent orchialgia after laparoscopic living-donor nephrectomy: an underestimated complication requiring information adjustment |
Q46012101 | Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur. |
Q40750152 | Personalized 3D printed model of kidney and tumor anatomy: a useful tool for patient education |
Q92535853 | Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated? |
Q37630958 | Perspectives on overactive bladder in the elderly population |
Q48357375 | Perugia ileal neobladder: functional results and complications |
Q92287911 | Peyronie's disease and testosterone deficiency: Is there a link? |
Q92103580 | Peyronie's disease in contemporary urological practice |
Q50995083 | Pharmacological modulation of ureteric peristalsis in a chronically instrumented conscious pig model: effect of adrenergic and nitrergic modulation. |
Q33545992 | Pheochromocytoma: evaluation, diagnosis, and treatment |
Q47710224 | Phimosis in antiquity |
Q34473236 | Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside |
Q36296249 | Phosphodiesterase inhibitors in female sexual dysfunction |
Q34209734 | Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction. |
Q46668254 | Phosphodiesterase type 2 distribution in the guinea pig urinary bladder |
Q54445165 | Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide/cyclic GMP signaling in the human prostate. |
Q43003879 | Photodynamic diagnosis in patients with T1G3 bladder cancer: influence on recurrence rate |
Q33573701 | Photodynamic therapy for focal ablation of the prostate |
Q58618445 | Photoselective vaporization has comparative efficacy and safety among high-risk benign prostate hyperplasia patients on or off systematic anticoagulation: a meta-analysis |
Q92006038 | Photoselective vaporization of the prostate: study outcomes as a function of risk of bias, conflicts of interest, and industrial sponsorship |
Q90994445 | Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective |
Q35537712 | Physical activity and body mass index as predictors of prostate cancer risk |
Q43345926 | Physical therapy management of pelvi/perineal and perianal pain syndromes |
Q34728021 | Physiology and pathophysiology of female sexual function and dysfunction |
Q30463944 | Physiology of the vas deferens |
Q46497764 | Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscle |
Q96110392 | Pillars to improve patient outcomes: training and assessment methods for surgery |
Q32005829 | Pilot study of the transdermal application of testosterone gel to the penile skin for the treatment of hypogonadotropic men with erectile dysfunction |
Q37586212 | Place of overactive bladder in male lower urinary tract symptoms |
Q92762765 | Placental membrane grafts for urethral replacement in a rabbit model: a pilot study |
Q38906007 | Platinum-refractory germ cell tumors: an update on current treatment options and developments. |
Q98718983 | Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique |
Q44511573 | Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer |
Q48365333 | Polymorphisms of nucleotide factor of activated T cells cytoplasmic 2 and 4 and the risk of acute rejection following kidney transplantation. |
Q71341504 | Polytetrafluoroethylene sling for failure in female stress incontinence surgery |
Q37068020 | Poor early graft function impairs long-term outcome in living donor kidney transplantation |
Q52672783 | Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA. |
Q87349673 | Poor standard mp-MRI and routine biopsy fail to precisely predict intraprostatic tumor localization |
Q120633370 | Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study |
Q98471830 | Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors |
Q38468910 | Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer |
Q41685647 | Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen |
Q38788460 | Population-based study of grade progression in patients who harboured Gleason 3 + 3. |
Q97533642 | Positive Ki-67 and PD-L1 expression in post-neoadjuvant chemotherapy muscle-invasive bladder cancer is associated with shorter overall survival: a retrospective study |
Q77877206 | Positive bladder cooling reflex in patients with bladder outlet obstruction due to benign prostatic hyperplasia |
Q71341507 | Positive ice-water test: a predictor of neurological disease? |
Q89396666 | Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies? |
Q87239697 | Positive surgical margins after radical prostatectomy: What should we care about? |
Q85410878 | Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy |
Q36877039 | Positron emission tomography (PET) in the urooncological evaluation of the small pelvis |
Q44128279 | Possible role of bioactive peptides in the regulation of human detrusor smooth muscle - functional effects in vitro and immunohistochemical presence |
Q50238254 | Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime |
Q51010000 | Postoperative complications and short-term oncological outcomes of patients aged ≥80 years undergoing robot-assisted radical cystectomy. |
Q53461526 | Postoperative drainage does not prevent complications after robotic partial nephrectomy. |
Q39662521 | Postoperative patient comfort in suprapubic drainage versus transurethral catheterization following robot-assisted radical prostatectomy: a prospective randomized clinical trial |
Q53300364 | Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis. |
Q41299955 | Postoperative vesicoureteral reflux after high-pressure balloon dilation of the ureterovesical junction in primary obstructive megaureter. Incidence, management and predisposing factors. |
Q40401352 | Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia |
Q37971322 | Potential for prostate cancer prevention through physical activity |
Q36626775 | Potential future options in the pharmacotherapy of female sexual dysfunction |
Q33827784 | Potential preventive strategies and therapies in urinary tract infection |
Q39387219 | Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer |
Q34473200 | Potential therapeutic targets for treatment of the overactive bladder. |
Q40812617 | Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients |
Q44092766 | Practice patterns and recurrence after partial cystectomy for bladder cancer |
Q44381480 | Pre-operative assessment of living renal transplant donors with state-of-the-art imaging modalities: computed tomography angiography versus magnetic resonance angiography in 118 patients |
Q100694850 | Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma |
Q52876531 | Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors. |
Q42501558 | Precision of MRI/ultrasound-fusion biopsy in prostate cancer diagnosis: an ex vivo comparison of alternative biopsy techniques on prostate phantoms |
Q91764537 | Preclinical comparison of superpulse thulium fiber laser and a holmium:YAG laser for lithotripsy |
Q91757899 | Preclinical study for treatment of hypospadias by advanced therapy medicinal products |
Q92915490 | Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator |
Q90259212 | Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics |
Q90264137 | Predicting posterior urethral obstruction in boys with lower urinary tract symptoms using deep artificial neural network |
Q36026045 | Predicting prostate cancer many years before diagnosis: how and why? |
Q88198559 | Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores |
Q38919326 | Predicting ureteral stones in emergency department patients with flank pain: an external validation of the STONE score |
Q36510984 | Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation |
Q44729341 | Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi (> or = 12)-core prostate biopsy |
Q57806098 | Prediction of biochemical failure using prostate-specific antigen half-life in patients with adverse pathologic features after radical prostatectomy |
Q91289268 | Prediction of early (30-day) and late (30-90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades |
Q33990885 | Prediction of locoregional extension and metastatic disease in prostate cancer: a review |
Q44075502 | Prediction of metastatic status in non-seminomatous testicular cancer |
Q44072004 | Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score. |
Q39458840 | Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate |
Q39608886 | Prediction of stone-free status and complication rates after tubeless percutaneous nephrolithotomy: a comparative and retrospective study using three stone-scoring systems and preoperative parameters |
Q71610498 | Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen |
Q90481283 | Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma |
Q40921335 | Predictive factors for immediate continence after radical prostatectomy |
Q36478530 | Predictive factors of recurrence and survival of upper tract urothelial carcinomas. |
Q92484329 | Predictive factors of stone-free rate and complications in patients undergoing minimally invasive percutaneous nephrolithotomy under local infiltration anesthesia |
Q90702711 | Predictive factors of urinary incontinence after holmium laser enucleation of the prostate: a multicentric evaluation |
Q58664288 | Predictive genetic testing in urology: ethical and social issues |
Q129157145 | Predictive markers for infections after extracorporeal shockwave lithotripsy in patients with kidney stone based on a large prospective cohort |
Q35613110 | Predictive medicine in non-malignant urological disorders |
Q75193500 | Predictive medicine in urology |
Q41502339 | Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection |
Q92268316 | Predictive risk factors of urinary tract infection following flexible ureteroscopy despite preoperative precautions to avoid infectious complications |
Q39023692 | Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS). |
Q43725656 | Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma |
Q38044252 | Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma |
Q112651574 | Predictive urinary RNA biomarkers of kidney injury after extracorporeal shock wave lithotripsy |
Q53098490 | Predictive value of neutrophil-lymphocyte ratio in renal cancer. |
Q53080956 | Predictors for the detection of prostate cancer and clinically significant prostate cancer using TRUS-guided biopsy in patients with negative initial biopsy results. |
Q40140131 | Predictors of admission in patients presenting to the emergency department with urinary tract infection |
Q98179250 | Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer |
Q35688493 | Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate |
Q91255288 | Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy |
Q89177943 | Predictors of pathological upgrading in low-risk prostate cancer patients without hypointense lesions on an apparent diffusion coefficient map of multiparametric magnetic resonance imaging |
Q45769842 | Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey |
Q33651537 | Predictors of septic shock in obstructive acute pyelonephritis |
Q42665998 | Predictors of short-term recovery of urinary continence after radical prostatectomy |
Q88222518 | Predictors of surgical intervention following initial surveillance for acute ureteric colic |
Q91469066 | Predictors of surgical site infection after radical cystectomy: should we enhance surgical antibiotic prophylaxis? |
Q90469828 | Predictors of thrombosis in testicular cancer during platinum-based chemotherapy |
Q83178908 | Preface: gynecologic urology |
Q91558570 | Pregnancy following urinary tract reconstruction using bowel segments: a review of published literature |
Q99251474 | Preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemic |
Q39356518 | Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome |
Q90042087 | Preliminary study on the application of en bloc resection combined with near-infrared molecular imaging technique in the diagnosis and treatment of bladder cancer |
Q53372454 | Premalignant lesions of the kidney share the same genetics changes as conventional renal cell carcinoma. |
Q33840742 | Preoperative 3D and 4D-CT imaging using 640-Multislice CT (640-MSCT) in diagnosis of female urethral diverticulum |
Q37903751 | Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures |
Q50126305 | Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg? |
Q47594245 | Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. |
Q42617082 | Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy |
Q39479322 | Preoperative cystometrography in patients with clinical benign prostatic hypertrophy |
Q98727744 | Preoperative diagnosis, treatment, and outcomes of FEPs of ureters in children: a 13-year retrospective study based on data at a large pediatric medical center |
Q40677072 | Preoperative frailty predicts postoperative complications and mortality in urology patients |
Q34549825 | Preoperative imaging in renal cell cancer |
Q42407054 | Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer |
Q38272447 | Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice. |
Q37976280 | Preoperative patient counseling for diagnostic renal biopsy and complications with renal radiofrequency ablation |
Q45349485 | Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma |
Q45657847 | Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy |
Q46990159 | Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy |
Q95276194 | Preoperative urine nitrite versus urine culture for predicting postoperative fever following flexible ureteroscopic lithotripsy: a propensity score matching analysis |
Q90843380 | Preputial lichen sclerosus: a rare and easily ignored initial clinical presentation of newly diagnosed diabetes mellitus |
Q71324639 | Present experience with the Indiana pouch |
Q89145845 | Pressure matters 2: intrarenal pressure ranges during upper-tract endourological procedures |
Q89145848 | Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology |
Q34534593 | Prevalence and burden of overactive bladder in the United States |
Q48335526 | Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. |
Q57296512 | Prevalence and surgical management of concurrent adult acquired buried penis and urethral stricture disease |
Q86520236 | Prevalence of baseline chronic kidney disease in 2,769 Chinese patients with renal cancer: nephron-sparing treatment is still underutilized |
Q91952773 | Prevalence of distal renal tubular acidosis in patients with calcium phosphate stones |
Q40382559 | Prevalence of nocturnal enuresis and related risk factors in school-age children in Egypt: an epidemiological study |
Q53184241 | Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. |
Q44190732 | Prevalence of painful bladder syndrome/interstitial cystitis-like symptoms in women: a population-based study in Korea |
Q37038158 | Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis |
Q44714415 | Prevalence of the human papillomavirus (HPV) expression of the inner prepuce in asymptomatic boys and men. |
Q57211705 | Prevalence of urinary incontinence in Korean women: results of a National Health Interview Survey |
Q84943622 | Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes |
Q90951890 | Prevalence, assessment and surgical correction of penile curvature in hypospadias patients treated at one European Referral Center: description of the technique and surgical outcomes |
Q48064530 | Prevalence, risk factors, and symptom bother of nocturia: a population-based survey in China |
Q40831079 | Preventable causes of male infertility |
Q38069959 | Prevention and management of complications following robot-assisted radical cystectomy: lessons learned after >250 consecutive cases |
Q37264303 | Prevention and management of perioperative complications in laparoscopic and endoscopic radical prostatectomy |
Q37513766 | Prevention and management of ureteral injuries occurring during laparoscopic radical prostatectomy: the Heilbronn experience and a review of the literature |
Q46938525 | Prevention and treatment of septic shock following mini-percutaneous nephrolithotomy: a single-center retrospective study of 834 cases |
Q91285094 | Prevention of healthcare-associated infections (HAIs) in a surgical urology ward: observational study-analysis of the problem and strategies for implementation |
Q74782512 | Primary and reoperative hypospadias repair with the Snodgrass technique |
Q90008965 | Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes |
Q47732774 | Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival |
Q48032566 | Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4-10 ng/ml |
Q36359097 | Probiotics to prevent urinary tract infections: the rationale and evidence |
Q33840729 | Proctors exploit three-dimensional ghost tools during clinical-like training scenarios: a preliminary study |
Q48096443 | Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting |
Q40932311 | Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma |
Q38814000 | Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review |
Q88527533 | Prognostic factors and prognostic models for renal cell carcinoma: a literature review |
Q34235586 | Prognostic factors in T3b renal cell carcinoma |
Q113905240 | Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review |
Q47211592 | Prognostic factors in patients with penile cancer after surgical management |
Q83987586 | Prognostic factors in renal cell carcinoma |
Q40860524 | Prognostic factors in superficial bladder cancer |
Q81402838 | Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie |
Q51140876 | Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series. |
Q120633375 | Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort |
Q91916785 | Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC) |
Q92237865 | Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer |
Q34798549 | Prognostic markers in muscle invasive bladder cancer |
Q60198386 | Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review |
Q97070378 | Prognostic performance of magnetic resonance imaging-guided biopsy in defining prostate cancer anterior lesions |
Q40619712 | Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy |
Q41056921 | Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent |
Q37584125 | Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study |
Q33840690 | Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study |
Q91547342 | Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study |
Q38610950 | Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients |
Q37330109 | Prognostic significance of non-papillary tumor morphology as a predictor of cancer progression and survival in patients with primary T1G3 bladder cancer |
Q47931762 | Prognostic significance of phospho-histone H3 in prostate carcinoma |
Q92408299 | Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy |
Q39765407 | Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder |
Q93163814 | Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis |
Q43673241 | Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma |
Q41496553 | Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival |
Q37405231 | Prognostic value of intraoperative parameters observed during vasectomy reversal for predicting postoperative vas patency and fertility |
Q43542884 | Prognostic value of microvessel density in prostate cancer: a tissue microarray study |
Q51723701 | Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. |
Q39435117 | Prognostic value of pressure-flow study in surgical treatment of benign prostatic obstruction |
Q100756381 | Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy? |
Q53086647 | Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study. |
Q86435821 | Prognostic value of saturated prostate cryoablation for localized prostate cancer |
Q38429539 | Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma |
Q51465750 | Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis. |
Q90293700 | Prognostic value of unifocal and multifocal positive surgical margins in a large series of robot-assisted radical prostatectomy for prostate cancer |
Q40893287 | Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study |
Q40926921 | Progress and controversies in modern treatment of Wilms' tumors. |
Q34561009 | Progression delay in men with mild symptoms of bladder outlet obstruction: a comparative study of phytotherapy and watchful waiting |
Q36124618 | Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans |
Q30318125 | Prolapse surgery in octogenarians: are we pushing the limits too far? |
Q37584081 | Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy |
Q91860572 | Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy |
Q91002142 | Prophylactic abdominal or retroperitoneal drain placement in major uro-oncological surgery: a systematic review and meta-analysis of comparative studies on radical prostatectomy, cystectomy and partial nephrectomy |
Q45174314 | Propofol attenuates reperfusion injury after testicular torsion and detorsion |
Q91104073 | Prospective analysis of artificial urinary sphincter AMS 800 implantation after buccal mucosa graft urethroplasty |
Q44256728 | Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome |
Q36041347 | Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction |
Q97587743 | Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy |
Q53083579 | Prospective blinded comparison of real-time sonoelastography targeted versus randomised biopsy of the prostate in the primary and re-biopsy setting. |
Q92006049 | Prospective comparative study between the effect of CIDEX® OPA and STERRAD NX on the durability of digital flexible ureteroscope |
Q47227788 | Prospective comparison among three intrarectal anesthetic treatments combined with periprostatic nerve block during transrectal ultrasonography-guided prostate biopsy |
Q43820795 | Prospective comparison of scar-related satisfaction and quality of life after laparoscopic versus open radical prostatectomy: no differences from patients' point of view |
Q45116166 | Prospective comparison of short-term functional outcomes obtained after pure laparoscopic and robot-assisted laparoscopic sacrocolpopexy |
Q91613819 | Prospective evaluation of a urinary biomarker panel to detect and predict recurrence of non-muscle-invasive bladder cancer |
Q80786572 | Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG) |
Q89845717 | Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results |
Q48120334 | Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complications |
Q53104615 | Prospective evaluation of intra-observer variability of the hydronephrosis index in sonographic examination of 44 patients with acute renal colic. |
Q48250434 | Prospective evaluation of scrotal ultrasound and intratesticular perfusion by color-coded duplex sonography (CCDS) in TESE patients with azoospermia |
Q58116509 | Prospective evaluation of the performances of narrow-band imaging flexible videoscopy relative to white-light imaging flexible videoscopy, in patients scheduled for transurethral resection of a primary NMIBC |
Q75275418 | Prospective predictors of urinary continence after anatomical radical retropubic prostatectomy: a multivariate analysis |
Q49994121 | Prospective randomised controlled trial of written supplement to verbal communication of results to patients at the time of flexible cystoscopy. |
Q44518102 | Prospective randomized controlled trial of conventional laparoscopic versus laparoendoscopic single-site radical nephrectomy for localized renal cell carcinoma: a preliminary report regarding quality of life |
Q49506111 | Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation |
Q48690801 | Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes |
Q41536017 | Prospective therapeutic studies in nephrolithiasis |
Q92884437 | Prospective validation of a novel visual analogue uroflowmetry score (VAUS) in 1000 men with lower urinary tract symptoms (LUTS) |
Q99343976 | Prospects and Challenges of Artificial Intelligence and Computer Science for the Future of Urology |
Q33943101 | Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer |
Q62524728 | Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy |
Q40116168 | Prostate biopsy: results and advantages of the transperineal approach--twenty-year experience of a single center |
Q36846769 | Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implications |
Q87258467 | Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study |
Q48145211 | Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy. |
Q85541740 | Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? |
Q36049175 | Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score |
Q84778120 | Prostate cancer detection with real-time elastography using a bi-plane transducer: comparison with step section radical prostatectomy pathology |
Q37899807 | Prostate cancer diagnostics: innovative imaging in case of multiple negative biopsies |
Q38000053 | Prostate cancer epidemiology in the United States |
Q48147412 | Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer |
Q40803697 | Prostate cancer in men aged less than 50 years at diagnosis. |
Q44766588 | Prostate cancer incidence and survival in immigrants to Sweden |
Q92226934 | Prostate cancer management in the Middle East |
Q88634948 | Prostate cancer mortality is high in the elderly and can be reduced by selective individualized curative treatment |
Q91170745 | Prostate cancer navigation: initial experience and association with time to care |
Q34154173 | Prostate cancer pain management: EAU guidelines on pain management |
Q33802558 | Prostate cancer progression and mortality: a review of diet and lifestyle factors |
Q50053132 | Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy |
Q40212530 | Prostate cancer risk assessment tools in an unscreened population |
Q87654347 | Prostate cancer survivorship: a new path for uro-oncology |
Q50633870 | Prostate cancer survivorship: lifestyle changes, much needed! |
Q39374516 | Prostate cancer trends in Asia |
Q41111915 | Prostate cancer--biology of metastasis and its clinical implications |
Q82059599 | Prostate cancer: novel aspects of diagnostics and surgical technology |
Q41738422 | Prostate cancer: the diagnostic dilemma and the place of imaging in detection and staging |
Q57073679 | Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience |
Q48853490 | Prostate imaging--the future is now: current concepts and future potentials |
Q50960499 | Prostate interdisciplinary communication and mapping algorithm for biopsy and pathology (PIC-MABP) of multiparametric MRI findings. |
Q92466178 | Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy |
Q53079770 | Prostate volume reduction following pure transurethral bipolar plasma vaporization and conventional transurethral resection of the prostate: a prospective investigation using transrectal 3D ultrasound volumetry. |
Q40386553 | Prostate-specific antigen and androgen deprivation therapy |
Q39370012 | Prostate-specific antigen coordinated with digital rectal examination and transrectal ultrasonography in the detection of prostate cancer |
Q71115781 | Prostate-specific antigen density--a reliable parameter for the detection of prostate cancer? |
Q54177637 | Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma. |
Q71610491 | Prostate-specific antigen--a true progress in diagnosis and follow-up of prostate cancer |
Q49994113 | Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy. |
Q48875836 | Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study |
Q73502987 | Prostatic expression of human 5alpha-reductase type 2 during finasteride therapy: a randomized, double-blind, placebo-controlled study |
Q49567211 | Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trial |
Q40386547 | Prostatic intraepithelial neoplasia and prostate-specific antigen |
Q45394908 | Prostatic peripheral nerve distribution may impact the functional outcome of nerve-sparing prostatectomy |
Q41141569 | Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control study |
Q95789410 | Prostatitis: ancient history and new horizons |
Q35104009 | Prostatitis: the role of antibiotic treatment |
Q46397469 | Protective effect of trapidil on long-term histologic damage in a rat model of testicular ischemia-reperfusion injury |
Q42524614 | Protective effects of sildenafil administration on testicular torsion/detorsion damage in rats |
Q51795101 | Protective effects of taurine on protamine sulfate induced bladder damage. |
Q48575381 | Protective role of erythropoietin during testicular torsion of the rats |
Q39165981 | Protein tyrosine phosphatase ζ enhances proliferation by increasing β-catenin nuclear expression in VHL-inactive human renal cell carcinoma cells |
Q72017488 | Proteoglycan core protein syndecan in bladder biopsies |
Q40661780 | Proteoglycans and glycosaminoglycans in tumor growth and migration: first experience with tumors of bladder and prostate origin |
Q47764570 | Proteomic analysis of urethral protein expression in an estrogen receptor α-deficient murine model of stress urinary incontinence |
Q112302268 | Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry |
Q52651137 | Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer. |
Q40914149 | Psychological subtypes of erectile dysfunction: results of statistically analyses and clinical practice |
Q36147034 | Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome |
Q48036432 | Psychometric validation of a German language version of a PROM for urethral stricture surgery and preliminary testing of supplementary ED and UI constructs. |
Q90268975 | Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer |
Q36121976 | Psychophysiology of ejaculatory function and dysfunction |
Q34728034 | Psychotherapeutic interventions for treating female sexual dysfunction |
Q38526627 | Pubic symphysitis after transurethral resection of the prostate |
Q48424440 | Publication misrepresentation among urology residency applicants |
Q45608912 | Pudendal nerve block in HDR-brachytherapy patients: do we really need general or regional anesthesia? |
Q96162498 | Pulse modulation with Moses technology improves popcorn laser lithotripsy |
Q82256629 | Pure laparoscopic complete excision of distal ureter with a bladder cuff for upper tract urothelial carcinoma |
Q37948004 | Pure single-port laparoscopic surgery or mix of techniques? |
Q40517657 | Quality assessment in prostate cancer centers certified by the German Cancer Society. |
Q92692228 | Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy |
Q95655517 | Quality management in (prostate) cancer care: what do European cancer control plans tell us? |
Q37261045 | Quality of care in bladder cancer: trends in urinary diversion following radical cystectomy |
Q61982205 | Quality of leadership in multidisciplinary cancer tumor boards: development and evaluation of a leadership assessment instrument (ATLAS) |
Q73330275 | Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion |
Q100694851 | Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study |
Q58222984 | Quality of life assessment before and after transurethral resection of the prostate in patients with lower urinary tract symptoms |
Q53278775 | Quality of life following living donor nephrectomy comparing classical flank incision and anterior vertical mini-incision. |
Q41602376 | Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch. |
Q64883316 | Quality of life outcomes in patients with localised renal cancer: a literature review. |
Q78166819 | Quality of life research in urology |
Q94522407 | Quality of life with pharmacological treatment in patients with benign prostatic enlargement: results from the Evolution European Prospective Multicenter Multi-National Registry Study |
Q73502991 | Quality of micturition in male patients with orthotopic neobladder replacement |
Q30758877 | Quality-of-life aspects in urology - benign prostatic hyperplasia |
Q33719019 | Quality-of-life assessment in bladder cancer |
Q74321126 | Quality-of-life assessment in patients treated with lower-energy thermotherapy: Prostasoft 2.0. |
Q33719028 | Quality-of-life issues in the treatment of testicular cancer |
Q53543300 | Quality-of-life studies in patients with ambiguous genitalia. |
Q43410226 | Quantification of median lobe protrusion and its impact on the base surgical margin status during robot-assisted laparoscopic prostatectomy |
Q37423140 | Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3). |
Q37515137 | Quantifying subjective assessment of sleep quality, quality of life and depressed mood in children with enuresis |
Q87972843 | Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study |
Q84606451 | Quantitative assessment of urethral vascularity in nulliparous females using high-frequency endovaginal ultrasonography |
Q33869458 | Quantitative evaluation of electrodes for external urethral sphincter electromyography during bladder-to-urethral guarding reflex |
Q90394269 | RAB38 promotes bladder cancer growth by promoting cell proliferation and motility |
Q48182386 | RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease |
Q93111658 | RE Re Do urethroplasty after multiple failed surgeries of pelvic fracture urethral injury |
Q92597311 | RE: Geobiology reveals how human kidney stones dissolve in vivo (by: Sivaguru et al. 2018) |
Q94504068 | RE: Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies |
Q92828778 | RE: The evaluation of early predictive factors for urosepsis in patients with negative preoperative urine culture following mini-percutaneous nephrolithotomy |
Q90569632 | Radiation exposure during retrograde intrarenal surgery (RIRS): a prospective multicenter evaluation |
Q73774096 | Radiation for prostate cancer issue |
Q35201501 | Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy |
Q74068042 | Radiation therapy as treatment for stage T1c prostate cancers |
Q35214104 | Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. |
Q81660047 | Radiation therapy in the management of the primary penile tumor: an update |
Q102132240 | Radiation versus surgery in patients with clinically localized Gleason 9-10 prostate cancer |
Q40419224 | Radiation-induced complex anterior urinary fistulation for prostate cancer: a retrospective multicenter study from the Trauma and Urologic Reconstruction Network of Surgeons (TURNS). |
Q44209236 | Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes? |
Q46470892 | Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure |
Q50075582 | Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes |
Q82296466 | Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality |
Q42637271 | Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series |
Q95332008 | Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study |
Q37836461 | Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results |
Q37997967 | Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy |
Q91073431 | Radical prostatectomy after previous transurethral resection of the prostate: oncological, surgical and functional outcomes-a meta-analysis |
Q39458844 | Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer |
Q37107924 | Radical prostatectomy for high-risk prostate cancer |
Q37205035 | Radical prostatectomy for low risk carcinoma of the prostate |
Q47733047 | Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis. |
Q38102550 | Radical prostatectomy versus high dose permanent prostate brachytherapy using iodine-125 seeds for patients with high risk prostate cancer: a matched cohort analysis |
Q53863847 | Radical prostatectomy: a prospective comparison of oncological and functional results between open and laparoscopic approaches. |
Q83863906 | Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study |
Q71721268 | Radical surgery for renal-cell carcinoma: caval neoplastic excision, adrenalectomy, lymphadenectomy, adjacent organ resection |
Q83940442 | Radical versus postoperative radiotherapy for localized prostate cancer: a 10-year experience of an academic hospital |
Q33657187 | Radiographic staging of renal injuries |
Q71721280 | Radiolabeled monoclonal antibody G250 in renal-cell carcinoma |
Q35938970 | Radiological assessment of penile prosthesis: the role of magnetic resonance imaging. |
Q80477002 | Radiological evaluation of vaginal width and depth in male-to-female transsexuals by the use of magnetic resonance imaging |
Q97427683 | Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept |
Q35196651 | Radiotherapeutic approaches to metastatic disease |
Q53267613 | Radiotherapy for isolated lymph node metastases in patients with locally advanced prostate cancer after primary therapy. |
Q92026651 | Radiotherapy plus chemotherapy versus chemotherapy alone in penile cancer patients with extracapsular nodal extension after inguinal lymph node surgery: a multi-institutional study |
Q38218443 | Random biopsy: when, how many and where to take the cores? |
Q88564265 | Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR) |
Q37960825 | Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts |
Q40277141 | Randomized prospective trial of tubeless versus conventional minimally invasive percutaneous nephrolithotomy |
Q90901750 | Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson's disease |
Q36239162 | Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms. |
Q130104435 | Randomized, placebo-controlled, double-blinded study of prophylactic cranberries use in women with recurrent uncomplicated cystitis |
Q46286724 | Rapid diagnosis and follow up of bladder cancer patients using urinary high molecular weight cytokeratins |
Q50079102 | Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma |
Q92804276 | Rare and special robotic surgery indications in the pediatric population: ectopic organs and differences of sexual development |
Q37851039 | Rating the quality of evidence and the strength of recommendations using GRADE. |
Q36019390 | Rationale for the development and current status of calcitriol in androgen-independent prostate cancer |
Q38051008 | Re-irradiation for salvage of prostate cancer failures after primary radiotherapy |
Q48182397 | Re: A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy. |
Q92415421 | Re: A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills? From Slaoui et al., World J urol 2019. Long-term safety of local radiation therapy of newly diagnosed low burden met |
Q48365346 | Re: Comparison of retroperitoneal and transperitoneal robotic partial nephrectomy for Pentafecta perioperative and renal functional outcomes |
Q53097367 | Re: Imaging the urologic patient: the utility of intravenous pyelogram in the CT scan era. |
Q88011756 | Re: Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study |
Q91417293 | Re: Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study |
Q53303340 | Re: World J Urol. 2014 Nov 22. [Epub ahead of print]. HoLEP has come of age. Vincent MW, Gilling PJ. |
Q34508133 | Readmissions in the postoperative period following urinary diversion |
Q38845396 | Real-life clinical practice of onabotulinum toxin A intravesical injections for overactive bladder wet: an Italian consensus statement. |
Q40290599 | Real-time cancer diagnosis during prostate biopsy: ex vivo evaluation of full-field optical coherence tomography (FFOCT) imaging on biopsy cores. |
Q99251464 | Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones |
Q114692623 | Real-world data comparing minimally invasive surgeries for benign prostatic hyperplasia |
Q99602899 | Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm |
Q99545557 | Reasons to believe in vaporization: a review of the benefits of photo-selective and transurethral vaporization |
Q99618184 | Reasons to go for Rezūm steam therapy: an effective and durable outpatient minimally invasive procedure |
Q98188208 | Reasons to overthrow TURP: bring on Aquablation |
Q86207198 | Rebuttal to "Causal effect of vitamin D on prostate cancer using Mendelian randomization approach" |
Q36311550 | Recent advances in nutritional research on urolithiasis |
Q33342917 | Recent strategies for the use of paclitaxel in the treatment of urological malignancies |
Q35103008 | Recommendations for the evaluation of patients with prostatitis |
Q47662397 | Reconfigured colon segments as a ureteral substitute |
Q48342936 | Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques |
Q40769778 | Reconstruction of the lower urinary tract using autologous muscle transfer and cell seeding: current status and future perspectives |
Q91952758 | Recovery of pad-free continence in elderly men does not differ from younger men undergoing robot-assisted radical prostatectomy for aggressive prostate cancer |
Q91571246 | Recurrence in prostate cancer: salvage diagnostic and therapeutic strategies |
Q53820581 | Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. |
Q93250494 | Recurrent bladder cystitis: who takes the role? |
Q38913953 | Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era. |
Q101567667 | Redefining the urologist's role in kidney transplantation |
Q92403919 | Redo-urethroplasty for the management of recurrent urethral strictures in males: a systematic review |
Q83138042 | Redo-urethroplasty in pelvic fracture urethral distraction defect: an audit |
Q42624749 | Redo-urethroplasty: comparison of early functional results and quality of life in penile and bulbar strictures |
Q98283888 | Reduced cytoplasmic expression of MAGE-A2 predicts tumor aggressiveness and survival: an immunohistochemical analysis |
Q81939621 | Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration |
Q40332939 | Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. |
Q46767552 | Reduction of intercellular adhesion molecule 1 may play a role in anti-inflammatory effect of hyaluronic acid in a rat model of severe non-bacterial cystitis |
Q74782514 | Refinements in buccal mucosal grafts urethroplasty for hypospadias repair |
Q91143476 | Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies |
Q49827584 | Reflections on personalized management of UTUC. |
Q96956160 | Refractory lower urinary tract symptoms in patients with lumbar disc hernia relieved by non-surgical treatment |
Q57473514 | Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United States |
Q40599248 | Regulation of actomyosin and contraction in smooth muscle |
Q40958229 | Regulation of prostate growth by fibroblast growth factors |
Q40397943 | Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings |
Q91699607 | Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder |
Q89838596 | Relationship between each IPSS item score and erectile dysfunction in the Korean Internet Sexuality Survey (KISS): do men with weak streams have low sexual function? |
Q53084606 | Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study. |
Q40316580 | Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study |
Q94954910 | Release of severe chordee and urethroplasty in proximal hypospadias repair |
Q42933609 | Relevance of benign prostatic hyperplasia and associated conditions for urologists, health care systems, and society |
Q98283894 | Relevance of intravesical pressures during transurethral procedures |
Q53260322 | Reliability and validity of the National Institutes of Health: Chronic Prostatitis Symptom Index in a Malaysian population. |
Q81557193 | Reliable data from diverse regions of the world exist to show that there has been a steady increase in the prevalence of urolithiasis |
Q130030682 | Relocation of lower pole renal stones helps improve the stone-free rate during flexible ureteroscopy with a low complication rate |
Q91950651 | Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device |
Q81018220 | Renal cell carcinoma |
Q87867481 | Renal cell carcinoma |
Q44122543 | Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters |
Q40022143 | Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. |
Q91412256 | Renal cell carcinoma: standards and controversies |
Q33630520 | Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys |
Q35876100 | Renal function in the setting of urinary diversion |
Q50055581 | Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma. |
Q98160255 | Renal pelvis urine Gram stain as a traditional, but new marker in predicting postoperative fever and stone culture positivity in percutaneous nephrolithotomy: an observational, prospective, non-randomized cohort study |
Q88673188 | Renal stone composition does not affect the outcome of percutaneous nephrolithotomy in children |
Q33892232 | Renal therapy using tissue-engineered constructs and gene delivery |
Q36929501 | Renal transplant rejection markers |
Q71691011 | Renal transplantation is well established as the preferred form of replacement therapy for most patients with endstage renal disease |
Q33657195 | Renal trauma: indications and techniques for surgical exploration |
Q34041784 | Renal tumor ablation: energy-based technologies |
Q90324655 | Renal tumor biopsy: indicators, technique, safety, accuracy results, and impact on treatment decision management |
Q71721271 | Renal-cell carcinoma with intracaval neoplastic extension: stratification and surgical technique |
Q91622609 | Renorrhaphy techniques and effect on renal function with robotic partial nephrectomy |
Q37564079 | Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumor |
Q91860566 | Repair of sphincter urethral strictures preserving urinary continence: surgical technique and outcomes |
Q96023583 | Reply letter to: Breda, A., Territo, A. & Sanguedolce, F. Combination of holmium and thulium laser ablation in upper tract urothelial carcinoma. World J Urol (2020). https://doi.org/10.1007/s00345-020-03124-z |
Q89459231 | Reply letter to: Comments to "Systematic review and cumulative analysis of the managements for proximal impacted ureteral stones" by Gao ZY |
Q92835139 | Reply letter to: Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018 Nov 1;4(11):1535-154 |
Q96643171 | Reply to Peihua Liu, Yangle Li's Letter to the Editor regarding the article "Radical prostatectomy after previous transurethral resection of the prostate: oncological, surgical and functional outcomes-a meta-analysis" |
Q87850089 | Reply to letter to editor regarding: LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer |
Q48172102 | Reply to the Letter to the Editor by Reza Pakzad and Saeid Safiri, integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy: bias in the prediction model |
Q48225247 | Reply to: 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. Hamdy et al. NEJM October 2016. |
Q36935404 | Reproducibility and reliability of tumor grading in urological neoplasms |
Q40707127 | Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome |
Q34807462 | Resident involvement and experience do not affect perioperative complications following robotic prostatectomy |
Q52770295 | Residual stones after percutaneous nephrolithotomy: comparison of intraoperative assessment and postoperative non-contrast computerized tomography. |
Q89181643 | Residual tumor resection (RTR) |
Q42249793 | Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study |
Q46878499 | Response by authors re: Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography |
Q54618206 | Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients. |
Q88307314 | Response of the authors to comment by Lagana et al. on: Transvaginal specimen removal in minimally invasive surgery (World J Urol. 2016 Jun; 34(6):779-87) |
Q46817739 | Response of the renal pelvis and ureter to distension of the contralateral renal pelvis and ureter: identification of the reno-renal pelvic reflex |
Q98226947 | Response to comment regarding article with title: ''does bipolar energy provide any advantage over monopolar surgery in transurethral resection of non-muscle invasive bladder tumors? A systematic review and meta-analysis'' |
Q50086025 | Response to: Greenlight® users should move from photoselective vaporization to endoscopic enucleation in larger prostates : Benoit Peyronnet, Vincent Misrai, Tev Aho, Henry Woo, Thomas Herrmann, Fernando Gomez-Sancha |
Q34422193 | Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience |
Q88289542 | Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer |
Q36407008 | Results of day-case ureterorenoscopy (DC-URS) for stone disease: prospective outcomes over 4.5 years. |
Q37736321 | Results of kidney tumor cryoablation: renal function preservation and oncologic efficacy |
Q36468952 | Results of orchiopexy for the undescended testis |
Q37747186 | Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy |
Q48230097 | Results of transurethral resection of the prostate in renal transplant recipients: a single center experience |
Q36643620 | Retarded ejaculation |
Q36152830 | Retarded ejaculation in men: an overview of psychological and neurobiological insights |
Q84965868 | Retraction note: Targeting EGFR in bladder cancer. World J Urol (2007) 25:573-9 |
Q84293601 | Retraction. Erratum to: Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence |
Q91613838 | Retrograde intrarenal surgery must be considered as the treatment of choice in children having moderate-size renal stones |
Q94455378 | Retrograde intrarenal surgery of renal stones: a critical multi-aspect evaluation of the outcomes by the Turkish Academy of Urology Prospective Study Group (ACUP Study) |
Q87423530 | Retroperitoneal laparoendoscopic single-site surgery for the treatment of retrocaval ureter |
Q44128277 | Retroperitoneal laparoscopic radical nephrectomy and nephroureterectomy and comparison with open surgery |
Q81646176 | Retroperitoneal laparoscopic radical nephrectomy: intermediate oncological results |
Q45730782 | Retroperitoneal laparoscopic renal tumour enucleation with local hypotension on demand |
Q70485137 | Retroperitoneal laparoscopic ureterolithotomy |
Q53018538 | Retroperitoneal laparoscopic ureterolithotomy in comparison with ureteroscopic lithotripsy in the management of impacted upper ureteral stones larger than 12 mm. |
Q50062284 | Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes |
Q42653045 | Retroperitoneal nephroureterectomy with excision of cuff of the bladder for upper urinary tract transitional cell carcinoma: comparison of laparoscopic and open surgery with long-term follow-up |
Q74744407 | Retroperitoneal schwannoma mimicking an adrenal lesion |
Q74649309 | Retroperitoneoscopic adrenalectomy by a lumbodorsal approach: clinical experience with solo surgery |
Q51282449 | Retroperitoneoscopic donor nephrectomy: donor outcome and complication rate in comparison with three different techniques. |
Q85855479 | Retropubic, laparoscopic and mini-laparoscopic radical prostatectomy: a prospective assessment of patient scar satisfaction |
Q114692624 | Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB |
Q48113488 | Retrospective analysis of the development of PIRADS 3 lesions over time: when is a follow-up MRI reasonable? |
Q45830135 | Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer |
Q47173807 | Retrospective comparison of measured stone size and posterior acoustic shadow width in clinical ultrasound images |
Q101044985 | Retrotrigonal muscular layer sling associated with total anatomical reconstruction in robot-assisted radical prostatectomy and early continence |
Q92026992 | Retzius sparing robotic assisted radical prostatectomy vs. conventional robotic assisted radical prostatectomy: a systematic review and meta-analysis |
Q91613870 | Review article: MRI-targeted biopsies for prostate cancer diagnosis and management |
Q36831730 | Review of allelic loss and gain in prostate cancer |
Q92922114 | Review of clinical experience on biomaterials and tissue engineering of urinary bladder |
Q34317247 | Review on chronic pelvic pain from a urological point of view |
Q36351484 | Review on diagnosis and management of urolithiasis in pregnancy: an ESUT practical guide for urologists. |
Q38079516 | Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials |
Q95643610 | Revisiting the penoscrotal approach to artificial urinary sphincter surgery: how does it compare to a perineal incision for initial implantation? |
Q33285830 | RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up |
Q92027420 | Risk factors affecting post-pubertal high serum follicle-stimulating hormone in patients with hypospadias |
Q41063830 | Risk factors for artificial urinary sphincter failure |
Q92865745 | Risk factors for febrile genito-urinary infection in the catheterized patients by with spinal cord injury-associated chronic neurogenic lower urinary tract dysfunction evaluated by urodynamic study and cystography: a retrospective study |
Q99573206 | Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy |
Q46352182 | Risk factors for nephrolithiasis in children |
Q40707408 | Risk factors for recurrence in female urethral diverticulectomy: a retrospective study of 66 patients |
Q93016360 | Risk factors for sepsis in patients with struvite stones following percutaneous nephrolithotomy |
Q47631182 | Risk factors of severe incisional hernia after renal transplantation: a retrospective multicentric case-control study on 225 patients |
Q83641759 | Risk factors of treatment failure after retrourethral transobturator male sling |
Q40912345 | Risk formulas in calcium oxalate urolithiasis |
Q40656902 | Risk of metastasis for T1a renal cell carcinoma |
Q71951420 | Risk of progression and dying of clinically localized prostate cancer in Japan |
Q37130158 | Risk stratification and prognostication of renal cell carcinoma |
Q41462223 | Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder |
Q44051579 | Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy |
Q48767024 | Robert Proust--an eminent doctor in the shadow of his famous brother Marcel |
Q97636930 | Robot-assisted continent urinary diversion according to the Mitrofanoff principle: results of a bicentric study |
Q48534544 | Robot-assisted extravesical ureteral reimplantation (revur) for unilateral vesico-ureteral reflux in children: results of a multicentric international survey |
Q96772073 | Robot-assisted laparoscopic pyeloplasty (RALP) in children with complex pelvi-ureteric junction obstruction (PUJO): results of a multicenter European report |
Q91048404 | Robot-assisted laparoscopic pyeloplasty (RALP) in children with horseshoe kidneys: results of a multicentric study |
Q90046430 | Robot-assisted laparoscopic pyeloplasty in infants and children: is it superior to conventional laparoscopy? |
Q90026058 | Robot-assisted laparoscopic ureteral reimplantation in children: a valuable alternative to open surgery |
Q48156456 | Robot-assisted laparoscopic versus open ureteral reimplantation for pediatric vesicoureteral reflux: a systematic review and meta-analysis |
Q42667327 | Robot-assisted partial nephrectomy for renal tumors larger than 4 cm: results of a multicenter, international series. |
Q49898917 | Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant? |
Q94957457 | Robot-assisted radical cystectomy with intracorporeal urinary diversion decreases postoperative complications only in highly comorbid patients: findings that rely on a standardized methodology recommended by the European Association of Urology Guide |
Q90722834 | Robot-assisted simple prostatectomy versus open simple prostatectomy: a single-center comparison |
Q51343250 | Robot-assisted ureteral reconstruction using a tubularized peritoneal flap: a novel technique in a chronic porcine model. |
Q36424057 | Robot-assisted versus pure laparoscopic radical prostatectomy |
Q57100362 | Robot-sewn ileoileal anastomosis during robot-assisted cystectomy |
Q39755076 | Robotic and open partial nephrectomy for complex renal tumors: a matched-pair comparison with a long-term follow-up |
Q38963108 | Robotic and open partial nephrectomy for localized renal tumors larger than 7 cm: a single-center experience |
Q40591311 | Robotic assisted microsurgical vasal reconstruction in a model system |
Q91777635 | Robotic enucleation of adrenal masses: technique and outcomes |
Q51940388 | Robotic extended pyelolithotomy for treatment of renal calculi: a feasibility study. |
Q40321235 | Robotic kidney transplantation: one year after the beginning |
Q42631880 | Robotic management of complicated ureteropelvic junction obstruction |
Q91179584 | Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysis |
Q37417596 | Robotic partial nephrectomy shortens warm ischemia time, reducing suturing time kinetics even for an experienced laparoscopic surgeon: a comparative analysis |
Q51608989 | Robotic partial nephrectomy versus laparoscopic partial nephrectomy: a single laparoscopic trained surgeon's experience in the development of a robotic partial nephrectomy program. |
Q50684312 | Robotic radical cystectomy and enhanced recovery: a new pathway. |
Q47826370 | Robotic radical cystectomy: intracorporeal versus extracorporeal versus orthotopic neobladder-Which is better? |
Q91810712 | Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience |
Q48712954 | Robotic radical prostatectomy in Australia: initial experience |
Q42687601 | Robotic radical prostatectomy: evolution from conventional to VIP. |
Q51943956 | Robotic radical prostatectomy: the Vattikuti Urology Institute training experience. |
Q38081081 | Robotic retroperitoneal partial nephrectomy |
Q34041791 | Robotic surgery |
Q90259201 | Robotic surgery in infants and children: an argument for smaller and fewer incisions |
Q49827570 | Robotic surgery in public hospitals of Latin-America: a castle of sand? |
Q90440004 | Robotic surgery in urology: the way forward |
Q50090647 | Robotic surgery: new robots and finally some real competition! |
Q43425508 | Robotic urologic surgery: is this the way of the future? |
Q40470829 | Robotic versus conventional laparoscopic pyeloplasty in children less than 20 kg by weight: single-center experience. |
Q91413029 | Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group) |
Q91264184 | Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study |
Q91479777 | Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases |
Q93024871 | Robotic-assisted bladder neck procedures in children with neurogenic bladder |
Q93138173 | Robotic-assisted kidney transplant: a single center experience with median follow-up of 2.8 years |
Q96610763 | Robotic-assisted kidney transplantation in obese recipients compared to non-obese recipients: the European experience |
Q50862170 | Robotic-assisted kidney transplantation: our first case. |
Q44980944 | Robotic-assisted laparoendoscopic single-site radical nephrectomy: first experience with the novel Da Vinci single-site platform |
Q38091333 | Robotic-assisted laparoscopic radical cystectomy: history, techniques and outcomes |
Q52012915 | Robotic-assisted laparoscopic radical prostatectomy: the Frankfurt technique. |
Q51940389 | Robotic-assisted laparoscopy applied to reconstructive surgeries in children. |
Q90440001 | Robotic-assisted partial nephrectomy: a new era in nephron sparing surgery |
Q41379707 | Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes. |
Q129674627 | Robotic-assisted radical prostatectomy: a multicenter experience with the Senhance Surgical System |
Q36958930 | Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target |
Q93143790 | Role of MRI in planning radical prostatectomy: what is the added value? |
Q44012818 | Role of US in acute scrotal pain. |
Q40875442 | Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers |
Q91118052 | Role of androgen receptor splice variants, their clinical relevance and treatment options |
Q35043206 | Role of behavioral changes and biofeedback in urology |
Q74497048 | Role of cathepsin D in prostatic cancer cell growth and its regulation by brefeldin A |
Q36053523 | Role of flexible uretero-renoscopy in management of renal calculi in anomalous kidneys: single-center experience |
Q38152243 | Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer |
Q37873396 | Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU). |
Q122961066 | Role of immunotherapy in the prevention of recurrence and invasion of urothelial bladder tumors: a review |
Q90058200 | Role of intraoperative ultrasound in robotic-assisted radical nephrectomy with inferior vena cava thrombectomy in renal cell carcinoma |
Q38784315 | Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A. |
Q36761284 | Role of lymphadenectomy in clinically organ-confined prostate cancer |
Q34661359 | Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy |
Q99637611 | Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3 + 4 |
Q96688196 | Role of multiparametric prostate MRI in the management of prostate cancer |
Q36749371 | Role of nomograms for prostate cancer in 2007. |
Q127175801 | Role of oxygen reserve index monitoring in patients undergoing robot-assisted radical prostatectomy: a retrospective study |
Q37970913 | Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination |
Q92268320 | Role of phosphodiesterase inhibitors in stent-related symptoms: a systematic review and meta-analysis |
Q93118131 | Role of phosphodiesterase inhibitors in stent-related symptoms: a systematic review and meta-analysis |
Q44536483 | Role of positive urethrovesical feedback in vesical evacuation. The concept of a second micturition reflex: the urethrovesical reflex |
Q101135023 | Role of prehabilitation following major uro-oncologic surgery: a narrative review |
Q52575623 | Role of quantitative computed tomography texture analysis in the prediction of adherent perinephric fat. |
Q53274011 | Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis. |
Q33602395 | Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction |
Q41599088 | Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer |
Q35862201 | Rupture and perforation of urinary reservoirs made from bowel |
Q86207195 | SIU 2015 Abstracts |
Q88713141 | SIU Newsletter - December 2016 |
Q89385727 | SIU Newsletter - June 2016 |
Q88646223 | SIU Newsletter - June 2018 |
Q87288279 | SIU Newsletter - March 2016 |
Q88122664 | SIU Newsletter - September 2016 |
Q92439271 | SIU Newsletter - September 2019 |
Q86788425 | SIU newsletter - March 2015 |
Q91149746 | SIU-ICUD consultation on bladder cancer 2018 |
Q90469821 | SIU-ICUD consultation on bladder cancer: basic science |
Q91229856 | SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer |
Q91460040 | SIU-ICUD on bladder cancer: pathology |
Q91606366 | SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer |
Q93166533 | SIU-NewsLetter - December 2018 |
Q91243682 | SWL outcome in artificial hydronephrotic vs. non-hydronephrotic kidney for preschool children with high-density renal stones |
Q46788478 | Sacral colpopexy using mersilene mesh in the treatment of vaginal vault prolapse |
Q51054121 | Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System. |
Q37944507 | Sacral neuromodulation for lower urinary tract dysfunction |
Q92318210 | Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents |
Q60704843 | Sacral neuromodulation in patients with multiple sclerosis |
Q47713492 | Safe introduction of laparoscopic and retroperitoneoscopic nephrectomy in clinical practice: impact of a modular training program |
Q64885837 | Safe transition from extracorporeal to intracorporeal urinary diversion following robot-assisted cystectomy: a recipe for reducing operative time, blood loss and complication rates. |
Q46333989 | Safe-R: a novel score, accounting for oncological safe nerve-sparing at radical prostatectomy for localized prostate cancer |
Q43614535 | Safety and effectiveness of Thulium VapoEnucleation of the prostate (ThuVEP) in patients on anticoagulant therapy |
Q91455324 | Safety and efficacy of Tamsulosin as medical expulsive therapy in pregnancy |
Q92137467 | Safety and efficacy of bipolar versus monopolar transurethral resection of bladder tumor: a systematic review and meta-analysis |
Q95276169 | Safety and efficacy of bipolar versus monopolar transurethral resection of bladder tumor: a systematic review and meta-analysis |
Q99633087 | Safety and efficacy of superior calyceal access versus inferior calyceal access for pelvic and/or lower calyceal renal calculi- a prospective observational comparative study |
Q46973699 | Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia |
Q77740462 | Safety and efficacy of tubeless percutaneous nephrostolithotomy |
Q47252688 | Safety and efficacy using a low-powered holmium laser for enucleation of the prostate (HoLEP): 12-month results from a prospective low-power HoLEP series. |
Q35087046 | Safety and feasibility of concomitant surgery during holmium laser enucleation of the prostate (HoLEP). |
Q48303167 | Safety and feasibility study of holmium laser enucleation of the prostate (HOLEP) on patients receiving dual antiplatelet therapy (DAPT). |
Q92026654 | Safety of decreasing ureteral stent duration following radical cystectomy |
Q92161309 | Safety of on- vs off-clamp robotic partial nephrectomy: per-protocol analysis from the data of the CLOCK randomized trial |
Q35554284 | Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature |
Q34262379 | Salvage chemotherapy in relapsed germ cell tumors |
Q91149748 | Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes |
Q92865778 | Salvage lymphadenectomy in recurrent prostate cancer: is there evidence of real benefit? |
Q38077465 | Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications |
Q35201497 | Salvage radiotherapy following radical prostatectomy. |
Q47967585 | Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results |
Q37811992 | Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes |
Q90156006 | Salvage robotic-assisted radical prostatectomy: oncologic and functional outcomes from two high-volume institutions |
Q88873976 | Salvage topical therapy for upper tract urothelial carcinoma |
Q120633373 | Same-day discharge following minimally invasive partial and radical nephrectomy: a National Surgical Quality Improvement Program (NSQIP) analysis |
Q89741701 | Same-day discharge surgery for robot-assisted radical prostatectomy in the era of ERAS and prehabilitation pathways: a contemporary, comparative, feasibility study |
Q39065531 | Sarcopenia as a predictor of complications in penile cancer patients undergoing inguinal lymph node dissection. |
Q57210275 | Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer |
Q57693520 | Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen |
Q46505829 | Schistosoma hematobium soluble egg antigens induce proliferation of urothelial and endothelial cells. |
Q91071981 | Scientific language trends among Swedish urologists and surgeons 1900-1955 |
Q99251460 | Scoping review: hotspots for COVID-19 urological research: what is being published and from where? |
Q37009889 | Screening for bladder cancer: a perspective |
Q89724124 | Screening of characteristic biomolecules related to bladder cancer based on construction of ceRNA regulation network |
Q42503421 | Scrotal cancer survival is influenced by histology: a SEER study |
Q50698163 | Scrotal signs and symptoms in the general population, the value of testis self-examination and the pitfalls of a scrotal screening programme: is the two-week rule relevant? |
Q84850140 | Scrutiny of cardiovascular risk factors by assessing arterial stiffness in erectile dysfunction patients |
Q95274167 | Seasonal variations in overactive bladder drug prescription rates in women: a nationwide population-based study |
Q43690945 | Second cancer after treatment of malignant germ-cell tumors |
Q89986163 | Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study |
Q38877161 | Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution |
Q38834749 | Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms |
Q46907494 | Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study |
Q35723753 | Secondary surgery in germ cell tumors--when and how extensively should it be performed? |
Q34127538 | Selective angioembolization for traumatic renal injuries: a survey on clinician practice |
Q44111607 | Selective clamping under the usage of near-infrared fluorescence imaging with indocyanine green in robot-assisted partial nephrectomy: a single-surgeon matched-pair study |
Q73330289 | Selective culture conditions for different types of primary human bladder cells |
Q40833754 | Selective detrusor activation by sacral ventral nerve-root stimulation: results of intraoperative testing in humans during implantation of a Finetech-Brindley system |
Q43260335 | Selective α1A-blocker improves bladder storage function in rats via suppression of C-fiber afferent activity |
Q36473811 | Self-management in lower urinary tract symptoms: the next major therapeutic revolution |
Q45117297 | Semen quality and associated reproductive indicators in middle-aged males: the role of non-malignant prostate conditions and genital tract inflammation |
Q33840701 | Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report |
Q84066576 | Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men |
Q47605594 | Sequential comparisons of postoperative urodynamic changes between retropubic and transobturator midurethral tape procedures. |
Q52896102 | Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors. |
Q84551001 | Sequential resection of malignant ureteral margins at radical cystectomy: a critical assessment of the value of frozen section analysis |
Q54599109 | Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma. |
Q38072402 | Sequential therapy with targeted agents in metastatic renal cell carcinoma: beyond second-line and overcoming drug resistance |
Q46518171 | Serotonin used as prognostic marker of urological tumors |
Q41026893 | Serum 17β-estradiol fails as a marker in identification of aggressive tumour disease in patients with localized prostate cancer |
Q46967086 | Serum lipid levels in benign prostatic hyperplasia |
Q91622632 | Serum sphingosine-1-phosphate levels in bladder pain syndrome/interstitial cystitis patients: could it help in diagnosis? |
Q39256655 | Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer |
Q51828647 | Sexual activity, sexual dysfunction and associated help-seeking behaviours in middle-aged and older adults in Spain: a population survey. |
Q44921644 | Sexual behaviour, sexual dysfunctions and related help seeking patterns in middle-aged and elderly Europeans: the global study of sexual attitudes and behaviors |
Q38098400 | Sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome |
Q48081570 | Sexual quality of life after total phalloplasty in men with penile deficiency: an exploratory study |
Q52942614 | Shared decision-making--results from an interdisciplinary consulting service for prostate cancer. |
Q43148746 | Shock wave induces chronic renal lesion through activation of the nuclear factor kappa B signaling pathway |
Q90933059 | Shock wave lithotripsy versus endoscopic cystolitholapaxy in the management of patients presenting with calcular acute urinary retention: a randomised controlled trial |
Q85215386 | Shock wave lithotripsy versus ureteroscopy for ureteral calculi: a prospective assessment of patient-reported outcomes |
Q38235714 | Shock wave lithotripsy: the new phoenix? |
Q39368622 | Shockwave lithotripsy: techniques for improving outcomes |
Q101135027 | Short-term and long-term outcomes after resection of thoracic growing teratoma syndrome |
Q49204891 | Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube |
Q51582833 | Short-term ureteral catheter stenting after uncomplicated transurethral uretero-lithotomy. |
Q37238897 | Shortcomings of the current TNM classification for penile carcinoma: time for a change? |
Q53080988 | Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN. |
Q50039879 | Should mini percutaneous nephrolithotomy (MiniPNL/Miniperc) be the ideal tract for medium-sized renal calculi (15-30 mm)? |
Q91312670 | Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy |
Q83061166 | Should we abstain from Gleason score 2-4 in the diagnosis of prostate cancer? Results of a German multicentre study |
Q88154228 | Should we rely on Doppler ultrasound for evaluation of testicular solid lesions? |
Q36679110 | Side-firing devices for laser prostatectomy. An overview |
Q41379162 | Signal transduction in cavernous smooth muscle |
Q45984710 | Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI. |
Q71610500 | Significance of androgen deprivation prior to radical prostatectomy, with special reference to prostate-specific antigen |
Q85889828 | Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis |
Q36643608 | Significance of hypogonadism in erectile dysfunction |
Q51757934 | Significance of postbiopsy hemorrhage observed on preoperative magnetic resonance imaging in performing robot-assisted laparoscopic radical prostatectomy. |
Q34554130 | Significance of preoperative PSA velocity in men with low serum PSA and normal DRE. |
Q35164397 | Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate |
Q40436642 | Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy |
Q53031298 | Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography. |
Q43255237 | Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction |
Q34209740 | Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications. |
Q47775606 | Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney |
Q89324390 | Simple and practical nomograms for predicting the stone-free rate after shock wave lithotripsy in patients with a solitary upper ureteral stone |
Q50990741 | Simulated physiological stretch increases expression of extracellular matrix proteins in human bladder smooth muscle cells via integrin α4/αv-FAK-ERK1/2 signaling pathway. |
Q86029699 | Simulation of RIRS in soft cadavers: a novel training model by the Cadaveric Research On Endourology Training (CRET) Study Group |
Q91126224 | Simultaneous treatment of ureteropelvic junction obstruction complicated by renal calculi with robotic laparoscopic surgery and flexible cystoscope |
Q92454957 | Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer |
Q129674096 | Single incision robotic cystectomy and urinary diversion |
Q92465225 | Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey |
Q34250616 | Single session of high-intensity focused ultrasound for localized prostate cancer: treatment outcomes and potential effect as a primary therapy |
Q50652475 | Single- versus dual-console robot-assisted radical prostatectomy: impact on intraoperative and postoperative outcomes in a teaching institution. |
Q50540440 | Single- versus dual-console robotic surgery: dual improves the educational experience for trainees. |
Q87344969 | Single-Incision Transumbilical Surgery (SITUS) versus Single-Port Laparoscopic Surgery and conventional laparoscopic surgery: a prospective randomized comparative study of performance with novices in a dry laboratory |
Q92970913 | Single-port robotic surgery: the next generation of minimally invasive urology |
Q38470558 | Single-port transvesical enucleation of the prostate for benign prostatic hyperplasia with severe intravesical prostatic protrusion |
Q91574394 | Single-stage buccal mucosal graft urethroplasty for meatal stenoses and fossa navicularis strictures: a monocentric outcome analysis and literature review on alternative treatment options |
Q85076655 | Single-stage dorsal inlay for reconstruction of recurrent peno-glandular stenosis |
Q91048407 | Single-surgeon series of delayed anastomotic urethroplasty for pelvic fracture urethral injury: an analysis of surgical and patient-reported outcomes of a 10-year experience in a Japanese referral center |
Q47410280 | Single-use flexible ureteropyeloscopy: a systematic review. |
Q88993035 | Single-use versus reusable ureterorenoscopes for retrograde intrarenal surgery (RIRS): systematic comparative analysis of physical and optical properties in three different devices |
Q94954907 | Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by 68Ga-PSMA-11 PET/CT or 11C-Choline PET/CT: impact of postoperative treatments |
Q92553039 | Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond |
Q47383013 | Size and status of metastases after inductive chemotherapy of germ-cell tumors. Indication for salvage operation |
Q92452119 | Size does matter: ureteral stents with a smaller diameter show advantages regarding urinary symptoms, pain levels and general health |
Q129669813 | Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients |
Q38223077 | Sky is no limit for ureteroscopy: extending the indications and special circumstances |
Q37946314 | Slings in surgery of genuine stress incontinence |
Q92828773 | Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection |
Q43916587 | Small-incision access retroperitoneoscopic technique (SMART) pyeloplasty in adult patients: comparison of cosmetic and post-operative pain outcomes in a matched-pair analysis with standard retroperitoneoscopy: preliminary report. |
Q38549654 | Small-intestinal submucosa for bladder augmentation: a review of preclinical studies |
Q92287917 | Smarter screening for prostate cancer |
Q90622302 | Smartphone technology and its applications in urology: a review of the literature |
Q74744424 | Smooth muscle cells from human urinary bladder express connexin 43 in vivo and in vitro |
Q71766924 | Smooth-muscle myosin heavy-chain isoform expression in bladder-outlet obstruction |
Q53062988 | Socio-economic deprivation and outcomes following radical nephroureterectomy for clinically localized upper tract transitional cell carcinoma. |
Q91959865 | Socioeconomic and patient-related factors for the management of male urethral stricture disease |
Q39200312 | Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study |
Q43338166 | Some historical aspects of urinals and urine receptacles |
Q34712070 | Some historical reflections on the ageing male |
Q90291469 | Sonographic twinkling artifact for diagnosis of acute ureteral calculus |
Q35854181 | Sonography of the bladder |
Q90019569 | Special considerations in the urological management of the older spinal cord injury patient |
Q36718645 | Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro |
Q91959838 | Specific characteristics of urethral strictures in a developing country (Brazil) |
Q54392904 | Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. |
Q96766468 | Specific spatial distribution patterns of tumor foci are associated with a low risk of biochemical recurrence in pT2pN0R0 prostate cancer |
Q41379127 | Spinal control of penile erection |
Q28255642 | Spinal cord control of ejaculation |
Q42576655 | Spirituality and end-of-life care in disadvantaged men dying of prostate cancer |
Q96128917 | Split-leg modified lateral versus prone position in percutaneous nephrolithotomy: a prospective, randomized trial |
Q36494191 | Spontaneous versus precipitated AUR: the same? |
Q40568418 | Stage I nonseminomatous germ-cell testicular cancer--management options and risk-benefit considerations. |
Q71655078 | Stage II nonseminomatous germ-cell testicular tumors ? the Indiana experience and risk-benefit analysis |
Q41685656 | Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy |
Q38270565 | Stage pT0 after radical prostatectomy: a diagnostic dilemma |
Q36606951 | Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective? |
Q53183754 | Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? |
Q50180411 | Standard vs. anatomical 180-W GreenLight laser photoselective vaporization of the prostate: a propensity score analysis |
Q38739753 | Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project. |
Q43783840 | Standardization of isothermal microcalorimetry in urinary tract infection detection by using artificial urine. |
Q83749724 | Standardized ex vivo comparison of different upper urinary tract biopsy devices: impact on ureterorenoscopes and tissue quality |
Q88222516 | Standards, innovations, and controversies in urologic imaging |
Q36414573 | Standing the test of time: long-term outcome of reconstruction of the exstrophy bladder |
Q36410083 | Standing the test of time: the long-term results of urethroplasty. |
Q36619428 | State-of-the-art management of metastatic disease at initial presentation or recurrence |
Q77422094 | Statements of the committees of the WHO consensus conference, 20 August 1997. 1st International Conference on Urinary Incontinence in the Elderly. Bonn, Germany, 20-21 August 1997 |
Q87527196 | Statin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy |
Q36430210 | Status of robotic cystectomy in 2005. |
Q41222243 | Stemming the Tide: Infectious Complications After Prostate Biopsy |
Q40660675 | Stereoscopic (3D) versus monoscopic (2D) laparoscopy: comparative study of performance using advanced HD optical systems in a surgical simulator model |
Q91324983 | Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment |
Q92190344 | Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer |
Q53093291 | Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience. |
Q85849430 | Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer |
Q40237893 | Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments. |
Q97532567 | Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions |
Q91343849 | Stone composition independently predicts stone size in 18,029 spontaneously passed stones |
Q89068157 | Stone free rates (SFRs) after retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PCNL); are we comparing apples with watermelons? |
Q91289259 | Stone removal for treating recurrent urinary tract infections in stone-formers: two birds with one stone or just too soon to tell? |
Q36400134 | Stone technology: intracorporeal lithotripters |
Q39167381 | Stones in special situations |
Q35156544 | Strategies to promote recovery of cavernous nerve function after radical prostatectomy |
Q38492726 | Stress incontinence surgery at the time of prolapse surgery: mandatory or forbidden? |
Q40661762 | Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. |
Q40386535 | Structure, function, and regulation of the enzyme activity of prostate-specific antigen |
Q46083327 | Structured learning for robotic surgery utilizing a proficiency score: a pilot study |
Q72608629 | Study of the artefacts induced by linear array transvaginal ultrasound scanning in urodynamics |
Q51646602 | Study of the electromechanical activity of the urinary bladder. An experimental study. |
Q74782524 | Study of the female urethra's submucous vascular plexus by color Doppler |
Q53537196 | Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits. |
Q101218261 | Study on the effect of rapid rehabilitation nursing in postoperative rehabilitation of PCNL patients |
Q50898139 | Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM). |
Q93018866 | Substantial radiation dose reduction with consistent image quality using a novel low-dose stone composition protocol |
Q51416476 | Substantial utilization of Facebook, Twitter, YouTube, and Instagram in the prostate cancer community. |
Q80965289 | Substratification of high-risk localised prostate cancer treated by radical prostatectomy |
Q91794073 | Suctioning ureteral access sheath use in flexible ureteroscopy might decrease operation time and prevent infectious complications |
Q33943097 | Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene |
Q71115769 | Summary of 10 years' experience with an ileal low-pressure bladder substitute combined with an afferent tubular isoperistaltic segment |
Q89838592 | Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study |
Q50076534 | Super-, perfect-, ultra-, micro-, mini-, …: does anybody benefit from miniaturized percutaneous nephrolithotomy? |
Q40860518 | Superficial bladder carcinoma. Factors affecting the natural history |
Q94497406 | Superior early and long-term continence following early micturition on day 2 after robot-assisted radical prostatectomy: a randomized prospective trial |
Q46482254 | Superiority of the EF-120-00-3F biopsy forceps in the histopathological evaluation of upper urinary tract specimens |
Q90601352 | Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis |
Q46969430 | Suppression of renal TRPM7 may alleviate kidney injury in the renal transplantation |
Q88222521 | Supra-pubic versus urethral catheter after robot-assisted radical prostatectomy: systematic review of current evidence |
Q57292771 | Supracostal access tubeless percutaneous nephrolithotomy: minimizing complications |
Q90156008 | Suprapubic versus urethral catheter drainage in robotic-assisted laparoscopic prostatectomy: advancing systematic review quality |
Q54019595 | Suramin administration is associated with a decrease in serum calcium levels. |
Q30865540 | Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients |
Q94462081 | Surgery associated with increased survival compared to radiation in clinically localized Gleason 9-10 prostate cancer: a SEER analysis |
Q61613941 | Surgery for detrusor overactivity |
Q36179344 | Surgery for metastatic renal cell cancer. |
Q70803465 | Surgery in rhabdomyosarcoma of the bladder, prostate and vagina |
Q90322141 | Surgical and patient-reported outcomes of urethroplasty for bulbar stricture due to a straddle injury |
Q34798537 | Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer |
Q35865810 | Surgical complications of urinary diversion |
Q98390924 | Surgical complications risk in obese and overweight recipients for kidney transplantation: a predictive morphometric model based on sarcopenia and vessel-to-skin distance |
Q88069666 | Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence? |
Q88171821 | Surgical landscape of radical cystectomy for bladder cancer in France over the last 10 years |
Q50595494 | Surgical learning curve for open radical prostatectomy: Is there an end to the learning curve? |
Q38202061 | Surgical management of metastatic renal cell carcinoma in the era of targeted therapies |
Q37948631 | Surgical management of pelvic organ prolapse: abdominal and vaginal approaches |
Q53821966 | Surgical management of the neurogenic bladder after spinal cord injury. |
Q35819452 | Surgical management of vesicoureteral reflux in pediatric patients |
Q88687654 | Surgical margin status and its impact on prostate cancer prognosis after radical prostatectomy: a meta-analysis |
Q84425488 | Surgical margin status of specimen and oncological outcomes after laparoscopic radical prostatectomy: experience after 400 procedures |
Q39153917 | Surgical method influences specimen margins and biochemical recurrence during radical prostatectomy for high-risk prostate cancer: a systematic review and meta-analysis |
Q33545995 | Surgical options for open adrenalectomy |
Q53085751 | Surgical planning and manual image fusion based on 3D model facilitate laparoscopic partial nephrectomy for intrarenal tumors. |
Q94948870 | Surgical safety |
Q92762780 | Surgical safety in radical cystectomy: the anesthetist's point of view-how to make a safe procedure safer |
Q88431871 | Surgical teaching in urology: patient safety and educational value of 'LIVE' and 'SEMI-LIVE' surgical demonstrations |
Q45247395 | Surgical team composition has a major impact on effectiveness and costs in laparoscopic donor nephrectomy. |
Q38726738 | Surgical therapy of prostatitis: a systematic review. |
Q49720931 | Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy |
Q74744411 | Surgical treatment for stress urinary incontinence with urethral hypermobility: what is the best approach? |
Q90264150 | Surgical treatment of large volume prostates: a matched pair analysis comparing the open, endoscopic (ThuVEP) and robotic approach |
Q41645538 | Surgical treatment of sphincteric incontinence in women |
Q63966178 | Surveillance after prostate focal therapy |
Q88912830 | Surveillance and management of urologic complications after spinal cord injury |
Q50604982 | Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors. |
Q88538606 | Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer |
Q57296514 | Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract |
Q83735891 | Survival in prostate cancer patients > or = 70 years after radical prostatectomy and comparison to younger patients |
Q92785780 | Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder |
Q91192533 | Survival of the artificial urinary sphincter in a changing patient profile |
Q36982448 | Survivin: a promising biomarker for detection and prognosis of bladder cancer |
Q48158255 | Symptom prevalence, bother, and treatment satisfaction in men with lower urinary tract symptoms in Southeast Asia: a multinational, cross-sectional survey. |
Q43226841 | Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia |
Q92608776 | Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial |
Q91796977 | Synchronous genitourinary lichen sclerosus signals a distinct urinary microbiome profile in men with urethral stricture disease |
Q73503013 | Synchronus renal cell carcinoma and Bellini duct carcinoma: a case report on a rare coincidence |
Q73655253 | Systematic application of ESWL and percutaneous nephrolithotomy |
Q95937757 | Systematic assessment of information about surgical urinary stone treatment on YouTube |
Q93085123 | Systematic review and cumulative analysis of the managements for proximal impacted ureteral stones |
Q96306203 | Systematic review and meta-analysis comparing Adjustable Transobturator Male System (ATOMS) and male Readjustment Mechanical External (REMEEX) system for post-prostatectomy incontinence |
Q38051005 | Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement |
Q92078054 | Systematic review of augmented reality in urological interventions: the evidences of an impact on surgical outcomes are yet to come |
Q99560626 | Systematic review of the endoscopic enucleation of the prostate learning curve |
Q90325861 | Systematic review: bacterial colonisation of conduits and neobladders-when to test, watch, and treat |
Q89357492 | Systematic reviews and meta-analysis in stone disease: is this what we need to get stronger evidence? |
Q77400310 | Systemic and cavernosal plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction |
Q74497081 | Systemic and cavernous plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction |
Q74111372 | Systemic and cavernous plasma levels of endothelin 1 in healthy males during different functional conditions of the penis |
Q74377441 | Systemic and cavernous plasma levels of vasoactive intestinal polypeptide during sexual arousal in healthy males |
Q34262346 | Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer |
Q56966129 | Systemic therapy in metastatic renal cell carcinoma |
Q54385397 | Systemic therapy of renal cell carcinoma. |
Q34262390 | Systemic treatment of hormone refractory prostate cancer |
Q45866754 | Systems for therapeutic angiogenesis in tissue engineering |
Q91536740 | T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation |
Q86727183 | T. R. W. Herrmann and T. Bach (eds.): Editorial comment on "What is relevant for Lasers in Urology?" |
Q41750995 | TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma |
Q43813974 | TGFB1 gene polymorphism Leu10Pro (c.29T>C), prostate cancer incidence and quality of life in patients treated with brachytherapy |
Q88221733 | TMPRSS2-ERG fusion transcripts expression in patients referred for prostate biopsy: combining detection in urine and needle rinse material |
Q35780014 | TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer. |
Q36679116 | TULIP: transurethral ultrasound-guided laser-induced prostatectomy |
Q89533453 | TUR-P phantom for resident surgical training: food-based design as a human mimicking model of the prostate |
Q101565847 | TURPxit or not: the guidelines perspective-Panta Rhei |
Q43645124 | TVT versus TOT, 2-year prospective randomized study |
Q128607928 | Tadalafil versus tamsulosin as combination therapy with 5-alpha reductase inhibitors in benign prostatic hyperplasia, urinary and sexual outcomes |
Q34648301 | Tamsulosin: an overview. |
Q41214926 | Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results |
Q44211594 | Targeted genomic disruption of H-ras and N-ras has no effect on early renal changes after unilateral ureteral ligation |
Q80676130 | Targeted therapy in renal cell carcinoma |
Q26991589 | Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy |
Q36706373 | Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors |
Q36050408 | Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer |
Q40095585 | Targeting EGFR in bladder cancer |
Q36752747 | Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma |
Q100535261 | Tea and coffee consumption and pathophysiology related to kidney stone formation: a systematic review |
Q36911272 | Technical and anatomical essentials for transrectal ultrasound of the prostate |
Q33286038 | Technical aspects of lasers in urology |
Q42684533 | Technical difficulties of transumbilical laparoendoscopic single-site adrenalectomy: comparison with conventional laparoscopic adrenalectomy. |
Q36679073 | Technique and results of interstitial laser coagulation |
Q89802585 | Temperature changes during laser lithotripsy with Ho:YAG laser and novel Tm-fiber laser: a comparative in-vitro study |
Q36425954 | Temporal expression of hyaluronic acid and hyaluronic acid receptors in a porcine small intestinal submucosa-augmented rat bladder regeneration model |
Q44182546 | Temporary urethral stenting after high-energy transurethral microwave thermotherapy of the prostate |
Q42681367 | Ten year experience of retroperitoneal laparoscopic resection for pheochromocytomas: A dual-centre study of 72 cases |
Q39051306 | Ten-year outcomes of I¹²⁵ low-dose-rate brachytherapy for clinically localized prostate cancer: a single-institution experience in Japan |
Q84230837 | Tensor fascia lata flap reconstruction following groin dissection: is it worthwhile? |
Q90439990 | Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial |
Q49915142 | Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study |
Q114229789 | Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review |
Q70803459 | Testicular germ-cell tumors in childhood and adolescence |
Q39230606 | Testicular lymphoblastic leukemia/lymphoma. |
Q37258356 | Testicular metastases: a poor prognostic factor in patients with advanced prostate cancer |
Q54049155 | Testis cancer: some problems still remain unsolved. |
Q34728014 | Testosterone insufficiency in women: fact or fiction? |
Q92566537 | Testosterone replacement therapy is associated with an increased risk of urolithiasis |
Q90472944 | The "Omega Sign": a novel HoLEP technique that improves continence outcomes after enucleation |
Q77740458 | The "mini-perc" technique: a less invasive alternative to percutaneous nephrolithotomy |
Q38653281 | The "old" 15 mm renal stone size limit for RIRS remains a clinically significant threshold size. |
Q41379173 | The "syncytial tissue triad": a model for understanding how gap junctions participate in the local control of penile erection |
Q36445337 | The 'scrubbed surgeon' in robotic surgery |
Q94504069 | The 2014 ISUP grade group system: the Holy Grail or yet another hype? |
Q92484318 | The 365 μm holmium laser in flexible ureteroscopic lithotripsy: prospect and risk coexist? |
Q40401357 | The Abrams-Griffiths nomogram |
Q88574632 | The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference? |
Q89207844 | The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells |
Q99573210 | The BUSCOPAN study: a randomized-controlled non-inferiority trial of a continuous butylscopolamine infusion versus placebo in patients with a renal colic not responding to oral non-steroidal anti-inflammatory drugs |
Q41443006 | The E-cadherin cell-cell adhesion pathway in urologic malignancies |
Q38848971 | The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ). |
Q98390923 | The German linguistic validation of the Wisconsin Stone Quality of Life questionnaire (WisQoL) |
Q73885697 | The Gore-tex sling procedure for female sphincteric incontinence: indications, technique, and results |
Q83426925 | The IDEAL recommendations and urological innovation |
Q39188444 | The IL-1RN and IL-4 gene polymorphisms are potential genetic markers of susceptibility to bladder cancer: a case-control study. |
Q48181174 | The Integral Theory System Questionnaire: an anatomically directed questionnaire to determine pelvic floor dysfunctions in women |
Q92741136 | The LACE + index as a predictor of 90-day urologic surgery outcomes |
Q101567668 | The Mayo Adhesive Probability score can help predict intra- and postoperative complications in patients undergoing laparoscopic donor nephrectomy |
Q71324643 | The Mitrofanoff principle for continent urinary diversion |
Q36836686 | The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches? |
Q89986153 | The PT2D-Score: a novel tool to predict complications and economic outcome after radical cystectomy |
Q44186279 | The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater reliability |
Q35131292 | The Prostate Cancer Prevention Trial: design, status, and promise |
Q50002154 | The T-plasty as therapy for recurrent bladder neck stenosis: success rate, functional outcome, and patient satisfaction. |
Q47826386 | The T-plasty: a modified YV-plasty for highly recurrent bladder neck contracture after transurethral surgery for benign hyperplasia of the prostate: clinical outcome and patient satisfaction. |
Q73885694 | The UCLA surgical approach to sphincteric incontinence in women |
Q31943474 | The University of Tennessee experience with the Indigo 830e laser device for the minimally invasive treatment of benign prostatic hyperplasia: interim analysis |
Q53140777 | The Urological Dyna-CT: ex vivo feasibility study of interventional cross-sectional imaging in the endourological operation room. |
Q33464366 | The Zeiss-loop stone extraction: minimal invasive and effective or obsolete? |
Q124935930 | The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations |
Q120633369 | The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients |
Q51037310 | The accuracy of renal tumor biopsy: analysis from a national prospective study. |
Q34712063 | The ageing male |
Q34712045 | The ageing male and erectile dysfunction |
Q34712021 | The ageing male: demographics and challenges |
Q34712053 | The ageing penis |
Q77422108 | The aging bladder: morphology and urodynamics |
Q90614488 | The alternating bidirectional versus the standard approach during shock wave lithotripsy for upper lumbar ureteric stones: a randomized controlled trial |
Q77422155 | The antegrade continence enema procedure why, when and how? |
Q39691714 | The application of ultrasound contrast agents in the characterization of renal tumors |
Q73330280 | The artificial urinary bladder |
Q89770695 | The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy |
Q101212514 | The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men |
Q49331695 | The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol |
Q95937762 | The association between plant-based content in diet and testosterone levels in US adults |
Q90472950 | The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan |
Q35611466 | The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review |
Q41727394 | The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients |
Q34258789 | The association of cruciferous vegetables intake and risk of bladder cancer: a meta-analysis |
Q89794820 | The basics of transition in congenital lifelong urology |
Q34473188 | The basis for drug treatment of the overactive bladder |
Q39136550 | The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma |
Q50870843 | The bone-anchor sub-urethral sling for the treatment of iatrogenic male incontinence: subjective and objective assessment after 41 months of mean follow-up. |
Q33827769 | The bowel microflora: an important source of urinary tract pathogens |
Q90795679 | The cardiovascular risk factors in men with lower urinary tract symptoms |
Q41111881 | The cellular basis of metastasis |
Q90728803 | The change of IPSS 7 (nocturia) score has the maximum influence on the change of Qol score in patients with lower urinary tract symptoms |
Q52899875 | The changes of urethral morphology recognized in voiding cystourethrography after endoscopic transurethral incision for posterior urethral valve in boys with intractable daytime urinary incontinence and nocturnal enuresis. |
Q43265885 | The clinical analysis of young children's urolithiasis due to melamine-tainted infant formula |
Q37662394 | The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials |
Q37918901 | The clinical impact of pathological review on selection the treatment modality for localized prostate cancer in candidates for brachytherapy monotherapy |
Q38438246 | The clinical significance of intra-operative ureteral frozen section analysis at radical cystectomy for urothelial carcinoma of the bladder |
Q90219973 | The clinicopathological characteristics and prognostic value of squamous differentiation in patients with bladder urothelial carcinoma: a meta-analysis |
Q40186112 | The comparison of minimally invasive percutaneous nephrolithotomy and retrograde intrarenal surgery for stones larger than 2 cm in patients with a solitary kidney: a matched-pair analysis |
Q34728027 | The complexities of female sexual arousal disorder: potential role of pharmacotherapy |
Q98566436 | The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery |
Q73330282 | The concept of functioning free skeletal muscle transfer in combination with tissue engineering for bladder substitution |
Q38202060 | The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation |
Q51095330 | The contemporary role on surgery in the management of renal masses. |
Q40322115 | The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS). |
Q38405520 | The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients |
Q45813481 | The correlations of incontinence-related quality of life measures with symptom severity and pathophysiology in women with primary stress urinary incontinence |
Q34996363 | The crossroads of evidence-based medicine and health policy: implications for urology |
Q58116506 | The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder |
Q37878398 | The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology. |
Q37189396 | The decision-related psychosocial concerns of men with localised prostate cancer: targets for intervention and research |
Q39414619 | The detection of prostatic carcinoma. 4- or 7-MHz transrectal ultrasonography? |
Q30988469 | The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy |
Q33827774 | The development of bacterial biofilms on indwelling urethral catheters |
Q58554877 | The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside |
Q30741501 | The development of urological endoscopy in America |
Q38723570 | The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis |
Q45948651 | The difference in oxidative stress of the blood between using 5% glucose water and distilled water as the irrigant for BPH patients undergoing transurethral resection of the prostate. |
Q91104083 | The discrepancy between European Association of Urology (EAU) guidelines and daily practice in the evaluation and management of nocturia: results of a Dutch survey |
Q74321122 | The economic impact of introducing transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia: a scenario analysis |
Q48708483 | The economics of stone disease |
Q44044029 | The effect of N-acetyl-L-cysteine on the viscosity of ileal neobladder mucus |
Q42363768 | The effect of a cyclic uniaxial strain on urinary bladder cells |
Q57147888 | The effect of abdominal and pelvic floor muscle activation patterns on urethral pressure |
Q40831091 | The effect of age on male reproductive function |
Q57063454 | The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer |
Q90857750 | The effect of appropriate bladder management on urinary tract infection rate in patients with a new spinal cord injury: a prospective observational study |
Q97646938 | The effect of botulinum toxin on ureteral inflammation |
Q99576219 | The effect of cannabis on prostate-specific antigen level among men in the United States: results from the National Health and Nutrition Examination Survey |
Q48111710 | The effect of corticosteroid on postoperative early pain, renal colic and total analgesic consumption after uncomplicated and unstented ureteroscopy: a matched-pair analysis |
Q40256153 | The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders |
Q93336914 | The effect of diet on BPH, LUTS and ED |
Q92565918 | The effect of focus size and intensity on stone fragmentation in SWL on a piezoelectric lithotripter |
Q90356225 | The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study |
Q50479490 | The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder. |
Q80559755 | The effect of labor and/or ovariectomy on rodent continence mechanism--the neuronal changes |
Q91002146 | The effect of mirabegron on bladder blood flow in a rat model of bladder outlet obstruction |
Q43685398 | The effect of nitric oxide and peroxynitrite on rabbit cavernosal smooth muscle relaxation |
Q48328931 | The effect of onabotulinumtoxinA according to site of injection in patients with overactive bladder: a systematic review and meta-analysis. |
Q71678664 | The effect of orgasm on prostate-specific antigen |
Q98165512 | The effect of partial nephrectomy on blood pressure in patients with solitary kidney |
Q90394277 | The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence |
Q90857738 | The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence |
Q36688936 | The effect of popcorn and carbonization on neodymium: YAG laser dosimetry in the canine model |
Q91933310 | The effect of prostatic tissue density on the perioperative outcomes of Holmium laser enucleation of prostate (HoLEP): a pilot study |
Q57296509 | The effect of short-term preoperative ureteral stenting on the outcomes of retrograde intrarenal surgery for renal stones |
Q40905653 | The effect of stones on renal and ureteric physiology |
Q89749171 | The effect of tetrahydrocannabinol on testosterone among men in the United States: results from the National Health and Nutrition Examination Survey |
Q43169552 | The effect of tolterodine 4 and 8 mg on the heart rate variability in healthy subjects |
Q48094332 | The effect of urethral transection on erectile function after anterior urethroplasty |
Q41243409 | The effect of urologist experience on choosing active surveillance for prostate cancer |
Q49908676 | The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis |
Q51287907 | The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis. |
Q49827554 | The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer. |
Q49117373 | The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome |
Q34419321 | The effects of testosterone on the cavernous tissue and erectile function |
Q84571692 | The effects of warm ischaemia time on renal function after laparoscopic partial nephrectomy in patients with normal contralateral kidney |
Q91769236 | The efficacy of medical dissolution therapy for uric acid nephrolithiasis |
Q39283213 | The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound biopsy of prostate: a prospective randomised control study. |
Q43920067 | The electrified catheter. Role in sterilizing urine and decreasing bacteriuria |
Q35866969 | The en-bloc no-touch holmium laser enucleation of the prostate (HoLEP) technique |
Q53871053 | The endoscopic extraperitoneal radical prostatectomy (EERPE): technique and initial experience. |
Q34727988 | The epidemiology and definition of female sexual disorders |
Q89604051 | The era of the digital natives is approaching: Insights into online peer-to-peer support for persons affected by prostate cancer |
Q70485129 | The evaluation and follow-up of patients with Ta, Tcis, and T1 bladder cancer |
Q30447332 | The evaluation and treatment of acute epididymitis in a large university based population: are CDC guidelines being followed? |
Q91902630 | The evaluation of early predictive factors for urosepsis in patients with negative preoperative urine culture following mini-percutaneous nephrolithotomy |
Q91769229 | The evolution and resurgence of perineal prostatectomy in the robotic surgical era |
Q30815538 | The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia |
Q37442671 | The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates |
Q34996369 | The example of CaPSURE: lessons learned from a national disease registry |
Q91430495 | The eye of the endourologist: what are the risks? A review of the literature |
Q39891267 | The f/t-PSA ratio in diagnosis of in-patients and out-patients: a unitary cutoff value is not useful! |
Q45923766 | The face of high risk prostate cancer. |
Q37668079 | The fate of conference abstracts: systematic review and meta-analysis of surgical treatments for men with benign prostatic enlargement |
Q91560724 | The fate of urological systematic reviews registered in PROSPERO |
Q41818860 | The fish-hook configuration of the distal ureter indicates bladder outlet obstruction due to benign prostatic hyperplasia |
Q42711315 | The function of P2X3 receptor and NK1 receptor antagonists on cyclophosphamide-induced cystitis in rats |
Q33287682 | The future of lasers in urology |
Q91063201 | The global burden of urinary bladder cancer: an update |
Q95499582 | The gordian knots |
Q30926499 | The historical development of endophotography |
Q53515994 | The history of endocrine therapy of benign and malignant diseases of the prostate. |
Q47216951 | The history of robotics in urology. |
Q50856168 | The hydrodynamic basis of the vacuum cleaner effect in continuous-flow PCNL instruments: an empiric approach and mathematical model. |
Q46720614 | The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy |
Q51361271 | The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. |
Q45105324 | The ileal neobladder--updated experience with 306 patients |
Q92104571 | The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis |
Q95648712 | The impact of COVID-19 pandemic on urological emergencies: a single-center experience |
Q46691749 | The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia. |
Q91537272 | The impact of age at orchiopexy on testicular cancer outcomes |
Q97088018 | The impact of atrial fibrillation on outcomes in patients undergoing radical prostatectomy |
Q97636940 | The impact of atrial fibrillation on outcomes in patients undergoing radical prostatectomy |
Q44145786 | The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study |
Q35102229 | The impact of chronic prostatitis/chronic pelvic pain syndrome on patients |
Q92618802 | The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy |
Q40867556 | The impact of days off between cases on perioperative outcomes for robotic-assisted laparoscopic prostatectomy |
Q92933635 | The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy |
Q74744402 | The impact of extracorporal circulation on therapy-related mortality and long-term survival of patients with renal cell cancer and intracaval neoplastic extension |
Q97646933 | The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre |
Q40034275 | The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma. |
Q101123014 | The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery |
Q48100012 | The impact of klotho gene polymorphisms on urinary tract stone disease. |
Q44091125 | The impact of location and number of cores on the diagnostic accuracy of renal mass biopsy: an ex vivo study |
Q100563743 | The impact of low pressure pneumoperitoneum in robotic assisted radical prostatectomy: a prospective, randomized, double blinded trial |
Q57565099 | The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy |
Q90548170 | The impact of nephrostomy drainage prior to mini-percutaneous nephrolithotomy in patients with ESBL-positive Escherichia coli |
Q36834176 | The impact of obesity on prostate cancer |
Q40052942 | The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy |
Q34364440 | The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgery |
Q96688425 | The impact of phone counseling on urinary stone prevention |
Q46426113 | The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer |
Q96232924 | The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature |
Q77617289 | The impact of sacral root anatomy on selective electrical stimulation for bladder evacuation |
Q53237808 | The impact of signet-ring cell carcinoma histology on bladder cancer outcome. |
Q37525794 | The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. |
Q39014520 | The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy |
Q91658928 | The impact of surgical sequence on outcome rates of artificial urinary sphincter implantation: comparative effectiveness of primary, secondary and repeat implantation |
Q53574858 | The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. |
Q127175342 | The impact of the COVID-19 pandemic on renal cancer care |
Q96824378 | The impact of the laser fiber-tissue distance on histological parameters in a porcine kidney model |
Q41733910 | The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma |
Q88184415 | The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomy |
Q53705968 | The impact of time to metastasis on overall survival in patients with prostate cancer. |
Q94476909 | The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration |
Q44583136 | The impact of type 2 diabetes on the outcome of localized renal cell carcinoma |
Q33719024 | The impact of urinary incontinence on the quality of life of women |
Q38760806 | The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy |
Q81029090 | The importance of histology and cytogenetics in decision making for renal cell carcinoma |
Q57806102 | The importance of targeting intracrinology in prostate cancer management |
Q91501128 | The increase of stage, grading, and metastases in patients undergoing radical prostatectomy during the last decade |
Q57937137 | The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma |
Q38084204 | The ineligible patient: how to treat patients not included in clinical studies |
Q51370992 | The influence of age on bioavailable and free testosterone is independent of body mass index and glucose levels. |
Q90434769 | The influence of dietary supplementation with cranberry tablets on the urinary risk factors for nephrolithiasis |
Q74142786 | The influence of obstructive interval on patency rates following microsurgical epididymovasostomy |
Q35878710 | The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis |
Q47836919 | The inhibitory effect of sacral dorsal root ganglion stimulation on nociceptive and nonnociceptive bladder reflexes in cats |
Q40958235 | The insulin-like growth factor system in the prostate. |
Q71703580 | The laser in the management of benign prostatic hyperplasia |
Q51910315 | The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert. |
Q36643610 | The male biological clock |
Q34317257 | The male chronic pelvic pain syndrome |
Q81221667 | The management of high-risk prostate cancer in 2008 |
Q38436634 | The management of the access tract after percutaneous nephrolithotomy |
Q86854932 | The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancer |
Q38030439 | The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma. |
Q50704259 | The minimally invasive management of ureteropelvic junction obstruction in horseshoe kidneys. |
Q42702516 | The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate |
Q46797991 | The modified rectal bladder in children: long-term follow-up |
Q91255292 | The molecular limitations of biomarker research in bladder cancer |
Q40775537 | The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology |
Q34709612 | The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum |
Q41435839 | The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence |
Q97532914 | The natural course of urinalysis after urinary diversion |
Q52894655 | The need for further reproductive medical advice after vasectomy reversal. |
Q77877190 | The need for microdissectional tumor cell preparation during the molecular genetic analysis of prostate cancer |
Q34728004 | The neurophysiology of female sexual function |
Q77617277 | The neurophysiology of urinary retention in young women and its treatment by neuromodulation |
Q92807338 | The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literature |
Q40656911 | The new concept of ureteral access sheath with guidewire disengagement: One wire does it all. |
Q39093294 | The new grasper-integrated single use flexible cystoscope for double J stent removal: evaluation of image quality, flow and flexibility |
Q37209592 | The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms |
Q44447358 | The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study |
Q46123240 | The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience |
Q45034569 | The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database |
Q38226522 | The oncologic role of local treatment in primary metastatic prostate cancer |
Q92958901 | The outcomes of Kulkarni's one-stage oral mucosa graft urethroplasty in patients with panurethral stricture: a single centre experience |
Q41645531 | The pathophysiology of stress urinary incontinence in women and its implications for surgical treatment |
Q40695463 | The pelvic pain centre |
Q34520096 | The portrait of James Israel by the German impressionist Max Liebermann: a selected pictorial view on the early twentieth century development of surgical urology in Berlin |
Q60357984 | The potential value of 5-alpha-reductase inhibition in the treatment of bladder outflow obstruction due to benign prostatic hyperplasia |
Q37067964 | The predictive value of immunohistochemical markers in untreated Wilms' tumour: are they useful? |
Q118146063 | The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy |
Q34945758 | The present and future burden of urinary bladder cancer in the world |
Q57211675 | The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study |
Q41685417 | The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer |
Q91571268 | The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy |
Q40396731 | The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy |
Q53327091 | The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer. |
Q90235552 | The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis |
Q38451690 | The prognostic value of p53 and DNA ploidy following radical prostatectomy |
Q97531898 | The prognostic value of serum procalcitonin in acute obstructive pyelonephritis |
Q97907348 | The prospect of machine learning in predicting post-lithotripsy outcomes |
Q31943483 | The prostate anesthetic block for outpatient prostate surgery |
Q40995864 | The prosthetic bladder |
Q84006189 | The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats |
Q44905283 | The protective effects of grape seed extract on MDA, AOPP, apoptosis and eNOS expression in testicular torsion: an experimental study |
Q44128284 | The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion |
Q38882558 | The rationale and the role of lymph node dissection in renal cell carcinoma. |
Q80382927 | The rationale for radical cystectomy as primary therapy for T4 bladder cancer |
Q40905625 | The recurrence rate of stones following ESWL. |
Q88197345 | The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer |
Q91094392 | The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer |
Q92828763 | The relationship between glucose homeostasis status and prostate size in aging Chinese males with benign prostatic hyperplasia |
Q46448437 | The relationship between solar UV exposure, serum vitamin D levels and serum prostate-specific antigen levels, in men from New South Wales, Australia: the CHAMP study |
Q28300671 | The renal paracrine peptide system--possible urologic implications of urodilatin |
Q101567666 | The reporting quality of randomized controlled trials and experimental animal studies for urethroplasty |
Q91119691 | The reporting quality of studies of diagnostic accuracy in the urologic literature |
Q85067163 | The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study |
Q43484990 | The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection |
Q92641657 | The risk factors of urinary tract infection after transurethral resection of bladder tumors |
Q80973570 | The risk of associated urological abnormalities in children with pre and postnatal occasional diagnosis of solitary, small or ectopic kidney: is a complete urological screening always necessary? |
Q80461836 | The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies |
Q91784746 | The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer |
Q63966206 | The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer |
Q49833204 | The role of PSMA PET scans in salvage therapy planning |
Q44736274 | The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management |
Q35043213 | The role of acupuncture in the treatment of urologic conditions |
Q34262356 | The role of adjuvant chemotherapy for locally advanced bladder cancer |
Q84523428 | The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas |
Q36364510 | The role of biofilm infection in urology |
Q91460035 | The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer |
Q38211603 | The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used? |
Q36017885 | The role of bisphosphonates in hormone-refractory prostate cancer |
Q38546973 | The role of bladder neck suspension in the era of mid-urethral sling surgery |
Q41111887 | The role of cell adhesion molecules and proteases in tumor invasion and metastasis |
Q34798516 | The role of chemotherapy and radiation in organ-preservation strategies for muscle-invasive bladder cancer |
Q80573096 | The role of complete surgical resection in stage IV neuroblastoma |
Q35143753 | The role of cytokines in prostatitis |
Q37851041 | The role of ethical publishing in promoting the evidence-based practice of urology |
Q90251760 | The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy |
Q38099238 | The role of functional imaging in the era of targeted therapy of renal cell carcinoma |
Q28072710 | The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK |
Q35701225 | The role of high-dose chemotherapy in relapsed germ cell tumors. |
Q35854176 | The role of imaging in urinary tract infections |
Q35934320 | The role of imaging techniques in renal transplantation |
Q92608768 | The role of international partnerships in improving urethral reconstruction in low- and middle-income countries |
Q37633444 | The role of invasive and non-invasive urodynamics in male voiding lower urinary tract symptoms |
Q37330114 | The role of lymph node density in bladder cancer prognostication. |
Q37120265 | The role of lymphadenectomy in high risk prostate cancer |
Q38203841 | The role of lymphadenectomy in the management of renal cell carcinoma |
Q34728040 | The role of mechanical devices in treating female sexual dysfunction and enhancing the female sexual response |
Q92318183 | The role of metastatic burden in cytoreductive/consolidative radical cystectomy |
Q88886432 | The role of mpMRI and PSA density in patients with an initial negative prostatic biopsy |
Q41169092 | The role of mycophenolate mofetil in clinical renal transplantation |
Q36364514 | The role of nanobacteria in urologic disease |
Q41465650 | The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder |
Q128661950 | The role of oral antioxidants in the improvement of sperm parameters in infertile men |
Q40955297 | The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors |
Q37259262 | The role of pathologic prognostic factors in squamous cell carcinoma of the penis |
Q34129602 | The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia |
Q35692732 | The role of positron emission tomography in germ cell cancer |
Q92915506 | The role of prostatic apex shape in voiding symptoms and urine flow: an exploratory and confirmatory study |
Q37737120 | The role of radiologic imaging and biopsy in renal tumor ablation |
Q37834362 | The role of randomized controlled trials in evidence-based urology |
Q36383267 | The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis |
Q38094592 | The role of surgery for metastatic renal cell carcinoma in the era of targeted therapies |
Q44481193 | The role of the carbachol test and concomitant diseases in patients with nonobstructive urinary retention undergoing sacral neuromodulation |
Q41205948 | The role of the cell cycle in genitourinary carcinoma |
Q41583020 | The role of the papilla in idiopathic calcium oxalate nephrolithiasis |
Q38156070 | The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer |
Q90821247 | The role of vacuum-assisted closure (VAC) therapy in the management of FOURNIER'S gangrene: a retrospective multi-institutional cohort study |
Q91860560 | The safety of lasers for BPH surgery in men taking clopidogrel: one cannot judge a book by its cover |
Q92717395 | The safety of urologic robotic surgery depends on the skills of the surgeon |
Q40905649 | The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription |
Q91572530 | The search of new biomarkers in the prediction of BCG response in patients with high-risk NMIBC |
Q35131287 | The selenium and vitamin E cancer prevention trial |
Q93361420 | The side and the location of the primary tumor does not affect the probability of lymph node invasion in patients with renal cell carcinoma |
Q71324632 | The sigma rectum pouch (Mainz pouch II) |
Q71341481 | The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder |
Q96688423 | The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates |
Q97070381 | The sky is clear: robotic surgery is now a valuable player in pediatric urology practice |
Q74782519 | The staged approach to bladder exstrophy closure and the role of osteotomies |
Q38641835 | The state and potential of social media in bladder cancer |
Q47197853 | The stone surgeon in the mirror: how are German-speaking urologists treating large renal stones today? |
Q40763585 | The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery |
Q34504323 | The surgeon and his intention: Gustav Simon (1824-1876), his first planned nephrectomy and further contributions to urology |
Q42601575 | The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy |
Q38099237 | The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence? |
Q48218597 | The suspension sutures during minimally invasive radical prostatectomy. |
Q35904498 | The technique of ultrasound guided prostate biopsy |
Q88085998 | The transgluteal approach to shockwave lithotripsy to treat distal ureter stones: a prospective, randomized, and multicenter study |
Q77422140 | The transverse ileal tube as second-line modification of the Mitrofanoff principle |
Q33827779 | The urinary tract response to entry of pathogens |
Q90933054 | The urological management of children with spinal cord injury |
Q45005938 | The use of a ureteral access sheath does not improve stone-free rate after ureteroscopy for upper urinary tract stones |
Q73885700 | The use of bone anchoring in the surgical management of female stress urinary incontinence |
Q93259967 | The use of buccal mucosa graft for correction of severe chordee and urethroplasty in proximal hypospadias repair |
Q41143759 | The use of hemostatic agents does not prevent hemorrhagic complications of robotic partial nephrectomy |
Q91711956 | The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial |
Q87182734 | The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries |
Q64859974 | The use of indocyanine green during robotic ureteroenteric reimplantation for the management of benign anastomotic strictures |
Q46855870 | The use of mannitol in partial and live donor nephrectomy: an international survey. |
Q91699619 | The use of mirabegron in neurogenic bladder: a systematic review |
Q40625785 | The use of molecular genetic analysis in the diagnosis of renal cell carcinoma |
Q40995852 | The use of neobladders in women undergoing cystectomy for transitional-cell cancer |
Q46090251 | The use of orthotopic neobladders in women undergoing cystectomy for pelvic malignancy |
Q42650622 | The use of partial nephrectomy: results from a contemporary national prospective multicenter study |
Q41169090 | The use of tacrolimus in renal transplantation |
Q41465640 | The use of the BTA Test in the detection of persistent or recurrent transitional-cell cancer of the bladder |
Q34727999 | The use of validated questionnaires to assess female sexual dysfunction. |
Q39624158 | The uses and outcomes of the Martius fat pad in female urology. |
Q57109624 | The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis |
Q93143807 | The utility of vaginal erbium: YAG laser in the treatment of overactive bladder syndrome is in need of confirmation |
Q87038943 | The vacuum cleaner effect in minimally invasive percutaneous nephrolitholapaxy |
Q51816765 | The value of an artificial neural network in the decision-making for prostate biopsies. |
Q40703732 | The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours |
Q45074093 | The value of newborn urinary proteome analysis in the evaluation and management of ureteropelvic junction obstruction: a cost-effectiveness study |
Q89220071 | The value of periprostatic fascia thickness and fascia preservation as prognostic factors of erectile function after nerve-sparing robot-assisted radical prostatectomy |
Q41702310 | The value of the preoperative 1-h pad test with pessary insertion for predicting the need for a mid-urethral sling following pelvic prolapse surgery: a cohort study |
Q36199116 | The value of urodynamic tools to guide patient selection in sacral neuromodulation |
Q85524481 | The varied presentations of dhat syndrome |
Q51045523 | The zero ischemia index (ZII): a novel criterion for predicting complexity and outcomes of off-clamp partial nephrectomy. |
Q36749367 | Therapy of recurrent disease after radical prostatectomy in 2007. |
Q88462740 | Thermal effects of Ho: YAG laser lithotripsy: real-time evaluation in an in vitro model |
Q92099305 | Thermal effects of Ho:YAG laser lithotripsy during retrograde intrarenal surgery and percutaneous nephrolithotomy in an ex vivo porcine kidney model |
Q38202887 | Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death |
Q47710578 | Three dimensional models in uro-oncology: a future built with additive fabrication. |
Q35953288 | Three dimensional ultrasound and prostate cancer |
Q47557898 | Three- and twelve-month follow-up outcomes of TVT-EXACT and TVT-ABBREVO for treatment of female stress urinary incontinence: a randomized clinical trial |
Q86492819 | Three-Tesla dynamic contrast-enhanced MRI: a critical assessment of its use for differentiation of renal lesion subtypes |
Q80581059 | Three-dimensional transrectal ultrasound of the male urethral rhabdosphincter |
Q46753328 | Three-dimensional ultrasound (3D US) methods in the evaluation of calcular and non-calcular ureteric obstructive uropathy |
Q81415802 | Three-dimensional ultrasound reconstruction of the pelvicaliceal system: an in-vitro study |
Q120633371 | Three-dimensional virtual models assistance predicts higher rates of “successful” minimally invasive partial nephrectomy: an Institutional analysis across the available trifecta definitions |
Q83971965 | Three-tesla MRI biphasic angiography: a method for preoperative assessment of the vascular supply in renal tumours: a surgical perspective |
Q50126297 | Thromboprophylaxis and the route of administration of chemotherapy in testicular cancer patients in German-speaking countries. |
Q129659523 | Thulium fiber laser vs. holmium laser enucleation of the prostate: results of a prospective randomized non-inferiority trial |
Q94504066 | Thulium fiber laser: ready to dust all urinary stone composition types? |
Q91390832 | Thulium fiber laser: the new player for kidney stone treatment? A comparison with Holmium:YAG laser |
Q88348171 | Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis |
Q33523073 | Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction |
Q91336500 | Thulium laser enucleation versus thulium laser resection of the prostate for prevention of bladder neck contracture in a small prostate: a prospective randomized trial |
Q53308415 | Thulium laser for the treatment of upper urinary tract carcinoma (UTUC)? Are we there, yet? |
Q35050129 | Thulium laser resection versus plasmakinetic resection of prostates larger than 80 ml. |
Q35314832 | Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis |
Q88581225 | Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial |
Q89931037 | Thulium-fiber laser for lithotripsy: first clinical experience in percutaneous nephrolithotomy |
Q48190749 | Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life. |
Q33537216 | Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? |
Q33492438 | Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up |
Q41503446 | Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma |
Q88086002 | Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter? |
Q86910780 | Time to say good bye to shockwave lithotripsy? |
Q73157900 | Time-dependent up-regulation of neuronal 5-hydroxytryptamine binding sites in the detrusor of a rabbit model of partial bladder outlet obstruction |
Q98293978 | Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic |
Q92104313 | Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review |
Q48222308 | Timing of blood transfusion and oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma. |
Q85662734 | Tips and Tricks in Intra-Detrusor Botulinum Toxin A (BoNTA) Injections |
Q89679553 | Tips and tricks for robotic urology using ICG |
Q96581312 | Tips and tricks in achieving zero peri-operative opioid used in onco-urologic surgery |
Q46553805 | Tissue engineered testicular prostheses with prolonged testosterone release |
Q34114719 | Tissue engineering for bladder substitution |
Q47677989 | Tissue engineering from Adam to the zygote: historical reflections |
Q81741442 | Tissue engineering in urology |
Q44661759 | Tissue engineering of the bladder |
Q92692207 | Tissue engineering of the urethra: where are we in 2019? |
Q36560290 | Tissue microarrays: applications in urological cancer research. |
Q73678766 | Tissue-engineered therapies for the treatment of urinary incontinence and vesicoureteral reflux |
Q40769763 | Tissue-engineering applications for phallic reconstruction |
Q33892829 | Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience |
Q51593817 | To clamp or not to clamp? Bladder management by suprapubic catheterization in patients with neurogenic bladder dysfunction. |
Q38105006 | To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma |
Q34473206 | Tolterodine: an overview |
Q90439998 | Tolvaptan treatment of cystine urolithiasis in a mouse model of cystinuria |
Q35131277 | Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancer |
Q43114449 | Topic issue on new treatments in bladder cancer |
Q91903789 | Topic issue: men's health in 2019 |
Q55047180 | Topical steroid application versus circumcision in pediatric patients with phimosis: a prospective randomized placebo controlled clinical trial. |
Q31061498 | Touchless gesture user interface for interactive image visualization in urological surgery |
Q36653227 | Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer |
Q90843376 | Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers |
Q91944658 | Tract dilation monitored by ultrasound in percutaneous nephrolithotomy: feasible and safe |
Q90785247 | Training in robotic surgery, replicating the airline industry. How far have we come? |
Q44774280 | Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies |
Q44522278 | Transcriptionally regulated adenoviruses for prostate-specific gene therapy |
Q45167261 | Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome? |
Q52597323 | Transcutaneous tibial nerve stimulation: 2 years follow-up outcomes in the management of anticholinergic refractory overactive bladder. |
Q46694169 | Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials |
Q35556846 | Transdermal testosterone delivery: testosterone patch and gel |
Q41442972 | Transforming growth factor-beta and prostate cancer. |
Q73262569 | Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities |
Q74782503 | Transperineal bulbo-prostatic anastomotic urethroplasty |
Q91073436 | Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results |
Q54685231 | Transperineal reanastomosis for the treatment for highly recurrent anastomotic strictures as a last option before urinary diversion. |
Q48182283 | Transperineal reanastomosis for treatment of highly recurrent anastomotic strictures after radical retropubic prostatectomy: extended follow-up |
Q45986944 | Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies. |
Q85158233 | Transperitoneal in situ intraarterial cooling in laparoscopic partial nephrectomy |
Q83971944 | Transperitoneal laparoscopic nephroureterectomy for native upper tract urothelial carcinoma in renal transplant recipients |
Q74255084 | Transperitoneal unstented ureteral reimplantation for injuries postgynecological surgery |
Q38210946 | Transperitoneal versus retroperitoneal robotic partial nephrectomy: matched-pair comparisons by nephrometry scores |
Q92669387 | Transperitoneal vs. retroperitoneal robotic partial nephrectomy: a matched-paired analysis |
Q36861529 | Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer |
Q81322517 | Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions |
Q38805795 | Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem |
Q33489676 | Transurethral 2-microm laser in the treatment of urethral stricture |
Q35577831 | Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement |
Q89471073 | Transurethral endoscopic enucleation of the prostate (EEP) |
Q38677800 | Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials |
Q74497061 | Transurethral fistulography--a useful technique in investigating recurrent undiagnosed pneumaturia |
Q90857742 | Transurethral incision as initial option in treatment guidelines for ectopic ureteroceles associated with duplex systems |
Q45370003 | Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates |
Q36679084 | Transurethral laser ablation of the prostate--long-term results. |
Q99595655 | Transurethral laser ablation of the prostate: from "which technique does better" to "what patient benefits the most" the real challenge in contemporary surgery |
Q53871695 | Transurethral microwave thermotherapy for benign prostatic hyperplasia--experience with the Prostcare. |
Q36496826 | Transurethral microwave thermotherapy for the treatment of BPH: still a challenger? |
Q39405955 | Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: results obtained with the Prostalund device |
Q74321135 | Transurethral microwave thermotherapy in BPH |
Q74321140 | Transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia: results obtained with the Urologix T3 device |
Q40398368 | Transurethral microwave thermotherapy: past, present and future |
Q91699613 | Transurethral prostate surgery as a preventive method against progression of chronic kidney disease in patients with urodynamically proven bladder outlet obstruction |
Q52677845 | Transurethral resection of bladder cancer on the lateral bladder wall without obturator nerve block: extent of adductor spasms using the monopolar versus bipolar technique-a prospective randomised study. |
Q90111420 | Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis |
Q34694714 | Transurethral thermotherapy using the Prostatron device |
Q50934464 | Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. |
Q92367129 | Transurethral ventral buccal mucosa graft inlay for treatment of distal urethral strictures: international multi-institutional experience |
Q35764032 | Transurethral versus suprapubic catheter at robot-assisted radical prostatectomy: a prospective randomized trial with 1-year follow-up |
Q86198626 | Transutricular seminal vesiculoscopy in the management of symptomatic midline cyst of the prostate |
Q38718620 | Transvaginal specimen removal in minimally invasive surgery |
Q48290946 | Transvaginal specimen removal in minimally invasive surgery: feasibility and possible complications during the incision of the posterior vaginal wall |
Q48735613 | Transverse preputial onlay island flap urethroplasty for single-stage correction of proximal hypospadias |
Q92612318 | Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database |
Q64889420 | Treating benign ureteroenteric strictures: 27-year experience comparing endourological techniques with open surgical approach. |
Q36307487 | Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors |
Q46672274 | Treatment and outcome in muscle invasive bladder cancer: a population-based survey. |
Q96349117 | Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer |
Q43886570 | Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series |
Q40568433 | Treatment intensification in disseminated germ-cell tumors. |
Q39368092 | Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation |
Q36080487 | Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery? |
Q43744681 | Treatment of large impacted proximal ureteral stones: randomized comparison of minimally invasive percutaneous antegrade ureterolithotripsy versus retrograde ureterolithotripsy |
Q79889486 | Treatment of localized prostate cancer |
Q34262351 | Treatment of metastatic urothelial cancer in the post-MVAC era. |
Q51536712 | Treatment of moderate to severe female stress urinary incontinence with the adjustable continence therapy (ACT) device after failed surgical repair |
Q38615547 | Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit |
Q90915187 | Treatment of non-obstructive, non-struvite urolithiasis is effective in treatment of recurrent urinary tract infections |
Q43618036 | Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine |
Q33337444 | Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy |
Q82257687 | Treatment of pediatric urolithiasis: how small is "small enough"? |
Q47825116 | Treatment of penile curvature--how to combine the advantages of simple plication and the Nesbit-procedure by superficial excision of the tunica albuginea. |
Q103827130 | Treatment of post-prostatectomy urinary incontinence and erectile dysfunction: there is insufficient utilisation of care in German cancer survivors |
Q44619949 | Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate |
Q36626779 | Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido). |
Q93232138 | Treatment of the primary tumor in metastatic prostate cancer |
Q33827790 | Treatment of urinary tract infection: what's old, what's new, and what works |
Q90716024 | Treatment of urinary tract infections in the old and fragile |
Q36615027 | Treatment options for BCG failures. |
Q49073287 | Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany. |
Q47832806 | Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology. |
Q40290598 | Treatment selection for urolithiasis: percutaneous nephrolithomy, ureteroscopy, shock wave lithotripsy, and active monitoring |
Q41536056 | Treatment update on pediatric urolithiasis |
Q91862798 | Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines |
Q43073887 | Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is associated with drug-induced hyperparathyroidism: a single center experience in 59 patients |
Q91469070 | Treatments of 1242 bulbar urethral strictures: multivariable statistical analysis of results |
Q36553487 | Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States |
Q91711984 | Trends in penile prosthesis implantation and analysis of predictive factors for removal |
Q93201646 | Trends in risk-group distribution and Pentafecta outcomes in patients treated with nerve-sparing, robot-assisted radical prostatectomy: a 10-year low-intermediate volume single-center experience |
Q99251470 | Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort study |
Q47211582 | Trends in urinary diversion after radical cystectomy for urothelial carcinoma. |
Q93020863 | Trends in utilization and perioperative outcomes in live donor nephrectomies: a multi-surgical discipline analysis |
Q36395547 | Trends of 'urolithiasis: interventions, simulation, and laser technology' over the last 16 years (2000-2015) as published in the literature (PubMed): a systematic review from European section of Uro-technology (ESUT). |
Q38936506 | Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy |
Q90418610 | Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center |
Q43835601 | Triple therapy in refractory detrusor overactivity: a preliminary study |
Q34473227 | Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia |
Q53405748 | True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts. |
Q34804695 | Tubularized urethral replacement with unseeded matrices: what is the maximum distance for normal tissue regeneration? |
Q82606442 | Tubulocystic renal carcinoma: a clinical perspective |
Q40607327 | Tulane experience with management of urinary incontinence after placement of an artificial urinary sphincter |
Q41111904 | Tumor angiogenesis: the pivotal role of vascular endothelial growth factor |
Q92774242 | Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age |
Q49588433 | Tumor complexity and the impact on MIC and trifecta in robot-assisted partial nephrectomy: a multi-center study of over 500 cases |
Q39900744 | Tumor diameter accurately predicts perioperative outcomes in T1 renal cancer treated with robot-assisted partial nephrectomy |
Q37107926 | Tumor vaccines in renal cell carcinoma. |
Q51743377 | Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods. |
Q51721144 | Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins. |
Q33866932 | Tumor-associated macrophages in clear cell renal cell carcinoma express both gastrin-releasing peptide and its receptor: a possible modulatory role of immune effectors cells. |
Q92259177 | Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study |
Q35865819 | Tumour formation within intestinal segments transposed to the urinary tract |
Q47973584 | Turkish version of the Ureteral Stent Symptoms Questionnaire: linguistic and psychometric validation. |
Q48128054 | Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG). |
Q43200928 | Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study |
Q92649039 | Two-stage repair of proximal hypospadias with moderate to severe chordee using inner preputial skin graft: prospective evaluation of functional and cosmetic outcomes |
Q37222380 | Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer |
Q90322114 | Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy |
Q80382926 | Type of renal calculi: variation with age and sex |
Q44490828 | Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis. |
Q85037235 | Tyrosine kinase expression profile in clear cell renal cell carcinoma |
Q92774233 | UTI in kidney transplant |
Q40943113 | Ultra-mini PCNL versus flexible ureteroscopy: a matched analysis of analgesic consumption and treatment-related patient satisfaction in patients with renal stones 10-35 mm. |
Q41539302 | Ultra-mini PCNL versus flexible ureteroscopy: a matched analysis of treatment costs (endoscopes and disposables) in patients with renal stones 10-20 mm. |
Q38103477 | Ultrasonography in prostate cancer: current roles and potential applications in radiorecurrent disease |
Q54762321 | Ultrasound detrusor wall thickness measurement in combination with bladder capacity can safely detect detrusor underactivity in adult men. |
Q41685651 | Ultrasound findings are not useful for defining stage T1c prostate cancer |
Q130040357 | Ultrasound imaging of male urethral stricture disease: a narrative review of the available evidence, focusing on selected prospective studies |
Q36020774 | Ultrasound in patients affected with Peyronie's disease |
Q91656792 | Ultrasound-guided versus fluoroscopy-guided percutaneous nephrolithotomy: a systematic review and meta-analysis |
Q72017483 | Ultrastructural study of an antibody-stabilized bladder surface: a new perspective on the elusive glycosaminoglycan layer |
Q40580691 | Ultrastructure of the urethra of the Mongolian gerbil |
Q38979983 | Uncovering the real outcomes of active renal stone treatment by utilizing non-contrast computer tomography: a systematic review of the current literature. |
Q45972311 | Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). |
Q38664797 | Understanding patients' preferences for surgical management of urethral stricture disease. |
Q36643614 | Understanding the needs and objectives of erectile dysfunction patients |
Q101240132 | Understanding urologic scientific publication patterns and general public interests on stone disease: lessons learned from big data platforms |
Q45790154 | Unfavorable outcomes of laparoscopic pyeloplasty using barbed sutures: a multi-center experience |
Q35143748 | Unilateral transurethral incision for primary bladder neck obstruction: symptom relief and fertility preservation. |
Q90019554 | Unintended consequences of decreased PSA-based prostate cancer screening |
Q72405703 | Unusual neoplasms detected in testicular cancer patients undergoing postchemotherapy retroperitoneal lymphadenectomy |
Q48617912 | Update from third international consultation on stone disease |
Q91606353 | Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversion |
Q38661108 | Update of the ICUD-SIU consultation on stone technology behind ureteroscopy |
Q39865101 | Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease |
Q38846250 | Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma |
Q90703106 | Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder |
Q41465678 | Update of urethra-sparing approaches in cystectomy in women |
Q35393178 | Update on Greenlight laser vaporization (PVP) 2014. |
Q30399665 | Update on biofilm infections in the urinary tract. |
Q40599234 | Update on bladder smooth-muscle physiology |
Q38676256 | Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients |
Q35237695 | Update on lasers in urology 2014: current assessment on holmium:yttrium-aluminum-garnet (Ho:YAG) laser lithotripter settings and laser fibers. |
Q86939803 | Update on lasers in urology 2015 |
Q37697631 | Update on systemic therapies of metastatic renal cell carcinoma |
Q40995857 | Update on the Camey II procedure |
Q57109634 | Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer |
Q35318182 | Update on the current evidence for Tm:YAG vapoenucleation of the prostate 2014. |
Q104693070 | Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma |
Q35173722 | Update on the use of diode laser in the management of benign prostate obstruction in 2014. |
Q49099254 | Updated results of a randomized, double-blind, multicenter sham-controlled trial of microwave thermotherapy with the Dornier Urowave in patients with symptomatic benign prostatic hyperplasia. Urowave Investigators Group |
Q34950145 | Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer |
Q90393454 | Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what |
Q83940452 | Upper and lower urinary tract evaluation of 104 patients with myelomeningocele without adequate urological management |
Q38876486 | Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. |
Q83424036 | Upper transverse scrotal approach for muscle- and nerve-sparing urethral stricture repair |
Q38027302 | Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols |
Q38046115 | Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes |
Q41738410 | Upper urinary tract trauma--current concepts |
Q38007104 | Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma |
Q81786197 | Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease |
Q40922459 | Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China |
Q91476634 | Ureteral stenting practices following routine ureteroscopy: an international survey |
Q127245048 | Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis |
Q44293404 | Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria |
Q91192538 | Ureteral wall thickness as a significant factor in predicting spontaneous passage of ureteral stones of ≤ 10 mm: a preliminary report |
Q77422147 | Ureterocystoplasty update |
Q95937760 | Ureteroenteric anastomosis in orthotopic neobladder creation: do urinary tract infections impact stricture rate? |
Q50052151 | Ureteroscopic holmium laser-assisted retrograde nephrostomy access: a novel approach to percutaneous stone removal |
Q33540717 | Ureteroscopic laser treatment of upper urinary tract neoplasms |
Q35285361 | Ureteroscopy and laser lithotripsy: technologic advancements |
Q88581228 | Ureteroscopy is more cost effective than shock wave lithotripsy for stone treatment: systematic review and meta-analysis |
Q98571061 | Urethral bulking agents: a retrospective review of primary versus salvage procedure outcomes |
Q45747137 | Urethral compliance in hypospadias operated by tubularized incised urethral plate (TIP) with and without a dorsal inlay graft: an experimental controlled study |
Q74497088 | Urethral pressure profiles in the female canine implanted with sacral anterior nerve root electrodes |
Q90008951 | Urethroplasty performed with an autologous urothelium-vegetated collagen fleece to treat urethral stricture in the minipig model |
Q77422113 | Urge incontinence in the elderly--supraspinal reflex incontinence |
Q61613592 | Urgency as the cardinal symptom of overactive bladder: a critical analysis |
Q41958324 | Urgent percutaneous nephrolithotomy for acute kidney injury secondary to bilateral stones: is it safe and effective in infants? |
Q36509699 | Urinary BTA: indicator of bladder cancer or of hematuria |
Q86182152 | Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma |
Q98772609 | Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study |
Q36874248 | Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases |
Q91330792 | Urinary biomarkers profiles in patients with neurogenic detrusor overactivity according to their neurological condition |
Q28566817 | Urinary bladder mucosal responses to ischemia |
Q46180811 | Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder. |
Q39890839 | Urinary collecting system invasion is no independent prognostic factor in renal cell carcinoma |
Q83943748 | Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer |
Q53666320 | Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia. |
Q73330269 | Urinary diversion in the new millennium |
Q43753687 | Urinary functional outcomes in female neobladder patients |
Q91558563 | Urinary fungi associated with urinary symptom severity among women with interstitial cystitis/bladder pain syndrome (IC/BPS) |
Q41535988 | Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation |
Q40959741 | Urinary kidney injury molecule-1 levels in renal stone patients |
Q37024885 | Urinary markers in screening patients with hematuria. |
Q91658921 | Urinary metabolites identified using metabolomic analysis as potential biomarkers of nocturia in elderly men |
Q89476453 | Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity? |
Q91711977 | Urinary neutrophil gelatinase-associated lipocalin as a biomarker to monitor renal function in patients with obstructive ureteral calculi |
Q46723105 | Urinary nitrite excretion and urinary variables in patients with primary nocturnal frequency of micturition: effects of indomethacin suppositories |
Q114694711 | Urinary pyrophosphate excretion in renal stone formers with normal and impaired renal acidification |
Q44877359 | Urinary tract glycoprotein: distribution and antigenic specificity |
Q37896519 | Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder |
Q33827787 | Urinary tract infection: a moving target |
Q37203769 | Urinary tract infections and post-operative fever in percutaneous nephrolithotomy |
Q49670710 | Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients |
Q36757398 | Urinary tract injuries in patients with multiple trauma. |
Q90614492 | Urinary tuberculosis: still a challenge |
Q37919752 | Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome |
Q44478508 | Urine flow cytometry as a primary screening method to exclude urinary tract infections |
Q35096979 | Urine protein profiling identified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation |
Q92506963 | Urine routine tests: a guideline-neglected, but indispensable investment in stone-removing endourological procedures |
Q41957459 | Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation |
Q41583053 | Urodynamic abnormalities in two brothers with adrenomyeloneuropathy |
Q73157914 | Urodynamic analysis of voiding dysfunction in orthotopic ileal neobladder |
Q47449970 | Urodynamic changes and response rates in patients treated with permanent electrodes compared to conventional wire electrodes in the peripheral nerve evaluation test |
Q51795641 | Urodynamic characterization of lower urinary tract symptoms in men less than 40 years of age. |
Q74255068 | Urodynamic features of the pelvic pain patient and the impact of neurostimulation on these parameters |
Q36679101 | Urodynamics and laser prostatectomy |
Q34694698 | Urodynamics and transurethral microwave thermotherapy |
Q50251155 | Urodynamics in the anatomical work of Leonardo da Vinci (1452-1519). |
Q40540599 | Uroflowmetry in elderly men. |
Q91589547 | Urogenital infections |
Q35878824 | Urolithiasis in enterocystoplasties |
Q46303351 | Urolithiasis in infants: evaluation of risk factors |
Q39119052 | Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. |
Q91376700 | Urologic Management of the Spinal Cord Injured Patient |
Q37930453 | Urologic complications of genitourinary schistosomiasis |
Q36765478 | Urologic imaging for localized prostate cancer in 2007. |
Q91072948 | Urologic provider experiences in transitioning spina bifida patients from pediatric to adult care |
Q33892223 | Urologic tissue engineering with small-intestinal submucosa: potential clinical applications |
Q92958895 | Urologic trauma and reconstruction: where are we today |
Q34996375 | Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines |
Q89931042 | Urological infections in the developing world: an increasing problem in developed countries |
Q45883338 | Urological surgery in patients with hemorrhagic bleeding disorders Hemophilia A, Hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysis |
Q81093516 | Urological views and perspectives |
Q88431877 | Urologists' attitudes to sexual complications of LUTS/BPH treatments |
Q73330292 | Urology in Dubrovnik |
Q51731965 | Urothelial carcinogen resistance driven by stronger Toll-like receptor 2 (TLR2) and Uroplakin III (UP III) defense mechanisms: a new model. |
Q84584168 | Urothelial carcinoma |
Q39065861 | Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy |
Q53264010 | Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasms. |
Q33892228 | Urothelium-lined enteric segments |
Q96772071 | Use of EPIC 26 to identify men likely to benefit from surgical interventions for urinary incontinence after radical prostatectomy |
Q51434049 | Use of XenX™, the latest ureteric occlusion device with guide wire utility: results from a prospective multicentric comparative study. |
Q84569910 | Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer |
Q52592134 | Use of anastomotic urethroplasty with partial pubectomy for posterior urethral obliteration injuries: 10 years experience. |
Q37342222 | Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer |
Q36072084 | Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer |
Q36640991 | Use of nomograms as predictive tools in bladder cancer. |
Q86483412 | Use of the Bulbocavernosus Reflex System in assessing voiding dysfunction |
Q41645550 | Use of the artificial urinary sphincter in men and women |
Q40831075 | Use of ultrasonography in the evaluation of the infertile man. |
Q44383020 | Usefulness of perflubutane microbubble-enhanced ultrasound in imaging and detection of prostate cancer: phase II multicenter clinical trial |
Q87620326 | Usefulness of the diameter-axial-polar nephrometry score for predicting perioperative parameters in robotic partial nephrectomy |
Q42536342 | Uselessness of radiological differentiation of oncocytoma and renal cell carcinoma in management of small renal masses |
Q92190354 | Using objective robotic automated performance metrics and task-evoked pupillary response to distinguish surgeon expertise |
Q92834522 | Using video review to understand the technical variation of robot-assisted radical prostatectomy in a statewide surgical collaborative |
Q37986565 | Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy cores |
Q92618809 | Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection |
Q38255762 | Utility of urodynamics in the management of asymptomatic tethered cord in children |
Q48250837 | Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice |
Q38366122 | Utilization of a novel valveless trocar system during robotic-assisted laparoscopic prostatectomy |
Q33580964 | Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project |
Q42023344 | VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model |
Q94497397 | VEGF inhibition in urothelial cancer: the past, present and future |
Q52654849 | VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen. |
Q85196163 | Vacuum cleaner effect, purging effect, active and passive wash out: a new terminology in hydrodynamic stone retrival is arising--Does it affect our endourologic routine? |
Q96766465 | Vacuum-assisted mini-percutaneous nephrolithotomy: a new perspective in fragments clearance and intrarenal pressure control |
Q90111407 | Validating the European randomised study for screening of prostate cancer (ERSPC) risk calculator in a contemporary South African cohort |
Q89017427 | Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy |
Q85319717 | Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapy |
Q41620841 | Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world |
Q82299425 | Validation of the German prostate-specific module |
Q87916420 | Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRI |
Q92663518 | Validation of the endoscopic stone treatment step 1 (EST-s1): a novel EAU training and assessment tool for basic endoscopic stone treatment skills-a collaborative work by ESU, ESUT and EULIS |
Q39050892 | Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients |
Q51607396 | Validation of the preoperative aspects and dimensions used for an anatomical (PADUA) score in a robot-assisted partial nephrectomy series. |
Q100309060 | Validity and reliability of the Greek version of the neurogenic bladder symptom score (NBSS) questionnaire in a sample of Greek patients with multiple sclerosis |
Q34104689 | Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: a retrospective data analysis |
Q37350647 | Value of frozen section biopsies during radical prostatectomy: significance of the histological results |
Q36849419 | Value of magnetic resonance imaging in prostate cancer diagnosis |
Q89669367 | Value-based care for the treatment and evaluation of benign prostatic hyperplasia: an analysis of a metropolitan service area claims database |
Q43566595 | Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study |
Q123147050 | Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer |
Q82712251 | Varicocele is associated with an increase of connective tissue of the pampiniform plexus vein wall |
Q47710202 | Varicocele--a historical perspective |
Q72405692 | Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava |
Q72405697 | Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part II |
Q45948653 | Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: results of the VITA study. |
Q30408124 | Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure |
Q42646828 | Vasomax for the treatment of male erectile dysfunction |
Q50639422 | Venous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional database. |
Q58550181 | Versatile algorithmic midline approach to perineal urethrostomy for complex urethral strictures |
Q91613794 | Very long-term follow-up of the anterior vaginal wall suspension procedure for incontinence and/or prolapse repair |
Q89986173 | Very low-dose computerized tomography for confirmation of urinary stone presence |
Q90821241 | Vesico-urethral anastomotic stenosis following radical prostatectomy: a multi-institutional outcome analysis with a focus on endoscopic approach, surgical sequence, and the impact of radiation therapy |
Q47549283 | Viability and biocompatibility of an adhesive system for intrarenal embedding and endoscopic removal of small residual fragments in minimally-invasive stone treatment in an in vivo pig model. |
Q50251146 | Victor Ivánchich (1812-1892) and Josef Weiger (1810-1863): early cooperation of a urologist and an anesthesiologist |
Q48238470 | Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment |
Q39748228 | Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study |
Q42709776 | Viral macrophage inflammatory protein-II improves acute rejection in allogeneic rat kidney transplants |
Q99210558 | Visceral Obesity in living kidney Asian donors - long term impact of renal function after donor nephrectomy |
Q93232148 | Visceral obesity in Asian living kidney donors significantly impacts early renal function after donor nephrectomy |
Q87250339 | Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study |
Q57419742 | Visual assessment of uroflowmetry curves: description and interpretation by urodynamists |
Q41549654 | Vitamin D and prostate cancer prognosis: a Mendelian randomization study |
Q83116154 | Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer |
Q39658509 | Vitamins, metabolomics, and prostate cancer |
Q30306613 | Voiding dysfunction in the orthotopic neobladder |
Q92027429 | Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma |
Q87044870 | Volumetric measurement of compensatory hypertrophy in the contralateral normal kidney by the tumor growth |
Q91032995 | WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies |
Q86566593 | WJU special edition: Surgical and medical management of stones |
Q90899767 | Wake-up call for more doctor-patient communication and an increase in public information campaigns on the risk factor of smoking with regard to the development and prognosis of bladder cancer |
Q83390513 | Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection |
Q73565140 | We can really reduce the risk for prostate cancer? |
Q48377313 | Werner Forssmann: surgeon, urologist, and Nobel Prize winner |
Q38587547 | What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer? |
Q42702519 | What do we really know about benign prostatic hyperplasia and lower urinary tract symptoms in adult men? |
Q91916708 | What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? |
Q37196270 | What is low-risk prostate cancer and what is its natural history? |
Q37067987 | What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours? |
Q91747574 | What is the exact definition of stone dust? An in vitro evaluation |
Q37137644 | What is the molecular pathology of low-risk prostate cancer? |
Q36494187 | What patients take without telling you: holistic approach for BPH. |
Q96642179 | What you need to know: updates in penile cancer staging |
Q48316777 | What's New at SIU Academy |
Q84711298 | When is it necessary to perform nuclear renogram in patients with a unilateral neonatal hydronephrosis? |
Q33719015 | When the bladder is gone: quality of life following different types of urinary diversion |
Q84108410 | When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool |
Q40417319 | Whether adrenal mass more than 5 cm can pose problem in laparoscopic adrenalectomy? An evaluation of 22 patients |
Q53137864 | Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases. |
Q91566367 | Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy? |
Q40181236 | Which factors affect the hospital re-admission and re-hospitalization after flexible ureterorenoscopy for kidney stone? |
Q46872190 | Which factors may effect urinary leakage following percutaneous nephrolithotomy? |
Q91637675 | Which flexible ureteroscope is the best for upper tract urothelial carcinoma treatment? |
Q39039402 | Which is better? Guy's versus S.T.O.N.E. nephrolithometry scoring systems in predicting stone-free status post-percutaneous nephrolithotomy. |
Q34473193 | Which muscarinic receptor is important in the bladder? |
Q97646930 | Who can safely evade a magnetic resonance imaging fusion-targeted biopsy (MRIFTB) for prostate imaging reporting and data system (PI-RADS) 3 lesion? |
Q53033210 | Who wants to go further has to know the past: A comment upon: Ultrasonography versus computed tomography for suspected nephrolithiasis-R. Smith-Bindman et al. N Engl J Med. 2014 Sep 18;371(12):1100-1110. |
Q38826188 | Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage |
Q47274638 | Wide-field autofluorescence-guided TUR-B for the detection of bladder cancer: a pilot study |
Q50251115 | William P. Didusch (1895-1981): an illustrator of urology |
Q49670696 | Worth a second look: outcomes of patients with initial finding of regular renal tissue in CT-guided renal tumor biopsies |
Q45916240 | X-ray-free percutaneous nephrolithotomy in supine position with ultrasound guidance. |
Q34039227 | XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence |
Q33757520 | XPA-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma |
Q52680358 | YRNA expression in prostate cancer patients: diagnostic and prognostic implications. |
Q34364431 | Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed? |
Q88504528 | Zero fluid balance and normotension prevents complications, not the amount of fluid per se |
Q38407501 | Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis |
Q41525439 | Zonal NephRo Score: external validation for predicting complications after open partial nephrectomy |
Q46113608 | [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy |
Q42479633 | beta2-microglobulin in patients with urothelial cancer |
Q91903781 | iPad-assisted percutaneous nephrolithotomy (PCNL): a matched pair analysis compared to standard PCNL |
Q36915110 | p53 and retinoblastoma pathways in bladder cancer. |
Q46558981 | ¹⁸F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer. |
Q44761271 | α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume |
Q83274848 | β-arrestin-2 is expressed in human prostate smooth muscle and a binding partner of α1A-adrenoceptors |
Q86617608 | β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection |
Q86361461 | βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma |
World Journal of Urology | wikipedia | |
World Journal of Urology | wikipedia |
Search more.